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Vascular cognitive impairment (VCI) describes a full spectrum of cognitive deficits caused by 
underlying cerebral vascular alterations, regardless of the specific mechanisms involved. 
Several factors such as ageing, stroke, hypertension and cerebral hypoperfusion are 
associated with an increased risk of developing VCI. Vascular dementia (VaD) is the second 
most common cause of dementia after Alzheimer’s disease (AD). It is now recognised that 
considerable overlaps exist between the features of VaD and AD. Key pathological and 
neuroimaging features including cerebral amyloid angiopathy (CAA), white matter lesions 
(WML), microinfarcts and microbleeds are evident in both VaD and AD. Furthermore, brain 
infarction has been reported to influence the presence and severity of clinical expressions 
such as cognitive performance of AD, suggesting a common pathophysiological mechanism 
that contributes to the development of cognitive deficits. However, gaps remain in 
understanding the exact mechanisms by which vascular risk factors contribute to cognitive 
decline and neurodegenerative processes leading to dementia. Given the importance of 
blood supply to the brain for maintaining its structural and functional integrity, it has been 
proposed that vascular risk factors may affect the cerebral haemodynamic and alter the 
vascular function resulting in damages to the brain. These changes may involve altered 
neurovascular coupling that is a critical mechanism for regulating the dynamic changes of 
local cerebral circulation. Further, impaired vascular function, amyloid-β (Aβ) accumulation in 
the cerebral vasculature and disrupted neurovascular unit are found in VCI. The glymphatic 
pathway, a clearance route for removing soluble waste from the brain to periphery, has been 
proposed to play a role in the pathogenesis of VCI. 
Mounting evidence has suggested that cerebral hypoperfusion, by large vessel occlusion 
and stenosis, is emerging as a major contributor to cognitive impairment. This has led to the 




narrowing both common carotid arteries by placing microcoils. The BCAS model has been 
reported to produce many features of VCI, including white matter damage, microglial 
activation, gliovascular disruption, increased oxidative stress (by increased NADPH oxidase 
2 (NOX2) levels) as well as memory impairment. To investigate whether there is an 
interaction between cerebral hypoperfusion and microvascular Aβ accumulation, a mixed 
model that demonstrates both microvascular amyloid (Tg-SwDI mouse model) and BCAS 
has been developed. In this thesis, it is hypothesized that the complex interaction of Aβ and 
BCAS leads to cognitive impairment via an impaired glymphatic function in addition to 
perfusion deficits that promote vascular related lesions and neurodegenerative changes. 
Second to this, given clear links between NOX2, hypoperfusion and amyloid accumulation, it 
was further hypothesised that NOX2 is a central mechanism leading to VCI. 
Methods 
Mice were given BCAS surgery to mimic cerebral hypoperfusion for a period of 3 months. In 
vivo laser speckle imaging was performed to evaluate the changes in cortical blood flow. 
This was followed by additional CBF measurements using arterial spin labelling (ASL)-based 
magnetic resonance imaging (MRI), which gave a non-invasive access to CBF information in 
the cerebral cortex, hippocampus and thalamus. Neurovascular coupling was assessed by 
performing whisker stimulation. Barnes maze was used to assess the spatial learning and 
memory function at 3 months following BCAS or sham surgery. For the examination of 
glymphatic function, in vivo intracisternal injection and ex vivo imaging of CSF fluorescent 
tracers were performed. Histological assessment and immunohistochemistry were used to 
examine vascular related pathology, Aβ burden, astrogliosis and basement membrane 
changes following BCAS.  
Results 
Part 1: To examine the effect of BCAS on cerebral perfusion deficits, glymphatic 




The first studies in the thesis sought to examine the effect of BCAS and microvascular 
amyloid on the extent of cerebral perfusion deficits and cognitive impairment. The first step 
was to validate whether the BCAS model has an effect on cerebral perfusion. Cortical 
cerebral blood flow (CBF) was examined by laser speckle imaging. This revealed sustained 
reductions of CBF at 24 hours, 1 and 3 months following the establishment of BCAS 
(p<0.001) but no effect of the microvascular Aβ was found to affect cortical perfusion 
(p>0.05). To further explore the CBF changes in other brain regions following BCAS, Arterial 
spin labelling (ASL), a technique widely used in clinical imaging, was performed. A 
significant effect of BCAS was confirmed in the dorsolateral cortex and hippocampus 
(p<0.001, respectively) but no genotype effect of the microvascular Aβ or any interaction 
was found (p>0.05, respectively). In order to investigate whether long-term carotid stenosis 
has a further effect on cognitive function in the experimental animals, assessment of Barnes 
maze demonstrated that BCAS mice spent longer escape latency than the sham mice in 
both wild-type and Tg-SwDI animals (p<0.05, respectively) indicating visuo-spatial learning 
was significantly impaired at 3 months following BCAS. To determine the effect of BCAS and 
Aβ on long-term memory, a probe test was taken to examine whether mice remember the 
previous training target after a period of time. This test revealed that all groups spent a 
significantly higher percentage of time than chance (25%). Exclusively in wild-type BCAS 
mice, the percentage of time spent in the target quadrant was significantly lower than by 
chance (p<0.05). In addition, there was no significant effect of BCAS or Aβ on the 
percentage of time spent in the correct quadrant (p>0.05, respectively). These results 
suggested long-term memory was not impaired in BCAS and the presence of amyloid. 
Further to enhance the detection of spatial learning and memory impairment, reversal trials 
were taken to evaluate the ability of experimental animals to learn a new location. Compared 
to wild-type mice that still learned the new tests showing significantly improved performance 
over time (p<0.05), both the Tg-SwDI sham and BCAS mice no longer learned the task 
(p>0.05). The long-term memory tested in reversal tests showed impairment in both wild-




difficulties in reversal probe tests. The results indicated the only mice from wild-type sham 
(37.40 ± 12.63) (p<0.05) spent a significantly higher percentage of time by 12.40 (95%CI, 
1.84 to 22.96) than by chance, t(7)=2.8, p=0.027 and a significantly higher percentage of 
time than Tg-SwDI BCAS mice (p<0.05) with all the other groups spending a lower 
percentage of time than chance (wild-type BCAS: 27.57 ± 11.12%, Tg-SwDI sham: 20.36 ± 
15.50%, Tg-SwDI BCAS: 26.79 ± 16.79%). 
To further explore the potential mechanisms by which BCAS causes cognitive impairment, 
the glymphatic entry was further assessed. This revealed that the global influx of CSF 
tracers was different across the anatomical levels (p<0.001) but unaltered post-BCAS in 
wild-type and Tg-SwDI mice (p>0.05, respectively). To explore whether BCAS influences 
CSF glymphatic influx, ex vivo images of the CSF tracer influx in the dorsolateral cortex (DL 
CTX) and hippocampus (CA1-DG molecular layer) on the D-3 tracer were measured. The 
results showed in both regions, altered CSF influx was found in the BCAS and Tg-SwDI 
mice due to the main effect of BCAS (p=0.037 and p=0.011, DL CTX and CA-DG regions 
respectively) but not Aβ (p>0.05, respectively). Taken together, these first studies support 
the original hypothesis that BCAS causes cognitive impairment via reduced cerebral 
perfusion and impaired glymphatic function. However, there was no exacerbation of these 
effects in Tg-SwDI mice. 
Part 2: To examine the effect of BCAS on neurovascular function, degenerative changes 
and amyloid accumulation in Tg-SwDI mice compared to wild-type mice. 
To begin with, responses of cortical blood vessels to whisker stimulation were recorded and 
quantified as the mean CBF percentage increase from the baseline. There was a significant 
effect of BCAS (p<0.001), whereby impaired neurovascular coupling was observed in the 
BCAS mice from both wild-type and Tg-SwDI mice. However, there was no significant effect 
of Aβ in these mice (p>0.05). Vascular related lesions including microinfarcts and 
microbleeds were compared by measuring the frequency in experimental animals. No 




found to have vascular lesions in the wild-type BCAS mice following 3 months of surgery. 
6/10 mice were identified with vascular lesions in the Tg-SwDI mice. No significant difference 
in proportions (p>0.05) was found between Tg-SwDI BCAS and wild-type BCAS mice. To 
discern the mechanisms by which BCAS and microvascular amyloid may impact on the 
glymphatic function, the extent of astrogliosis was further studied. GFAP immunostaining 
was undertaken to investigate the extent of reactive gliosis post-BCAS. Increased 
astrogliosis following BCAS was found (p<0.05), but no effect of Aβ or interaction was found 
in the dorsolateral cortex. The hippocampal CA1-DG molecular layer was further analysed, 
and this showed a significant effect of Aβ (p=0.002) but no effect of BCAS (p>0.05) and 
interactions (p>0.05) on astrogliosis. Further, Aβ load was evaluated in the cortex and co-
labelled with collagen 4 (COL4) (a marker of the basement membrane of blood vessels) to 
enable the assessment of microvascular amyloid in the Tg-SwDI mouse model. A significant 
increase in the total amount of amyloid as well as the percentage of vascular amyloid was 
detected post-stenosis (p<0.05, respectively). No changes of COL4 levels were found in the 
mice post-BCAS (p>0.05). In summary, these results demonstrated that BCAS impaired 
neurovascular coupling and promoted amyloid accumulation in the cerebral 
microvasculature.  
Part 3: To determine whether targeting NOX2 has an effect on cerebral perfusion, 
degenerative changes and cognitive impairment in Tg-SwDI mice compared to wild-
type mice. 
The third aim of the thesis was to determine the effect of NOX inhibitor (apocynin) on the 
previously reported cerebral hypoperfusion, impaired neurovascular coupling, development 
of neurodegenerative pathologies and cognitive deficits caused by BCAS in the Tg-SwDI 
mice. Following BCAS surgery, mice were immediately fed with either apocynin or vehicle in 
their drinking water for 3 months. Cortical CBF changes after the treatment of apocynin were 
assessed using laser speckle imaging, in apocynin treated mice, a recovery of CBF from the 




neurovascular coupling revealed that apocynin restored vascular function following carotid 
stenosis. A significant interaction between BCAS surgery and apocynin treatment (p<0.05) 
was found after 3 months of treatment. The mice that received 3 months of apocynin 
treatment showed a robust response during the stimulation. The frequency of vascular 
lesions was counted to compare whether inhibiting NOX activity could provide any beneficial 
effect on the development of vascular pathology. However, there was no significant 
difference in proportions between the mice treated with vehicle and apocynin (p>0.05). The 
cortical amyloid load was assessed by double labelling of COL4 and 6E10. The results 
revealed no effect of treatment on the Aβ burden and vessel densities compared to vehicle 
treated group (p>0.05). Finally, the cognitive function was assessed using Barnes maze. It 
demonstrated that apocynin did not improve spatial learning and memory in the behavioural 
tests (p>0.05, respectively). 
Conclusions 
The findings in this thesis demonstrate novel evidence of how carotid stenosis damages the 
cerebral microcirculation and structure, contributing to the pathogenesis of cognitive 
impairment. Specifically, long-term BCAS caused chronic cerebral hypoperfusion and 
impaired glymphatic function, which is likely to contribute to the accumulation of Aβ in the 
microvasculature. Additionally, carotid stenosis caused sustained cerebral hypoperfusion 
and led to impaired neurovascular coupling, neurodegenerative changes and cognitive 
deficits. However, despite evidence supporting a basis for targeting NADPH oxidase, there 
was only a modest beneficial effect of the NOX inhibitor on neurovascular function.  
Collectively, this thesis provides evidence that following the carotid stenosis, while reducing 
cerebral perfusion, the glymphatic drainage pathway may be affected, leading to cognitive 
impairment. This new data adds credence to a growing body of human studies that alternate 
mechanisms may exist in addition to cerebral hypoperfusion leading to VCI. The treatment 
with non-selective NOX inhibitor successfully restored blood perfusion and vascular function 




NOX to restore the full pathological processes in VCI. Thus, further studies using more 
specific method targeting post-carotid stenosis events will help to understand the proposed 






Vascular cognitive impairment (VCI) refers to the full spectrum of cognitive impairment (e.g. 
failure in memorising and reasoning, etc.) caused by damage to the brain blood vessels. 
Multiple vascular risk factors are associated with such vascular damage leading to the 
insufficient blood supply for delivering oxygen and nutrients to the brain. These affected 
vessels are either blocked by a clot or burst. Therefore, once the blood supply is cut off, and 
surrounding brain cells die. Damage to the brain blood vessels are also common in 
Alzheimer’s disease (AD), which is the most common type of dementia affecting memory, 
thinking skills and mental abilities. There are considerable overlaps between dementia 
caused by vascular damages and AD, suggesting a common mechanism may contribute to 
the development and pathogenesis of cognitive impairment. 
Brain hypoperfusion, a term used to describe the reductions in the brain blood flow due to 
the occlusion or narrowing of vessels, is emerging as a key mechanism leading to the 
decline of brain functioning. So far, significant gaps remain in our understanding and 
knowledge about VCI forming the basis of the studies within this thesis. It is yet not fully 
understood whether cerebral hypoperfusion interacts with vascular amyloid accumulation 
that is the pathological hallmark of AD and exacerbates the disease outcomes. Moreover, 
whether reductions in blood flow causes damage to the brain waste clearance system 
(glymphatic pathway) resulting in amyloid accumulation is not defined. It is also not clear 
whether targeting oxidative stress would prevent cognitive decline in response to reductions 
in blood flow. Multiple imaging techniques, tissue staining, and learning/memory tests were 
performed on mouse models to investigate the brain structural and functional changes 
following brain hypoperfusion. A surgery-induced mouse model of hypoperfusion and a 
transgenic mouse model of AD (Tg-SwDI) were used in the studies within the thesis. 
Collectively, the results suggest that sustained reductions in brain blood flow led to impaired 
vessel function, tissue damages and memory impairment. Impaired brain waste clearance 




contribute to the accumulation of amyloid in the blood vessel walls. The application of a safe 
and natural compound (apocynin) to inhibit the oxidative stress successfully improved brain 
blood supply, vascular function but did not prevent tissue damages and cognitive 
impairment. Thus, further studies using more specific method targeting hypoperfusion events 
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Chapter 1. Introduction 
 Overview 
The brain is an organ of high metabolic demand relying on the persistent supply of 
blood to maintain normal function. Several mechanisms, such as cerebral 
autoregulation and neurovascular coupling are responsible for regulating the 
dynamic changes of cerebral circulation. There is emerging evidence suggesting 
that vascular risk factors contribute to the functional and structural alterations in the 
cerebral vascular system leading to vascular damage. Cerebral vascular disease 
(CVD) is a significant factor associated with cognitive impairment and dementia, 
such as Alzheimer’s disease (AD). Key pathological and neuroimaging features 
including white matter lesions (WML), microbleeds, lacunes and enlarged 
perivascular space (PVS), which are evident in both Alzheimer’s disease (AD) and 
vascular dementia (VaD) (Dichgans and Leys, 2017). The considerable overlap 
between AD and VaD, representing the two most common causes of vascular 
cognitive impairment (VCI), suggest that a common pathophysiological mechanism 
involving cerebral vascular alterations, may contribute to the development of 
cognitive impairment.  
Cerebral hypoperfusion, induced by large vessel occlusion and stenosis is an early 
marker that can be detected before the onset of dementia symptoms (Iadecola, 
2013). Mouse models of cerebral hypoperfusion, induced by bilateral common 
carotid stenosis (BCAS), have been reported to disrupt the gliovascular integrity and 
cause cognitive deficits (Holland et al., 2015). Furthermore, cerebral hypoperfusion 
causes accumulation of Aβ, leading to the formation of cerebral amyloid angiopathy, 
microinfarcts and microbleeds via a potential mechanism of oxidative stress 




understanding about VCI as to whether there are alterations in vascular function 
following long-term perfusion deficits, cognitive impairment, and whether there is 
impaired Aβ clearance via the glymphatic pathway. It is also unclear whether there 
are further impacts upon vascular function, neurodegenerative changes following 
carotid stenosis and the variation in the presence of Aβ. The impact of blocking 
NADPH oxidase (NOX) by apocynin and possible improvement of perfusion deficits, 
neurovascular coupling and neurodegenerative changes remain to be investigated.  
 Cerebral blood flow and related control mechanisms  
 Fundamentals of CBF 
Cerebral blood flow (CBF) is defined as blood supply to the brain in a given period of 
time (Fantini et al., 2016). CBF levels are maintained within critical thresholds by 
homeostatic mechanisms to support healthy brain function. The brain is an energy-
demanding organ. While the brain is only 2% of the total body weight of a healthy 
adult human, it receives as much as 15-20% of the cardiac output and accounts for 
approximately 20% of the total energy consumption of a healthy adult at rest (Peters 
et al., 2004). Cerebral blood perfusion is responsible for delivering oxygen, an 
essential substrate for the neuronal oxidative metabolism of substrates, including 
glucose, ketone bodies and lactate. (Belanger et al., 2011). 
Cerebral circulation originates from two primary sources of blood perfusion: the 
anterior circulation and posterior or vertebrobasilar circulation. The anterior cerebral 
circulation is composed of branches of internal carotid arteries (ICA) that arise from 
common carotid arteries. Among these branches, anterior cerebral artery (ACA), 
middle cerebral artery (MCA), and the anterior choroidal artery (AChA) are arterial 
components with significant pathophysiological relevance. The function of the 




the forebrain, including the frontal, temporal, and parietal lobes. The anterior 
circulation also supplies other brain regions such as diencephalon and internal 
capsule. The posterior cerebral circulation is formed by two vertebral arteries (VA) 
that emerge from subclavian arteries. The vertebral arteries then merge 
intracranially becoming the basilar artery (BA) and further branch into posterior 
cerebral arteries. The cerebral anterior and posterior arterial circulation meet as the 
circle of Willis (Figure 1-1), a prominent landmark of anatomic variability located 
within the brain’s interpeduncular fossa surrounding the optic chiasm. The primary 
function of the circle of Willis is to form a collateral circulation to the brain. The circle 
of Willis is a network of cerebral blood vessels that provides connections between 
the vertebral and carotid circulations to ensure the brain does not lack blood and 
become affected by reduced blood flow when one system is occluded (Doyle et al., 
2012). Compared to humans, the B6 mice do not always have a complete circle of 
Willis (Barone et al., 1993, Kitagawa et al., 1998). It has been reported about 10% of 
B6 mice were found to have a complete circle of Willis, 60% were lacking posterior 
communicating artery (PComA) on one side and 30% were missing both PComAs 





Figure 1-1 Circle of Willis in human and mouse. 
Schematic diagrams show the human (left) and mouse (right) circle of Willis. The human circle of Willis 
consists of anterior cerebral arteries (ACA), anterior communicating artery (AComA), internal carotid 
arteries (ICA), posterior cerebral arteries (PCA) and posterior communicating arteries (PComA). In the 
C57Bl/6J mice, a deficient connection may occur between vertebral circulation and carotid circulation. 
Images were created in Biorender.com and edited in Inkscape. 
 Mechanisms that control CBF 
 Neurovascular coupling  
Neurovascular coupling, also referred to as functional hyperaemia, is a mechanism 
of local cerebral blood flow (CBF) regulation that ensures the adequate delivery of 
oxygen and energy substrates to the localised brain areas following changes in 
neuronal activity. Neurovascular coupling requires the finely tuned coordination and 
communication of multiple cell types: neurons, glial cells (e.g., astrocytes, microglia 
and oligodendrocytes) as well as mural cells (e.g., endothelial cells (ECs), smooth 
muscle cells (SMCs) and pericytes). These cells constitute a functional unit which is 
named the neurovascular unit. They work together, both temporally and spatially, to 




CBF (Iadecola, 2004, Iadecola and Nedergaard, 2007, Howarth, 2014, Iadecola, 
2017). The components of the neurovascular unit vary at different levels of the 
cerebrovascular tree (Figure 1-2). Pial arterioles are covered by thick SMCs layers 
and surrounded by subarachnoid space and innervated by nerve fibres originating 
from cranial autonomic and sensory ganglia. Penetrating arterioles enter the brain 
tissue and are surrounded by perivascular space which contains cellular 
components such as perivascular macrophages (PVMs). As the penetrating 
arterioles go deeper in the parenchyma, the perivascular space disappears, and 
arterioles become wrapped with astrocytic endfeet. Arterioles at this level contain a 
single layer of SMCs lacking the perivascular nerves. Capillaries that lack SMCs are 
endowed with pericytes, which are embedded in the basement membrane of the 
endothelium. Due to the close contact and communication between the critical 
cellular components of the neurovascular unit, this mechanism enables the brain to 
have the capacity to increase CBF and oxygen that exceeds the metabolic demand 





Figure 1-2 Structural diversity of neurovascular unit (NVU). 
Schematic diagrams demonstrate the structural differences at different levels along the cerebral 
vascular tree. (A) Neurovascular associations at pial arteries and penetrating arterioles level. (B) 
Neurovascular associations at intraparenchymal arterioles and capillaries level. Cerebral vasculature 
(green) and PVMs and meningeal macrophages (blue). Images are taken from The Neurovascular Unit 
Coming of Age: A Journey through Neurovascular Coupling in Health and Disease, reused with 






The specific mechanism of neurovascular coupling is not yet fully understood. 
Recent evidence suggests different mechanisms may exist at capillary and arteriole 
levels (Iadecola, 2017): Capillaries are ideally positioned to receive neuronal and 
astroglial signals. Therefore, it has been proposed that neurovascular coupling could 
be initiated at the capillary level and conducted to upstream along the cerebral 
vascular tree (Iadecola, 2004). Synaptic activity leads to an increased level of 
extracellular K+ and O2 utilisation. K+ activates inward rectifier potassium channels 
(Kir channels) located on the ECs and possibly pericytes, resulting in ECs 
hyperpolarisation. This hyperpolarisation propagates upstream via gap junctions on 
ECs and transmits to upstream penetrating arterioles. In the meantime, hypoxia 
causes increased deformability of red blood cells, leading to reduced viscosity and 
increased capillary blood flow. This causes shear stress on the capillary, which may 
cause hyperpolarisation of ECs to produce relaxation of SMCs by releasing 
endothelial vasodilators. At the level of intraparenchymal arterioles, the propagated 
response from capillaries is transferred to SMCs via myoendothelial junctions, 
leading to further relaxation and vasodilation. The vasodilation could be 
complemented by the vasoactive agents (nitric oxide (NO), adenosine, adenosine 
triphosphate (ATP), proteinoids, etc) released by nearby neurons and astrocytes 
during neural activity, which leads to sustain vasodilatory effects to upstream pial 
arterioles. Furthermore, the decrease in intravascular pressure and increased flow 
velocity induced by the downstream vasodilation may also lead to SMCs 
hyperpolarisation and relaxation by triggering myogenic response/flow-mediated 
vasodilation. At the level of pial arterioles, the haemodynamic response may not be 
driven directly by synaptic activity but depends on the retrograde propagation of 





 Alterations in neurovascular coupling 
A growing body of evidence has shown the disrupted neurovascular function in 
ageing and neurodegenerative diseases, such as Alzheimer’s disease (Duncombe 
et al., 2017b, Kisler et al., 2017). Most studies of the neurovascular alterations in AD 
have focused on the role of Aβ. Evidence from mouse models overexpressing APP 
provided evidence that Aβ can impair the neurovascular coupling leading to 
disruption in the cerebral microcirculation (Niwa et al., 2000, Iadecola et al., 1999, 
Tarantini et al., 2017). A common finding under these disease conditions is the 
mismatch between CBF, oxygen delivery, and local neuronal activity, suggesting 
compromised neurovascular unit integrity and functionality. Several mechanisms by 
which neurovascular coupling may be disrupted. A focus of this thesis is reactive 
oxygen species (ROS) that will be discussed in more detail in section 5 of this 
chapter. It is widely recognised that cells homeostasis is dependent on the well-
regulated levels of ROS. Excessive production of ROS induced by Aβ has been 
shown to induce vascular oxidative stress leading to attenuation of neurovascular 
coupling in a mouse model overexpressing mutant APP (Tg2576) (Park et al., 
2004a). Therefore, oxidative stress is believed to play a critical role in disruptions in 
neurovascular coupling (De Silva and Faraci, 2012, Takeda et al., 2009, Nicolakakis 
and Hamel, 2011, Chow et al., 2007, Zlokovic, 2005). 
 Cerebral autoregulation 
Another mechanism that ensures the brain receives a constant blood supply is 
cerebral autoregulation. Cerebral autoregulation is a homeostatic process that 
protects the brain from fluctuations in arterial pressure. In a healthy human, when 
the mean arterial pressure (MAP) fluctuates between 50~60 and 160 mmHg, there 
is minimal or no change in CBF level (Lassen, 1959, Cipolla, 2007). The underlying 




myogenic response, neurogenic, and metabolic mechanisms (Yang and Liu, 2017). 
The myogenic activity is referred to as the constriction or dilation of the vascular 
smooth muscle cell in response to an increased or decreased intravascular pressure 
(Osol et al., 2002, Cipolla et al., 2009). It is a critical mechanism for the vascular 
smooth muscle to maintain proper vascular resistance under physiological 
conditions. The neurogenic control on cerebral autoregulation has been suggested 
to have limited influence under physiological conditions. However, under severe 
pathophysiological situations such as vasospasm following stroke with compromised 
myogenic regulation, the sympathetic control of CBF may become a more critical 
mechanism regulating CBF (ter Laan et al., 2013). Cerebral autoregulation is 
proposed to be mediated by the vasoactive factors that regulate vascular resistance 
to maintain a constant blood supply. Inadequate CBF can stimulate the release of 
vasoactive substances from the brain leading to arterial dilation. Examples of 
vasoactive substances include adenosine, a by-product from the ATP metabolism 
when the neuronal energy demand overrides blood supply (Winn et al., 1985).  
 Alterations in cerebral autoregulation 
The main function of cerebral autoregulation is to stabilise blood supply to the brain 
during variations in perfusion pressure, thus defending the brain against risks 
caused by low or high systemic blood pressure (Claassen and Zhang, 2011). 
Impaired cerebral autoregulation has been seen in advancing ageing (Popa-Wagner 
et al., 2015). In animal models of AD producing Aβ protein, it has previously been 
reported that this vital mechanism is significantly affected. Work from Niwa et al. has 
shown that cerebral autoregulation was markedly disrupted in APP (+) mice and 
preserved in APP (-) mice. The disruption of autoregulation was paralleled by 
impairment in endothelium-dependent vascular responses. However, contrary to the 




preserved in humans. An earlier investigation in AD patients showed a preserved 
cerebral autoregulation during the disease by testing CBF responses to acute 
changes in arterial pressure (Simard et al., 1971). A recent study assessing cerebral 
autoregulation and baroreflex sensitivity in patients with dementia and mild cognitive 
impairment (MCI) showed no difference between these two mechanisms compared 
with controls (de Heus et al., 2018). Alterations in cerebral autoregulation may also 
occur in ischaemic brain injuries and lead to surviving brain tissue lacking protection 
against the potential damage subsequent to blood pressure changes. A review of 
transcranial Doppler (TCD) in combination with continuous blood pressure 
measurements has concluded impairment of cerebral autoregulation in several 
subtypes of ischemic stroke, and this is probably temporary and caused by stroke, 
or it may contribute to the stroke (e.g. in the case of chronic hypertension) (Aries et 
al., 2010).  
 Vascular cognitive impairment 
Dementia is one of the most significant public health issues affecting approximate 
35.6 million people worldwide with an estimated number increase to 66 million in the 
next decade and 115 million by the year of 2050 (Wortmann, 2012). Vascular 
dementia (VaD) is the second most common cause of dementia subtypes after 
Alzheimer’s disease (AD) (Lobo et al., 2000). VaD and AD mechanisms and 
pathology commonly occur together in dementia subjects. For instance, brain 
infarction may influence the presence and severity of clinical expressions such as 
cognitive performance of AD (Snowdon et al., 1997, Esiri et al., 1999). Furthermore, 
a large proportion of elderly dementia subjects present pathological evidence of 
neuritic plaques or neurofibrillary tangles alongside vascular pathology (Schneider et 
al., 2007). Recent multifactorial data-driven analysis from Alzheimer’s Disease 




is the earliest pathological feature in AD (Iturria-Medina et al., 2016). Although there 
are common overlaps between VaD and AD, these two dementias have been 
studied separately for many years. The medical terminology to describe the cerebral 
vascular disease (CVD) associated cognitive deficits has evolved. The current 
consensus is using the term of vascular cognitive impairment (VCI), which refers to 
all types of cognitive impairment that are associated with CVD (Skrobot et al., 2017). 
VCI encompasses a full spectrum of cognitive changes from mild cognitive 
impairment (MCI) to VaD, regardless of the specific mechanisms involved (Dichgans 
and Leys, 2017).  
 Pathogenesis underlying VCI 
The pathomechanisms underlying VCI are diverse. Theoretically, all causes of 
clinical stroke can result in brain damage and VCI (Figure 1-3). Given the 
importance of blood supply to the brain for maintaining its structural and functional 
integrity, it is evident that damage to the cerebral vascular system can influence 
brain function. Alterations in large and small blood vessels which cause perfusion 
deficits have been shown to have a significant impact on cognitive function. 
Dichgans et al. reported common mechanisms related to stroke aetiologies based 
on neuroimaging manifestations and pathological conditions including multiple 
infarcts, strategic infarcts, white matter lesion (WML) and lacunes, brain 
haemorrhages (including microbleeds), cerebral hypoperfusion, mixed vascular and 
Alzheimer’s disease, cerebral amyloid angiopathy (CAA) and CADASIL. (see 





Figure 1-3 Common mechanisms underlying VCI. 
Common pathogenesis underlying VCI includes all the aetiologies that can cause strokes, such as 
large artery occlusion and small vessel disease. In specific, white matter lesions (WML), microinfarcts, 
microbleeds, enlarged perivascular space (PVS), carotid stenosis, CAA and lobar haemorrhages. 




 Risk factors for VCI 
Evidence derived from several epidemiologic studies suggests that vascular risk 
factors are related to cognitive function (Li et al., 2011). Studies have identified 
several risk factors that increase the likelihood of developing cognitive impairment 
and dementia. Advanced age, poor diet, hypertension, atherosclerosis, 
hypoperfusion, amongst others, are known risk factors for the development of VCI. 
Gorelick et al. summarised a classification of risk factors according to their 
demographic, genetic, atherosclerotic and stroke-related features (Gorelick, 2004). 
Kalaria et al. also reviewed these risk factors and highlighted those modifiable or 
treatable risk factors for dementia with stroke-related injury (Kalaria et al., 2016). 
The demographic risk factors include older age, female sex and low education 
levels. In rare familial forms of the disease, such as cerebral autosomal dominant 
arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), cerebral 
autosomal recessive arteriopathy with subcortical infarcts (CARASIL) and 
COL4A1/COL4A2, gene mutations NOTCH3, HTRA1 and COL4A1/A2 are causal 
for the disease. However, more recently, it has been found that missense variants in 
these genes can be found in the general common population and increase risk 







Table 1-1 Risk factors of VCI. 





Advanced age No - (Pendlebury and 
Rothwell, 2009, Leys et 
al., 2005) 
Female sex No - (Lobo et al., 2000) 
Genetic 
factors 
No Yes APOE and MTHFR 






details in (Haffner et al., 
2016) 
Hypertension Yes Yes (Iadecola et al., 2016, 
Bucur and Madden, 




Yes Yes (Type 2DM) (Luchsinger et al., 2001, 
Saczynski et al., 2008, 
Peila et al., 2002, 




Stroke Yes Yes (Sahathevan et al., 2012, 
Gorelick, 1997) 
Hypoperfusion Yes Yes (Ruitenberg et al., 2005), 
(Wolters et al., 2017), 




Yes Yes (Johnston et al., 2004b, 
Romero et al., 2009, 
Arntzen et al., 2012, 
Hajjar et al., 2011, 
Flicker, 2010, Knopman 
et al., 2001) 
Cigarette 
smoking 
Yes Yes (Anstey et al., 2007) 
Data derived from several references: (Kalaria et al., 2016, Dichgans and Leys, 
2017).  
 Neuroimaging in VCI 
Neuroimaging techniques have been developed as powerful tools for the diagnosis 
of VCI. The visualisation of ischaemic and haemorrhagic brain injury of grey and 
white matter in VCI is constructive in the clinical evaluation when lacking the brain 
samples for definite pathological diagnosis. Current neuroimaging techniques 
provide essential information such as neuroanatomical alteration of the disease and 
add to the prediction of subsequent cognitive impairment. Different brain imaging 
methods allow the in vivo examination of the structure, function, metabolic state and 
biochemistry of the brain, which are expected to improve the diagnosis and to stage 




 Structural neuroimaging 
VCI manifests as white matter hyperintensities (WMH), lacunar infarcts, cerebral 
microbleeds and perivascular spaces (PVSs) identified by a neuroimaging modality 
(e.g. MRI) (Shi and Wardlaw, 2016, Wardlaw et al., 2013) (Figure 1-4). Findings of 
cerebral microinfarcts (CMI) on 3T MRI are particularly common in patients 
diagnosed with VaD (62%), AD (43%) and subjects with mixed AD vascular 
pathology (33%) (Brundel et al., 2012). Moreover, the frequent detection of CMI on 
MRI is observable after 12-month follow-up and therefore regarded as an MRI 
marker of CAA (van den Brink et al., 2018). A recent study using an MRI Double 
Inversion Recovery (DIR) sequence showed cortical ischaemic lesion burden is 
associated with carotid disease severity (Landi et al., 2015). The application of high-
resolution 7T MRI allows the detection of cortical microinfarcts in vivo for the 
neuropathological investigation of vascular lesions (van Veluw et al., 2013). PVS, 
also known as Virchow-Robin space, is a unique anatomical structure surrounding 
blood vessels filled with CSF/ISF. It is increasingly recognised as a vital marker 
associated with cognition and may have important clinical implications (see more 
information (Charidimou et al., 2013, Potter et al., 2015b, Riba-Llena et al., 2018, 
Ding et al., 2017, Kwee and Kwee, 2007)). The high-field 7T MRI also improved 
PVS detection, providing novel insights into the critical pathophysiological structure 
of VCI (Bouvy et al., 2016, Chen et al., 2011). Other MRI methods such as Diffusion 
tensor imaging (DTI) provide a unique sequence to characterise the location, 
orientation, and anisotropy of the brain white matter tracts. It enables the evaluation 
of specific WM integrity, revealing the microstructural changes that may not be 





Figure 1-4 Examples of images from MRI findings for lesions related to VCI. 
Example images of related lesions on human MRI scans. Subcortical infarcts, white matter 
hyperintensity (WMH), lacune, perivascular space (PVS) and microbleeds are features of VCI. Images 
adapted from (Wardlaw et al., 2013). 
 Arterial spin labelling in neuroimaging 
Cerebral vascular alterations are common pathological findings in aged and 
dementia subjects. Cerebral hypoperfusion as a result of the disrupted cerebral 
vascular system can be detected by arterial spin labelling (ASL)-based MR imaging 
techniques. ASL is an MR technique that is non-ionizing and completely non-
invasive for measuring tissue blood perfusion (Wolf and Detre, 2007). It utilises 
magnetically labelled arterial blood protons as an endogenous tracer. It provides a 
reliable and quantitative method suitable for measuring perfusion in healthy 
individuals and the population restricted by the exogenous contrast agents or 
radioactive agents. Clinical studies have demonstrated that ASL-based MRI detects 
hypoperfusion that is predictive of future functional and cognitive decline and the 
progression from MCI to dementia (Chao et al., 2010). Cerebral hypoperfusion and 
neurovascular uncoupling have been suggested to contribute to the pathogenesis of 
AD (Zlokovic, 2011). The presence of hypoperfusion occurs several years before the 
onset of clinical symptoms of AD. Therefore, CBF, as measured by ASL-based MRI, 
is considered a promising biomarker of AD, potentially even before the Aβ 




 Neuropathological diagnosis of VCI 
VCI is generally recognised as a net result of heterogeneous vascular lesions that 
cause impaired brain function. The pathological manifestations of vascular lesions 
are widely variable, and until the last few years, there has been no generally 
accepted protocol for post-mortem analysis for suspected VaD and VCI subjects. 
Cerebral vascular pathology, including microinfarcts, lacunes, brain haemorrhages 
and WML, is associated with cognitive decline (Snowdon et al., 1997, Launer et al., 
2011, Vermeer et al., 2003). Efforts have been made to develop a consensus of 
criteria for the diagnosis of VaD and VCI. Neuropathologists and other scientists 
from across the UK have collaborated to develop Vascular cognitive impairment 
neuropathology guidelines (VCING), that provide a validated consensus approach to 
the pathological assessment and scoring criteria of VCI. Seven pathologies are the 
most potent predictors of cognitive impairment: leptomeningeal CAA, large infarcts, 
lacunar infarcts, microinfarcts, arteriolosclerosis, perivascular space dilation and 
myelin loss (Figure 1-5) (Skrobot et al., 2016). These neuropathologies are focal, 
multifocal or diffuse vascular lesions and can coexist. The VCING demonstrates 
major progress in assessing the contribution of vascular pathology to cognitive 





Figure 1-5 Key pathologies confirmed in VCING that are predictive of cognitive impairment. 
In the VCING, univariable regression analysis shows that seven pathologies are significantly 
associated with cognitive impairment. Age, gender, APOE, and Braak stage were not associated with 
cognitive impairment (Skrobot et al., 2016). 
 Cerebral amyloid angiopathy, vascular dysfunction and VCI  
Cerebral vascular deposition of amyloid-β protein (Aβ) is a neuropathological 
hallmark of VCI and is a common finding in older adults. The Aβ deposits in the 




the form of cerebral amyloid angiopathy (CAA) (Figure 1-6) (Weller et al., 1998). 
Rare forms of familial CAA caused by specific mutations within the Aβ coding 
domain have amyloid deposition in the cerebral basement membrane and 
microvasculature (Levy et al., 1990, van den Boom et al., 2005). CAA is a risk factor 
in VCI that contributes to cognitive decline by promoting pathological consequences 
such as neuroinflammation, intracerebral haemorrhages, hypoperfusion and 
ischaemia associated with white matter hyperintensities and microinfarcts (Holland 
et al., 2008, Haglund et al., 2006, Dichgans and Leys, 2017, Chung et al., 2009, 
Okamoto et al., 2012, Rozemuller et al., 2005). There may be an interplay between 
Aβ accumulation and hypoperfusion/ischaemia, whereby perfusion deficits may also 
contribute to further Aβ accumulation as we have demonstrated previously in our 
group (Salvadores et al., 2017) and others (Kitaguchi et al., 2009, Huang et al., 
2012). As part of my thesis, I have aimed to investigate interactions between 
cerebral hypoperfusion and Aβ accumulation. There are also new emerging links 
between Aβ accumulation and impaired glymphatic function (Mestre et al., 2017), 
which form a central part of this thesis and will be discussed below. The potential 
role of cerebral hypoperfusion in the pathogenesis of VCI has been described in the 
figure below (Figure 1-7). 
The existing body of research on Aβ accumulation in the vasculature suggests that 
(Charidimou et al., 2012):  
1. Aβ is predominantly generated by neurons and subsequently aggregated in the 
cerebral vasculature (Herzig et al., 2006). The neuronal overexpression of mutant 
amyloid precursor protein (APP) leads to the formation of CAA (Calhoun et al., 
1999).  
2. In contrast to Aβ plaques, which are insoluble Aβ42 deposition in the 




walls of cerebral vessels. Therefore, an increased Aβ40:42 ratio may indicate the 
shifts of amyloid from parenchymal to the perivascular compartment (Herzig et al., 
2006).  
3. Vascular deposition of Aβ results from the impaired perivascular clearance rather 
than overproduction of amyloid. (Attems et al., 2011, Herzig et al., 2006, Bu, 2009). 
Emerging evidence suggests CVD may affect the drainage of Aβ along the 
perivascular routes, promoting the development of CAA. 
Aβ may cause brain injury through its complex effects on vascular function. Soluble 
Aβ can directly affect the endothelium-dependent vasomotor regulation of blood 
vessels (Dietrich et al., 2010). Reductions in cerebral blood flow are observed in 
transgenic mice overexpressing APP, preceding the formation of Aβ plaques (Niwa 
et al., 2002b). The Aβ disrupts the critical homeostatic mechanisms of cerebral 
blood flow; both cerebral autoregulation and neurovascular coupling were found 
markedly disrupted in transgenic mice studies (Niwa et al., 2002a, Niwa et al., 
2000). These effects involve endothelial dysfunction included by NADPH oxidase-
dependent oxidative stress (Thomas et al., 1996, Park et al., 2008).  
The histological examination of CAA requires staining methods such as Thioflavin-S, 
Congo red or immunohistochemical staining. Prussian blue (Perl’s) staining is useful 
to identify haemosiderin-laden macrophages related to CAA, suggesting chronic 
microbleeds (Figure 1-6F) (Serrano-Pozo et al., 2011). The characteristic 
histological alterations in CAA include the infiltration of Aβ in the media and 
adventitia, with smooth muscle cells replaced by Aβ deposition and acellular 
thickening of cerebral vessel walls (Kimbrough et al., 2015). The microvasculature 
becomes disrupted, demonstrating a “vessel-within-vessel” or “double-barrel” 











Figure 1-6 Amyloid accumulation in blood vessels in hAPPJ20 mouse and human post-mortem tissue. 
(A) High-resolution 3D rendering created from in vivo multi-photon imaging of a hAPPJ20 mouse (15-
months-old), where blood vessels are labelled with TRITC-Dextran (magenta) and vascular amyloid is 
labelled with methoxy-XO4 (green). Scale bar = 40 µm. (B and C) Regions partially covered or 
wrapped with vascular amyloid. (D) Image created from high-resolution confocal z-projection shows 
vascular amyloid in ring-like structures surrounding a vessel (subtracted from image) in an older 
hAPPJ20 mouse (27-month-old). Scale bar = 40 µm. (E) Post-mortem 7T MRI manifests a microbleed 
in the brain tissue of a patient diagnosed with dementia (81-year-old male) showing severe CAA on 
pathology. Corresponding haematoxylin and eosin (H&E) staining shows brown (haemosiderin) and 
yellow (haematoidin) deposits, indicating that this haemorrhage was not chronic but subacute. (F) 
Perl’s Prussian blue staining shows a cortical superficial siderosis of a patient with CAA. Blue deposits 
(haemosiderin) label microbleeds in the subarachnoid space (SAS) surrounding a leptomeningeal 
arteriole and in the superficial layers of the cortex. (G) Histopathological manifestation of a cortical 
microinfarct. Vascular amyloid accumulation is seen in the leptomeningeal vessels and cortical 





Figure 1-7 Potential pathways through which cerebral hypoperfusion causes accumulation of Aβ, 
vascular related damages and impaired vascular function.  
Possible mechanisms of cerebral hypoperfusion resulting in vascular cognitive impairment (VCI) 
include damage to the cerebral vasculature and disruption in the vascular function. As alterations in the 
blood vessels and their functional integrity may affect the glymphatic and perivascular drainage 
pathway, failure of the Aβ clearance may lead to its accumulation in the vascular walls. Oxidative 
stress, induced by cerebral hypoperfusion, may in turn promote the vascular damage and vascular 
dysfunction. Together, these processes may form a destructive combination responsible for 
accelerating the effects initiated by cerebral hypoperfusion and vascular Aβ accumulation may 
exacerbate the effects induced by cerebral hypoperfusion. 
 Experimental models relevant to VCI 
 Mouse cerebral hypoperfusion model 
The pathogenesis of VCI is still not fully understood this is in part due to the 
heterogeneity of the disease. Thus, animal models that recapitulate key pathological 
and behavioural features of human disease are critical to elucidate underlying 




reflects all of the features of the disease process of VCI. However, there are models 
that have been developed that are useful for investigating key aspects of the 
disease, as outlined below, and which have been studied as part of this thesis.  
Chronic cerebral hypoperfusion is closely associated with white matter pathology in 
VCI. As a result, models that mimic the reductions in perfusion were developed. 
Now a mouse model of Bilateral common carotid artery stenosis (BCAS) is the most 
promising for studying VCI (Venkat et al., 2015, Duncombe et al., 2017a). The 
BCAS model is induced by placing microcoils on both common carotid arteries 
(CCA) (Shibata et al., 2004). The selection of inner diameter for the microcoils is 
crucial since microcoils with varying inner diameters (from 0.16 to 0.22 mm) 
influence the degree of brain vascular injuries. A high mortality rate of 75% has been 
observed in mice when placing 0.16 mm microcoils after 14 days of BCAS surgery 
(Shibata et al., 2004). The 0.18 mm coil is the most acceptable setting as it provides 
expected pathological outcomes and an acceptable mortality rate. Extensive studies 
from our group and others have reported the pathophysiology identified in this model 
(Duncombe et al., 2017a). A common characteristic of this model is a modest 
reduction of mean cortical CBF of approximately 30-50% following BCAS surgery at 
24 hours (Hattori et al., 2016, Shibata et al., 2004, McQueen et al., 2014). Diffuse 
white matter pathology is detectable from 14 days in the corpus callosum, 
caudoputamen, capsule and optic tract. Diffuse white matter pathology is found 
throughout the brain, including damage to myelin integrity, degraded myelin, axons 
and microglia in the absence of grey matter damage (Coltman et al., 2011). 
Proliferation and activation of microglia in white matter have been repeatedly 
reported, indicating a pronounced inflammatory response following chronic cerebral 
hypoperfusion (McQueen et al., 2014, Shibata et al., 2004, Coltman et al., 2011, 




hypoperfusion, contributing to WM lesions (Holland et al., 2015, Nakaji et al., 2006). 
Furthermore, impaired cognitive function is a common finding in the short term and 
chronically hypoperfused animals. Selective working memory deficits are observed 
via 8-arm radial arm maze at 30 days following BCAS (Shibata et al., 2007). In 
longer-term (approximately 6 months old) hypoperfused mice spatial working 
memory, reference learning and memory were shown to be impaired using 
behavioural tests in a radial arm and Morris water maze (Nishio et al., 2010).  
There are several vessel occlusion models that produce cerebral hypoperfusion via 
permanent occlusion of common carotid arteries. The Bilateral common carotid 
artery occlusion (BCCAo) model was developed to mimic chronic cerebral 
hypoperfusion that is a common feature in human ageing and subjects with 
dementia. Extensive white matter damage, activation of microglia and astrogliosis 
were reported preferentially in the white matter (Farkas et al., 2004, Wakita et al., 
1994). Cognitive impairment and anxiety-related responses were seen in this model, 
tested by Morris water maze, open field test and elevated plus maze (Soares et al., 
2013). In BCCAo rats showing cognitive deficits, phosphodiesterase III inhibitor 
(cilostazol) was reported to promote differentiation and survival of oligodendrocytes 
and improve white matter damages (Miyamoto et al., 2010). Furthermore, 
permanent occlusion of a single common carotid artery (unilateral common carotid 
artery occlusion, UCCAO) in mice was reported to cause cognitive impairment 
following hypoperfusion with markedly increased pro-inflammatory cytokine 
interleukin-1 beta and interleukin-6 and decreased anti-inflammatory cytokines in the 
brain (Yoshizaki et al., 2008). 
 Spontaneously hypertensive stroke prone rats (SHRSP) 
Hypertension is a major vascular risk factor associated with pathophysiological 




Hypertensive Stroke Prone Rat (SHRSP) is a genetic rat model of severe 
hypertension and stroke with a genetic variant. It develops progressive hypertension 
from 8-9 weeks and severe hypertension with systolic pressure reaching 200 mmHg 
at about 12 weeks (Yamori, 1991). The SHRSP rat presents many features of VCI, 
such as cerebral infarction, haemorrhage and white matter damages. Since it is a 
genetic model altering the renin-angiotensin system, kidney and heart were also 
found to be affected (Kim et al., 1992). Gender differences have been reported and 
female rats appear to be less altered in endothelial cell dysfunction and 
inflammation (Ballerio et al., 2007). A recent study demonstrated that endothelial cell 
dysfunction is associated with white matter vulnerability via the secretion of shock 
protein 90α that affects the process of myelination (Rajani et al., 2018). It also 
showed that treatment with endothelial cell stabilising drugs reversed the observed 
pathologies and may be relevant to human VCI. 
 Animal models of amyloid accumulation 
Increased accumulation of vascular amyloid and cerebral amyloid angiopathy 
(CAA), are neuropathological hallmarks of VCI and closely linked to AD. Animal 
models have been developed as tools for elucidating the mechanisms and 
therapeutic approaches for vascular amyloid accumulation. In the past decade, 
several transgenic mouse models have been developed to express human amyloid 
precursor protein (APP) with mutations associated with familial forms of the disease. 
Many of these mouse models demonstrate accumulated vascular Aβ including CAA 
in addition to the extracellular accumulation of Aβ (Hsiao et al., 1996, Davis et al., 




 Tg2576 mice 
The Tg2576 mouse model is now one of the most well-characterised and commonly 
used models for AD preclinical studies (Hsiao et al., 1996). It expresses APP with 
the Swedish mutation KM670/671NL under a hamster prion protein cosmid vector. 
The hemizygous mice develop parenchymal Aβ plaques along with some amyloid 
accumulation in vessels by 11-13 months old. The Tg2576 mice exhibit many 
pathological features and cognitive impairment of AD, including increased Aβ 
production, Aβ42/Aβ40 ratio, plaque formation with associated age-dependent 
learning and memory deficits (Hsiao et al., 1996). The mouse model demonstrates a 
correlation between hippocampal dysfunction and the increased burden of 
extracellular Aβ42. Decreased dendritic spine density, impaired long-term 
potentiation and behavioural deficits occur months prior to the Aβ plaque deposition, 
and significant increases in astrogliosis and microglial activation could be observed 
in later stage at the 18 months of age (Jacobsen et al., 2006). Synapse loss may not 
be observed at an early age, but an increase of synaptophysin immunoreactivity can 
be detected and associated with the acquisition and spatial reference memory. This 
model has been used to examine the role of reactive oxygen species in behavioural 
dysfunction. This was reported that 12-15 months old Tg2576 mice lacking the 
catalytic subunit of NADPH oxidase 2 did not develop oxidative stress or 
behavioural deficits (Park et al., 2008).  
 Tg-SwDI mice 
Tg-SwDI mouse model is primarily designed to study microvascular accumulation of 
A. The Tg-SwDI expresses human neuronal amyloid precursor protein (APP), 
containing the transgenic Swedish K670N/M671L, Dutch (E693Q), and Iowa 
(D694N) mutations under the control of Thy1 promoter (Davis et al., 2004). In the 




those of endogenous mouse APP (Davis et al., 2004). Tg-SwDI mice demonstrate 
striking perivascular or vascular Aβ deposits closely associated with increased age 
(Davis et al., 2004). Tg-SwDI mice develop amyloid deposition with the high cerebral 
vascular association at an early stage starting at approximately 6 months of age. 
The amyloid depositions in the parenchyma are mostly deposited in the form of 
diffuse plaques that occur at about 3 months of age. Progressive and extensive Aβ 
deposits can be detected in the subiculum by 3 months, in the olfactory bulb, cortex, 
thalamus and basal forebrain by 6 months, and throughout the forebrain by 12 
months (Davis et al., 2004). Additionally abundant astrogliosis and activated 
microglia associated with vascular amyloid deposits were reported predominantly in 
the regions of thalamus and subiculum (Miao et al., 2005). The temporal and 
regional profile of the Aβ immunoreactive vessels showed a notable level of 
microvascular amyloid by 6 months old in the thalamus and subiculum. A significant 
increase of microvascular amyloid can be detected with increasing age in all 
investigated regions, including forebrain, thalamus and subiculum (Miao et al., 
2005). Occasionally, cerebral microhaemorrhages are observed in 12 month old 
mice and estimated to become more frequent as the mice age (Davis et al., 2004).  
ELISA analysis of tissue fractions from isolated vessels and microvascular-depleted 
parenchyma taken from Tg-SwDI mice revealed higher levels of Aβ40 than Aβ42 in 
both fractions (Davis et al., 2004). In response to cerebral hypoperfusion, a key risk 
factor of VCI, Tg-SwDI mice show significantly increased soluble Aβ levels 
(Aβ40/42) at 1 month that precede insoluble Aβ at 3 months (Salvadores et al., 
2017). Chronic cerebral hypoperfusion may increase the load of vascular Aβ, APP 
levels and processing through the mechanisms of pro-inflammatory and oxidative 
stress, leading to exacerbated cerebral microinfarcts and microhaemorrhages 




been reported in mice completing the Barnes maze task at 3, 9 and 12 months of 
age, tests/factors that are associated with the microvascular amyloid accumulation 
and neuroinflammation (Xu et al., 2007). Tg-SwDI is a unique mouse model well 
placed for studying microvascular amyloid. The model develops microvascular 
amyloid at an early stage of the mouse’s lifespan, exhibiting microvascular amyloid 
associated cognitive impairment, and a robust neuroinflammatory response.  
 Modulation of Aβ levels and accumulation and its implications 
for VCI  
Abnormal Aβ accumulation in the brain begins decades before the expected 
symptom onset, suggested to be mainly owing to the insufficient clearance of the 
deleterious peptide (Bateman et al., 2012, Panza et al., 2019). As indicated 
previously, there is substantive evidence showing Aβ has powerful detrimental 
effects on the vasculature. Soluble Aβ is a potent vasoconstrictor and increased 
vascular amyloid may contribute to localised microvascular inflammation, and 
degenerative changes such as haemorrhages and microinfarcts (Niwa et al., 2001b, 
Paris et al., 2000, Salvadores et al., 2017). Understanding how Aβ levels are 
modulated through increased accumulation and clearance out of the brain becomes 
extremely important since it might eventually provide strategies to remove excessive 
Aβ peptides and protect the brain.  
Aβ is removed from the brain by various mechanisms including enzymatic 
degradation, macrophage degradation, efficient clearance across the blood-brain 
barrier (BBB), ISF bulk flow, and CSF absorption into lymphatic systems (Figure 
1-8) (Tarasoff-Conway et al., 2015). Among these mechanisms, the perivascular or 
glymphatic clearance of soluble Aβ has been gaining surprising interest and 
progress since the failure of Aβ clearance is recognised as a critical mechanism 





Figure 1-8 Schematic diagram shows proposed pathways for Aβ clearance. 
Major pathways for the clearance of Aβ in the brain. Image is taken from Clearance systems in the 
brain-implications for Alzheimer disease, with permission of right holder (Tarasoff-Conway et al., 2015). 
 The glymphatic system 
One primary functional clearance mechanism involved in waste elimination and its 
drainage from the CNS is the glymphatic system. The glymphatic system is 
described as a macroscopic waste clearance pathway that relies on CSF movement 
via the perivascular tunnels, mainly comprised of astrocytes, to promote the 
clearance of solutes and metabolites from the CNS (Figure 1-9). The glymphatic 
system may also facilitate the brain-wide distribution of many compounds in the 
CNS, including glucose, amino acids and neuromodulators (Jessen et al., 2015). 




owing to its dependence on the glial water flux as well as the lack of conventional 
lymphatic vessels in the brain.  
 Anatomy of the glymphatic system 
In 2012, Iliff et al. reported the glymphatic system using advanced intravital two-
photon imaging that confirmed Rennels’s previous work (Rennels et al., 1990, 
Rennels et al., 1985). In the Iliff study, fluorescently labelled CSF tracer appeared in 
the perivascular space (PVS) of surface arteries within 5 minutes of administration in 
cisterna magna (CM), then subsequently moved deeper into the parenchyma within 
the PVS and basement membrane of penetrating arteries (Iliff et al., 2012). The 
spatial distribution of the CSF was validated using Tie2-GFP: NG2-DsRed double 
reporter mice that showed fluorescent ovalbumin flowed into the brain specifically 
within the arterial PVS between the smooth muscle and the astrocyte end-feet of the 
glial limitans (Iliff et al., 2012). Over the subsequent 3 hours, fluorescent ovalbumin 
was found within the basement membranes of capillaries and in the PVS of large 
draining veins (Iliff et al., 2012). Besides perivenous conduits, more recent studies 
reported exit routes of CSF clearance from the brain, perineural routes and 
meningeal lymphatic vessels were exit pathways potentially serving the glymphatic 
system (Eide et al., 2018, Ma et al., 2017b).  
The cerebral vasculature plays a unique role in the glymphatic system. As reviewed 
in previous sections, the cerebral anterior and posterior circulation unite via 
communicating arteries at the basal circle of Willis. The anterior circulation supplies 
the neocortex of cerebral hemispheres, while the posterior circulation mainly 
supplies the brain stem and cerebellum (Prince and Ahn, 2013). Jessen et al. have 
reviewed the specific anatomy involved in the glymphatic system (Jessen et al., 
2015). Cerebral arteries on the brain surface give rise to pial arteries running within 




parenchyma and become penetrating arteries that form a PVS. The PVS is also 
termed Virchow-Robin spaces, filled with CSF and covered with leptomeningeal 
cells between the outmost layer of a blood vessel and astrocytic endfeet. A 
characteristic of the cerebral vasculature is that almost all arterioles, capillaries and 
venules within parenchyma are covered by astrocytic endfeet, forming a donut 
shaped tunnel surrounding vessels. The PVS gradually becomes continuous with 
the basal lamina as the arterioles penetrate deeply into parenchyma. The basal 
lamina, also known as basement membrane, is a specific type of extracellular matrix 
comprised of a mixture of laminin, COL4, nidogen, and heparan sulfate 
proteoglycans (Thomsen et al., 2017). In the brain, endothelial cells, astrocytes and 
pericytes reside within the three-dimensional protein network and interact with 
neurons and smooth muscle cells. The low resistance of basal lamina enables the 
CSF influx from the PVS to flow deep into the brain parenchyma, enter the basal 





Figure 1-9 Proposed glymphatic CSF influx route. 
CSF moves from the subarachnoid space into perivascular space, penetrating artery branch into 
arteriole and capillary level the perivascular space narrows and merged with basal lamina (Jessen et 
al., 2015). Image is taken from The Glymphatic System: A Beginner’s Guide, with permission of the 
right holder. 
 Driving forces in the glymphatic pathway 
The primary role of the glymphatic pathway has been reported as performing a 
waste clearance pathway in the neurophysiology. Therefore, it becomes critical to 
understand the factors that drive the glymphatic influx. Since the concept of 




matrix, it is believed that any conditions influencing the integrity of the cellular and 
functional components within the system will direct the transport of CSF in the brain.  
Benveniste et al. have summarized several factors which drive the glymphatic 
transport: 1. Arterial pulsation; 2. CSF transport and production; 3. State of arousal; 
4. AQP4 water channels. Iliff et al. first demonstrated that unilateral ligation of 
internal carotid artery reduced arterial pulsation leading to the reduced rate of CSF-
ISF exchange, while increased pulsatility of penetrating arteries resulted in 
enhanced CSF-ISF exchange (Iliff et al., 2013b). In late 2018, Mestre et al. used 
adapted in vivo two-photon imaging quantitatively measured CSF speed within the 
PVS/basement membrane simultaneously with cardiac and respiratory cycles, 
providing direct evidence that arterial pulsation drives CSF flow, at the same 
frequency as the cardiac cycles and the same direction of blood flow (Mestre et al., 
2018b). While there were other claims that diffusion, a mechanism dependent on a 
solute’s MW, govern the glymphatic fluid transport (Smith et al., 2017, Asgari et al., 
2016). It is now likely the transport of glymphatic flow is governed by a mixed 
process of “convection” that includes both advection and diffusion, and each may 
have a variable contribution in different regions across the brain. Constant CSF 
production by the choroid plexus in the lateral ventricles and CSF reabsorption 
creates a pressure that drives the fluid flow through the ventricular system to the 
subarachnoid space. The normal production and transport of CSF may influence the 
glymphatic flow via a mechanism involving intracranial pressure (ICP) (Plog et al., 
2015). The state of arousal has been reported to affect the glymphatic influx. In a 
study, Xie and colleagues reported natural sleep or anaesthesia led to a 60% 
increase in the interstitial space, subsequently causing a striking increase in CSF-
ISF exchange, that improved clearance of Aβ (Xie et al., 2013). There is a debate 




glymphatic system. AQP4 water channels are expressed in astrocytic endfeet that 
ensheathe the cerebral vasculature. In the healthy brain, the transport of convective 
bulk fluid is facilitated by AQP4 water channels, and reactive astrogliosis induced by 
disease conditions are thought to cause mislocalization of AQP4 from the astrocytic 
endfeet to its soma (Iliff and Nedergaard, 2013). Mice lacking the AQP4 in 
astrocytes demonstrated reduced CSF influx and a significant reduction in the 
clearance of ISF solutes, including mannitol and Aβ (Iliff et al., 2012). Thus, the 
reduced CSF solutes influx and clearance in AQP4–/– mice supported the concept 
that AQP4 is necessary for the transport of glymphatic flow. 
The main issue is the proposed role of AQP4 in the transport of soluble solutes. 
Smith et al. re-examined the role of AQP4 in the solute movement in mouse brain 
following administration of tracer into the brain or parenchyma (Smith et al., 2017). 
First, they reported a size-dependent manner of CSF trace transport supporting a 
diffusion mechanism. This finding has been recently questioned by the evidence 
provided by Mestre and colleagues that clearly showed the in vivo pulsatile manner 
of CSF tracer transport in the PVS/basement membrane (Mestre et al., 2018b). 
Second, the transport of fluorescent tracer was reported not to be affected after 
cardiorespiratory arrest, whereas this conclusion has been challenged by the 
simultaneously measured cardiac and respiratory frequency, showing the CSF flow 
driven by cardiac cycle and reduced in hypertension. Third, Smith and colleagues 
also claimed that AQP4 gene deletion did not impair the CSF influx in both mice and 
rat models. Followed by a multicentre validation of AQP4 knock-out lines that CSF 
influx was shown to be higher in wild-type mice than AQP4 KO lines (Mestre et al., 
2018a). Accordingly, hydraulic forces associated with arterial pulsation, AQP4 water 
channels, and physiological CSF production absorption as well as sleep are 




 Imaging the glymphatic pathway 
There have been several approaches developed to visualise the glymphatic system. 
Ex vivo imaging is a commonly used method for the analysis of glymphatic system. 
It is performed by ex vivo imaging with thick brain sections following in vivo 
administration of CSF tracers (Iliff et al., 2012). It provides the high spatial resolution 
that enables the investigation of glymphatic function from the cellular to the brain-
wide level depending on the scale of the selected region of interests. This method is 
advantageous when assessing multiple markers in relation to glymphatic flow. It 
allows the use of immunohistochemical staining and transgenic reporter animals for 
labelling astrocytes, endothelial cells, and other cellular components within the NVU.  
In vivo two-photon imaging is a powerful tool in animal studies investigating the 
glymphatic system. A craniotomy is required to implant a glass window that allows 
an optimal depth of a few hundred micrometres for imaging. This method provides 
high spatial resolution, real-time monitoring of the fluorescent tracer’s transport. It 
can be used on transgenic reporter mice (Tie2-GFP: NG2-DsRed) to study the 
features of glymphatic influx, enabling the arteries and veins to be distinguished (Iliff 
et al., 2012).  
Transcranial macroscopic imaging is another in vivo imaging technique providing 
global information of the glymphatic pathway. It is less invasive than two-photon 
imaging but provides relatively lower spatial resolution. Other modalities for imaging 
glymphatic system include MRI and PET scans. MRI and PET scans are used in 
both clinical settings and basic research due to their least invasive feature compared 
to other imaging methods. For instance, contrast-enhanced MR has been used to 
demonstrate the CSF-ISF exchange in rodents following intrathecal paramagnetic 
contrast agent injection (Iliff et al., 2013a). In a recent study, intrathecal 




followed by multiple MRI exams showed the promise of assessing human 
glymphatic function (Ringstad et al., 2017).  
 Implications of the glymphatic system in AD and CVD 
Impaired glymphatic clearance has emerged as an essential mechanism in CVD 
and dementia. This conceptualised pathway allows the CSF-ISF exchange and 
downstream outflow of ISF and solute like Aβ to drain out of the brain. There is 
increasing evidence suggesting advanced age, acute ischaemic stroke and multiple 
infarcts impact on the glymphatic drainage (Gaberel et al., 2014, Kress et al., 2014, 
Wang et al., 2017). The glymphatic system also has important implications for 
understanding CAA, the primary Aβ40 deposition in the walls of penetrating and 
leptomeningeal arteries clinically associated with lobar haemorrhages (Attems et al., 
2011). The movement of CSF containing Aβ peptides along the periarterial spaces 
is a critical process for downstream drainage and disturbance to this pathway may 
contribute to the Aβ accumulation in the vessel walls. Importantly, in the settings of 
ageing and AD, vascular abnormalities, reactive astrogliosis, enlarged perivascular 
spaces and altered extracellular matrix are common findings that may directly affect 
the glymphatic system.  
 Oxidative stress is a link between vascular risk factors and 
CVD 
 Oxidative stress 
Oxidative stress is considered to play a significant role in the ageing process and 
neurodegenerative diseases. It is defined as an imbalance between the levels of 
free radicals and antioxidants in a biological system. Although the exact 
mechanisms behind the alterations of the cerebral vascular system and brain cells in 




oxidative damage caused by excess reactive oxygen species (ROS) is one of the 
most convincing theories. ROS includes radical species (e.g. superoxide anions and 
hydroxyl radicals) as well as non-radical oxidant (e.g. hydrogen peroxide). ROS can 
be produced by a variety of biomedical processes such as mitochondria, NADPH 
oxidase, nitric oxide (NO) synthase and xanthine oxidase (Starkov, 2008, 
Dworakowski et al., 2006, Porasuphatana et al., 2003, Kelley et al., 2010). Low 
levels of ROS demonstrate a physiological role modulating normal cellular function 
and redox signalling (Remacle et al., 1995, Schieber and Chandel, 2014). ROS are 
short-lived and readily react with a variety of substrates such as proteins and lipids 
to initiate neuronal cell death and neurodegeneration through different downstream 
pathways (Barnham et al., 2004).  
 Targeting NADPH oxidase mechanisms 
Although there are multiple enzymes and metabolic processes that can produce 
ROS, the key producers of ROS in brain cells are NADPH oxidase (NOX) family, 
including seven multisubunit enzymes with various tissue and cell distributions 
(Panday et al., 2015). The NOX isoforms consist of NOX1-NOX5, dual oxidase 1 
(DUOX1) and DUOX2, all of which produce superoxide except NOX4 producing 
hydrogen peroxide. NOX2, formerly known as gp91phox, is expressed in various 
cell types in the brain, including neurons, endothelial cells, and microglia 
(Chrissobolis et al., 2012, Brandes, 2003, Surace and Block, 2012). NOX2 is widely 
distributed in various tissues such as cerebral endothelium. The cerebral 
vasculature is a major target of oxidative damage, and emerging evidence indicates 
a direct link between cerebral vascular injuries and cognitive impairment.  
The activation of NOX2 is a critical source of the neurovascular oxidative stress 




of six different subunits that assemble to form an active enzymatic complex for the 
generation of superoxide (Figure 1-10) (Drummond et al., 2011). Two subunits 
gp91phox and p22phox are integral membrane-bounding proteins that form the 
heterodimeric flavocytochrome b558 (cyt b558) complex. Unstimulated subunits 
p67phox, p47phox, p40phox and GTPase RAC bind together as a complex in the 
cytosol, while upon stimulation the p47phox becomes phosphorylated and 
subsequently, this complex translocates to the membrane and interacts with cyt 
b558 to generate active oxidase. Activated gp91phox interacts with NADPH then 
convert molecular oxygen (O2) to superoxide (O2-), which participates in various 
harmful processes. Released superoxide (O2-) is highly reactive. It quickly reacts 
with iron to generate reactive hydroxyl radical, or in the presence of nitric oxide (NO) 






Figure 1-10 Schematic diagram shows the inactivated and activated forms of NADPH oxidase 2 
(NOX2). 
The NOX2 consists of six different subunits that assemble to form an active enzymatic complex for the 
generation of superoxide (O2-). The catalytic subunit gp91phox combines with p22phox forming the 
membrane-bounding complex (cyt b558). In the cytosol, p67phox, p47phox, p40phox form a cytosolic 
complex and bind with GTPase RAC then translocate to membrane docking with cyt b558 complex. 
Upon the activation, NADPH is processed by activated NOX2 and generate superoxide (O2-). 
 NOX in cerebral vascular disease  
NOX isoforms, including NOX1, NOX2, NOX4 and NOX5 in the blood vessel walls 
are described by Drummond et al.(Drummond et al., 2011). NADPH oxidase-
dependent oxidative stress has been implicated in many vascular pathological 
conditions such as hypertension, diabetes, cerebral haemorrhagic and ischaemic 
brain injuries (Rajagopalan et al., 1996, Gill and Wilcox, 2006, Ayer and Zhang, 
2008, Tang et al., 2012). Increased NOX activity is associated with CVDs and their 




the absence of these oxidases demonstrated protective effects against vascular 
injuries (Matsuno et al., 2005, Walder et al., 1997).  
Recent studies have shown that increased activation of NOX1, NOX2 and NOX4 are 
associated with ROS production and pathological processes after cerebral 
ischaemia (Choi et al., 2015, Yoshioka et al., 2011, Kleinschnitz et al., 2010). In 
particular, NOX1 expression was increased and associated with oxidative damage 
to DNA in vulnerable brain regions following experimental stroke (Choi et al., 2015). 
In mice subjected to middle cerebral artery occlusion (MCAO) followed by 
reperfusion, increased NOX2 activity resulted in oxidative stress and vascular 
dysfunction (De Silva et al., 2011). Upon acute stroke, NOX4 has been reported as 
a significant source of oxidative stress in human and mouse brains and proposed as 
a novel drug target for stroke therapy (Kleinschnitz et al., 2010). Furthermore, in 
cerebrovascular disease models such as global cerebral hypoperfusion, an increase 
of NOXs activity and expression lead to cognitive impairment via oxidative stress- 
apoptosis signal-regulating kinase 1 (ASK1) pathway. Pharmaceutical inhibition of 
NOX enzymes by NOX inhibitor apocynin improved cognitive function in mice 
subjected to BCAS surgery (Toyama et al., 2014). Ansari et al. have studied the 
various protein components of NOX2 in the post-mortem human brain samples and 
demonstrated increased levels of cytosolic subunits p67phox, p47phox and 
p40phox, but membrane-bound subunits (gp91phox) and p22phox) remained stable 
with the progression of AD (Ansari and Scheff, 2011). Clinical data also 
demonstrated that NOX isoforms (p47phox and gp91phox) expression and activity 
significantly increased in the mild cognitive impairment (MCI) patients suggesting 




 NOX inhibitors 
Mounting evidence suggests that NOX inhibition is neuroprotective against various 
brain pathological processes such as ischaemic damage. Several pharmacological 
compounds have been discovered to target NOX enzymes. Of all these compounds, 
apocynin and diphenyleneiodonium (DPI) are the most widely studied. Although 
these compounds have demonstrated a promising future for the therapeutic 
purpose, inhibitors with higher specificity and selectivity are still highly sought after 
to ensure the clinical application. 
 Diphenyleneiodonium (DPI) 
DPI was demonstrated to protect the brain by inhibiting the flavoprotein from 
preventing the production of superoxide. In the experimental rat model of stroke 
followed by reperfusion (MCAO/R), a combination of DPI and dimethylsulfoxide 
(DMSO) reduced infarct sizes and BBB damage and improved neurological outcome 
(Nagel et al., 2007). DPI also protected the brain by not only suppressing oxidative 
stress induced by transient focal cerebral ischaemia but also limiting leukocytes 
migration and infiltration (Nagel et al., 2012). However, DPI shows poor selectivity of 
all NOX isoforms and reacts with flavin adenine dinucleotide (FAD)-containing 
enzymes that play a role in many metabolic pathways (Kahles et al., 2007). 
 Apocynin 
Apocynin, also known as acetovanillone, is an oxidase assembly inhibitor that 
prevents the p47phox subunits binding with membrane-bound heterodimer 
(Drummond et al., 2011). It is derived initially from Apocynum species that has been 
used by Chinese and South Asian people to manage inflammatory diseases 




safety profile in a variety of studies (Yu et al., 2008). The intraperitoneal 
administration of apocynin in mice models of global cerebral ischaemia showed a 
neuroprotective effect on spatial learning and memory (Shen et al., 2011). CAA is a 
pathological hallmark in AD and characteristic finding in CVD. Han et al. reported 
ROS contributed to the formation of CAA, vascular function and microhaemorrhages 
in a mouse model of AD (Han et al., 2015). NOX-derived ROS is shown to mediate 
CAA-induced cerebral vascular injuries. The inhibition of NOX by apocynin 
successfully reduced oxidative stress that improved vascular reactivity in Tg2576 
mice. The improved vascular function is potentially attributed to reduced CAA. 
Interestingly, apocynin is reported to down-regulate the expression of ApoE that is a 
crucial factor in promoting CAA formation.  
 Summary 
Multiple vascular risk factors cause damage to the cerebral vascular network 
contributing to neurodegenerative changes (such as WMH, microbleeds and 
microinfarcts) leading to VCI. These types of vascular related changes are also 
present in AD (Skrobot et al., 2016). The considerable overlap between the 
pathology of AD and VaD suggest a common pathophysiological mechanism that 
contributes to cognitive impairment and neurodegeneration, resulting in dementia. 
Further, increased microvascular amyloid deposition and CAA increases the risk of 
stroke lesions (Okamoto et al., 2012, Soontornniyomkij et al., 2010) suggesting a 
vicious cycle of events. 
As outlined previously, sustained reductions in blood flow are emerging as a critical 
contributor to VCI promoting brain microvascular pathology, leading to cognitive 
deficits and dementia. In order to investigate the underlying mechanism, the BCAS 




amyloid deposition in pathomechanisms, a transgenic mouse model of 
microvascular amyloid has been developed. These models additionally allow 
interactions between carotid stenosis and amyloid accumulation to be investigated. 
Related to this work impaired glymphatic function is emerging as a key player in 
vascular disease and dementia and regulator of amyloid clearance. However, 
whether glymphatic function is altered with carotid stenosis remains to be 
determined. These gaps in pre-existing knowledge form the basis of the studies 
within the thesis.  
 Hypothesis 
It is hypothesized that the complex interaction of AD and carotid stenosis leads to 
cognitive impairment via impaired glymphatic function in addition to perfusion 
deficits that promote vascular amyloid accumulation. Moreover, given clear links 
between NOX2, hypoperfusion and amyloid, it was further hypothesised that NOX2 
is a central mechanism leading to VCI. 
 Study aims 
In this thesis, CBF changes following BCAS was the primary outcome of interest 
and glymphatic function, cognition, vascular function, vascular related pathology, 
neurodegenerative changes, and amyloid burden as well as the effect of NOX2 
inhibitor treatment were considered as secondary outcome of interest. These 
following study aims were investigated in chapter 3, 4 and 5: 
Aim 1: To examine the effect of BCAS on cerebral perfusion deficits, glymphatic 
function and cognition in Tg-SwDI mice compared to wild-type mice.  
Aim 2: To examine the effect of BCAS on neurovascular function, degenerative 




Aim 3: To determine whether targeting NOX2 has an effect on cerebral perfusion, 
degenerative changes and cognitive impairment in Tg-SwDI mice compared to wild-




Chapter 2. Material and methods 
 Animals 
All experimental animals used in the present thesis were conducted following the UK Home 
Office Animals (Scientific Procedures) Act 1986 and additional local ethical and veterinary 
approval (Biomedical Research Resources, University of Edinburgh). Mice were group held 
in standard cages with bedding, food, water and nestles under 12 h dark/light cycles. Male 
Tg-SwDI mice and wild-type C57Bl/6J littermates were bred in-house (a number of wild-type 
C57Bl/6J mice were imported from Charles River Laboratories Inc, UK). Tg-SwDI mice were 
used as an AD model to study microvascular amyloid accumulation. Tg-SwDI mice are 
known to express human neuronal amyloid precursor protein (APP), containing the 
transgenic Swedish K670N/M671L, Dutch (E693Q), and Iowa (D694N) mutations under the 
control of Thy1.2 promoter (Figure 2-1) (Davis et al., 2004). Surgeries including both sham 
and bilateral common carotid stenosis (BCAS) surgery were performed by an independent 
researcher. The mice were coded to ensure the surgery they received, and their genotypes 
were blinded from the researcher who completed the rest of the experiment. The detailed 
information regarding the age, gender, genotype and number of animals used in each study 
are described in the corresponding methods sections in Chapters 3, 4 and 5.  
The group size was decided based on power calculation of previous CBF data from arterial 
spin labelling (ASL), since CBF changes were considered as the primary outcome measure. 
A minimum group size of n=8 was required to achieve a significance value of p<0.05 at a 





Figure 2-1 Schematic diagram shows Thy1.2 promoter-transgenic human SwDI mutant APP construct. 
The Tg-SwDI mice express human APP gene, isoform 770, containing the Swedish 670N/671 L, Dutch (639Q) 
and Iowa (694N) mutations under the control of Thy1.2 promoter. 
 Bilateral common carotid stenosis (BCAS) surgery 
Mice were anaesthetised initially by 5% isoflurane in oxygen and then maintained under 
1.5% isoflurane/oxygen mix. After the incision area was shaved and cleaned with iodine, a 
midline incision is made and tissues dissected to reveal the common carotid arteries. These 
were isolated using silk threads (size: 4/0) and microcoils applied (0.18mm internal diameter, 
Sawane Spring Co, Shizuoka, Japan) permanently to both common carotid arteries (Figure 
2-2). Details of surgical methods have been outlined in previous studies (Shibata et al., 
2004, Coltman et al., 2011, Reimer et al., 2011a, Holland et al., 2011b). A 30 minutes 
interval was given between the application of the two microcoils to minimise the effects of 




underwent the identical procedure except for the application of microcoils to both arteries. 
Surgery was conducted by Prof. Karen Horsburgh.  
 
 
Figure 2-2 Demonstration of bilateral common carotid stenosis induced by placing microcoils. 
The microcoils are placed on the common carotid artery of a C57BL/6J mouse by surgical procedure (only one 
side is shown as an example). The microcoils used in the current thesis was made from piano wire with a wire 






 Administration of NOX inhibitor apocynin  
Apocynin is a non-specific NADPH oxidase assembly inhibitor that prevents the p47phox 
subunits binding with membrane-bound heterodimer (Drummond et al., 2011). Following the 
establishment of hypoperfusion, mice were given either via vehicle or apocynin (Sigma, UK) 
ain their drinking water at a dose of 30 mg/kg/day. A stock of apocynin was prepared and 
stored at -20 °C and deforested with light protection before the administration. Apocynin and 
vehicle were changed three times a week with maximal duration less than three days to 
maintain freshness. The consumption of apocynin and water were monitored throughout the 
study.  
 Cerebral blood flow measured by MR arterial spin labelling (ASL)  
A 7.0T Agilen (Varian) preclinical MRI system was used to collect T1-weighted and arterial 
spin labelling (ASL) data (Figure 2-3). Experimental animals were anaesthetised under 5% 
isoflurane in oxygen for induction then placed in an MRI compatible holder (Rapid 
Biomedical, Wurzburg, Germany). Isoflurane was maintained at 1.5% in oxygen during 
scanning. Rectal temperature was monitored and regulated at around 37 ºC by an airflow 
heating system. Respiratory rate was maintained at 70-100 breaths per minute. The T1-
weighted images were acquired at 1.7 mm posterior to Bregma in stereotactic coordinates of 
Mouse Brain Atlas (Paxinos and Franklin, 2001). Resting cerebral blood flow was measured 
using ASL at the level corresponding to T1-weighted scans with a Look-Locker FAIR single 
gradient echo (LLFAIRGE) sequence (Kober et al., 2008). Maps of cerebral blood flow were 
constructed from ASL data in Matlab using in-house scripts. Cerebral blood flow maps were 
analysed in ImageJ (v1.46, NIH, Bethesda, MD, USA) using unbiased regions of interest 
from T1-weighted images acquired with the ASL sequence. Imaging studies were conducted 





Figure 2-3 Cerebral blood flow measured by MR arterial spin labelling (ASL). 
A mouse was placed on a compatible holder to be placed in an MRI scanner. (A) Vital signs including body 
temperature and respiratory rate were monitored. (B and C) Regions of interests was drawn on T1 (B) then 
transferred to ASL sequence (C) and further analysed in ImageJ. 
 Assessment of cortical blood flow using laser speckle contrast 
imaging 
Laser speckle contrast imaging was applied for measuring in vivo cortical blood flow using a 
method reported previously (McQueen et al., 2014). Mice were given 5% isoflurane in 
oxygen in an anaesthetic chamber for induction. Then mice were placed on a stereotaxic 
frame with their head fixed into position. Isoflurane was maintained at 2-2.5% in oxygen-




around 37 ºC. An incision was made along the midline to expose the skull then properly 
covered with gel to keep the surface moisturised. Laser speckle contrast imager (moorFLPI-
2, Moor Instruments, UK) was positioned 20 cm above the incision. Image resolution was set 
at 752 x 580 pixels and the frequency at 1 frame/second (20 ms/frame). Two minutes of 
perfusion data was recorded after the stabilisation of reading. For repeated measures, laser 
speckle imaging was taken at baseline (before surgery), 24h, 1 month and 3 months 
following BCAS and the surgical incision was sutured, and mice were allowed to recover at 
the end of each imaging session except the endpoint experiment. 
Raw images from laser speckle imaging were analysed using moorFLPI2 Review software 
(v4.0). Two uniformed squares were drawn on barrel cortex on both left and right 
hemisphere and made to avoid any artefacts on the skull. The regions of interest were 
consistent over time and between each mouse. Data from both left and right barrel cortex 
were collected to obtain a mean value of CBF. The CBF data is presented in perfusion units 
(PU) and calculated as the percentage change to baseline blood flow. CBF laser speckle 
imaging study was conducted with the support of Dr Jessica Duncombe. 
 Assessment of neurovascular coupling by performing whisker 
stimulation 
Repeated whisker stimulation was used to evoke neurovascular coupling in the barrel cortex 
following the procedure described in (Figure 2-4). Mice were anaesthetised by 
intraperitoneal injection with α-chloralose (50 mg/kg) and urethane (750 mg/kg) to preserve 
physiological vascular responses. Whiskers on the right side were trimmed at approximate 1 
cm for stimulation and were cut on the left to avoid any unwanted disturbances. Mice were 
positioned on the stereotaxic frame with their head fixed into position. Oxygen was supplied 
via a nose cone, and rectal temperature was monitored and maintained at around 37 ºC. 
Laser speckle imager (moorFLPI-2, Moor Instruments, UK) was set up according to the 
methods described in the above section. Stable cortical blood flow in the Barrel cortex was 




whiskers were deflected by rapid back-and-forth movements using an electric stimulator for 
30 seconds to evoke the neuronal activity in the contralateral Barrel cortex. CBF was set to 
return to baseline before the next stimulation. Three successful recordings were recorded for 
data processing. Raw images from laser speckle imaging were analysed using moorFLPI2 
Review software (v4.0). The mean response amplitude was collected and calculated as the 
result of the percentage increase from baseline. Neurovascular coupling study was 
conducted with the support of Dr Jessica Duncombe. 
 
Figure 2-4 Neurovascular coupling assessed by whisker stimulation. 
The schematic diagram shows neurovascular coupling assessed by measuring the blood flow changes in the 
Barrel cortex after whisker stimulation. The stimulation was given on the right side of whiskers and reading was 
recorded from Barrel cortex on the contralateral side. Three successful recordings, including both before and 





Figure 2-5 Examples of ROIs drawn for neurovascular coupling assessment using whisker stimulation.  
(A) Three ROIs were placed on the Barrel cortex that was on the contralateral side of whisker stimulation. (B) 
Stable cortical blood flow in the Barrel cortex was recorded for 2 minutes for each stimulation as the baseline 
recording. All measurements of CBF data from baseline and stimulation phases were performed in triplicate (30 
seconds/stimulation, highlighted in green boxes) for each region to calculate the mean response amplitude.  
 Assessment of cognitive function using the Barnes maze  
The Barnes maze was used to assess the spatial learning and memory function at 3 months 
after the mice received BCAS or sham surgery. The Barnes maze used in the present thesis 
was comprised of one white circular platform and 20 circular holes around the outside edge 
of the platform, with 91.5 cm diameter and 115 cm height (Figure 2-6) (San Diego 
Instruments). There is one dark escape chamber attached to one of the holes allocated to 




objects and placed on the curtains and walls around the maze. There was one white cylinder 
with 10.5 cm diameter for retaining animals at the beginning of each trial. All the tests were 
recorded by a camera attached to a computer directly above the centre of the platform. 
Movements of the animals were recorded by using software ANY-maze v 4.99. All the tests 
were performed in the behaviour testing room where the room temperature can be controlled 
at a constant 20 ºC. A summarised schedule of Barnes maze used in this thesis is described 
below (Figure 2-7). Experimenters performing the tests were blinded throughout the 
experiments and mice were randomly allocated into a running order generated in Excel on a 






Figure 2-6 Barnes maze for testing spatial learning and memory. 
(Top) The schematic diagram demonstrates the maze consisted of four defined quadrants (northeast: NE, 
southeast: SE, southwest: SW and northwest: NW) and one central area, visual cues mounted on the walls and a 
speaker for generating white noise. A target hole in orange colour is shown as an example. In the acquisition 
tests, hole “3, 8, 13 and 18” were randomly allocated to each mouse as a target hole, then it was switched 180° 







Figure 2-7 A summarised schedule of Barnes maze.  
A summarised schedule shows the working flow of Barnes maze used in this thesis.  
 Acclimation, handling and habituation  
Animals were brought into the behavioural testing room and placed in the holding cylinder to 
acclimate to the testing environment for 10 seconds for two days before habituation. One 
week before the training session, mice were handled by experimenter and habituated to the 
maze and escape the cage. Each mouse was placed in the holding cylinder for 10 seconds 
then allowed to explore the arena for 3 minutes under low-stress conditions after removal of 
the cylinder, without aversive white noise stimulation. Then mice were guided to the escape 
cage and allowed inside for 2 minutes. All the animals were allocated one fixed number for 
the cage during the behaviour test. The maze and the escape cage were cleaned with 
ethanol to avoid any olfactory cues between each trial.  
 Visuo-spatial learning and working memory test (Acquisition training)  
During the training session, mice were trained to find the escape chamber over 6 days, with 
2 trials per day (60-minute inter-trial interval). The platform consists of 20 escape holes, and 
the location of escape chamber remained constant to each mouse but was shifted clockwise 
90 degrees between mice to avoid any olfactory cues. The mouse was placed in the holding 
cylinder for 10 seconds. The aversive white noise was given once the test started and 
switched off once the mouse entered the escape chamber. If the mouse failed to enter the 
target hole, the experimenter should guide the mouse to the escape cage; then the aversive 




 Acquisition 72 h probe test  
The acquisition 72 h probe trial was performed 72 hours after the acquisition probe, and all 
the elements remained the same. The acquisition probe and probe trials aimed to test the 
acquisition short and long-term memory of the mice.  
 Reminder training  
Following the final acquisition probe trials, retraining was carried out under the same 
condition as the acquisition training phase. The reminder training day was aimed to ensure 
no extinction of hole location memory occurred in the probe test.  
 Reversal training  
During the reversal training session, mice were trained to find the escape cage following 
same procedure as the acquisition training phase, but with the allocated escape cage shifted 
180 degrees to the opposite side of the stage. The mice were trained over 3 days, with 2 
trials per day (60-minute inter-trial interval) in reversal training to evaluate the spatial 
learning ability in the increased difficulty of the task.  
 Reversal 72 h probe test 
The reversal probe trial was performed 72 hours after the final reversal training. Animals 
were given 90 seconds to explore the maze with the escape cage removed. All the elements 
in the reversal probe remained same as reversal training test.  
 Measurements  
Trials were recorded by a recording system above the arena and measured using tracking 
software Any-maze version 4.99. Spatial learning was assessed by the total time to enter the 




was recorded as primary latency as well as the total time and path length spent in the trials 
recorded as total latency and total distance, respectively.  
 Assessment of glymphatic function 
 Intracisternal injection of CSF tracers  
Mice were initially anaesthetised with isoflurane (5% in oxygen), then positioned in a 
stereotaxic frame and anaesthetic maintained at approximately 1.5% (in oxygen). The 
respiration was regulated using a ventilator. The posterior atlanto-occipital membrane was 
surgically exposed, and a 32GA needle attached to a Hamilton syringe was inserted into 
cisterna magna (Figure 2-8). Alexa Fluor 488 fluorescein labelled 3 kDa soluble lysine 
fixable dextran D-3 (green) (D7156, Invitrogen) and Alexa Fluor 594 ovalbumin conjugate 
OA-45 (Red) (O34783, Invitrogen) were mixed at 1:1 ratio and infused at a concentration of 
5 μg/μl, at a rate of 0.5 μl/min over 20 minutes (10 μl total volume) through a syringe pump 
(Harvard Apparatus). The needle was held in place for 10 minutes and then removed, and 
atlantooccipital membrane was sealed to avoid any reflux of CSF. For fast observation of 
CSF glymphatic entry, 1% Evans blue dye in PBS was injected into cisterna magna using 





Figure 2-8 Intracisternal injection of fluorescent tracers. 
Fluorescent tracers were injected into cisterna magna under a microscope. (A) The schematic diagram shows the 
injection site and the location of cisterna magna of a mouse head. (B) Image taken before the injection shows the 
skull, atalanto-occipital membrane and CSF and a blood vessel underneath the membrane. (C) The needle was 
inserted into the membrane with no damage to the blood vessel and reflux of CSF. Image A was created from 
Biorender.com. 
 Ex vivo imaging of CSF fluorescent tracer 
Tracer movement from the subarachnoid space of the cisterna magna into the brain was 
imaged using a slide scanner (ZEISS Axio Scan.Z1). Multi-channel whole-slice images of 
each animal at eight sequential levels (1.18, 0.74, 0.14, -0.34, -1.06, -1.82, -2.46 and -2.70 
mm to bregma, Mouse Brain Atlas) were generated at 20x magnification. This included 
separate DAPI, Alexa Fluor® 488 fluorescein labelled 3 kDa soluble lysine fixable dextran D-
3 (green) and Alexa Fluor® 594 ovalbumin conjugate OA-45 (Red). 
All images were scanned using constant exposure time for each channel by the slide 
scanner. For the quantification of tracer movement into the brain, scanned images were 
analysed in ImageJ software (v1.46, NIH, Bethesda, MD, USA) as described previously. 




the DAPI channel to identify anatomical regions. Fluorescent intensity measure was used for 
comparing global glymphatic influx and % area measure was used for regional tracer influx 
quantification.  
 Perfusion fixation  
Mice were transcardially perfused with 30 ml phosphate-buffered saline (PBS) then whole 
brains were fixed in 4% paraformaldehyde in PBS for 24 hours. Tissues for further cryostat 
sectioning were transferred into 30% sucrose solution in PBS for 72 hours. Brains were 
placed in pre-cool isopentane -42 ºC for 5 minutes then stored in -80 ºC freezer and coronal 
sections (12 µm) were cut using a cryostat. Brain tissues for further vibratome were 
sectioned into coronal planes (100 µm) on a vibratome then stored in the cryoprotective 
medium in a -20 ºC freezer. 
 Histological assessment of vascular related lesions 
 Haematoxylin and eosin (H&E) staining  
To determine the vascular related lesions, such as microinfarcts, sections were stained with 
H&E method using standard protocols to visualise the presence of ischaemic tissue damage. 
6 stereotactic levels of brain sections (0.86 mm, 0.14 mm, -0.46 mm, -1.34 mm, -1.70 mm 
and -2.30 mm to Bregma) were examined for the presence of these vascular related 
changes. Sections were removed from the freezer and allowed to air dry. Sections were 
rinsed in running tap water and through a series of steps for delipidising. Staining was 
performed using filtered haematoxylin (Thermo Fisher, UK) for 3 minutes. Sections were 
rinsed in running tap water and added to 1% Acid Alcohol for maximum 10 seconds before 
being placed in running tap water for 2 minutes. Sections were then transferred to Scott’s tap 
water for 2 minutes until the tissue sections turn blue, washed in running tap water for 2 




were rinsed in running tap water, dehydrated through serial alcohols (70%, 90%, 100%) and 
placed in xylene for 15 minutes then mounted with DPX. 
 Perl’s Prussian blue staining 
Perl’s Prussian blue staining was used to detect the haemorrhagic tissue damage by 
examining the presence of iron using a standard kit (HT20, Sigma, UK). Frozen sections 
were removed from the freezer and allowed to air dry. Sections were rehydrated to distilled 
water, then placed in a 1:1 mix solution of potassium ferrocyanide and hydrochloric acid for 
10 minutes. Sections were then placed in distilled water and incubated in DAB/Metal 
concentrate diluted in peroxide buffer (Metal Enhanced DAB Substrate Kit, Thermo Fisher, 
UK) for 15 minutes. Finally, sections were rinsed in running tap water, dehydrated through 
serial alcohols (70%, 90%, and 100%) and placed in xylene for 10 minutes then mounted 
with DPX. 
 Immunohistochemistry 
Immunostaining was carried out according to standard protocols (Table 2-1). Frozen (12 μm) 
sections were removed from the freezer and allowed to air dry for 30 minutes. Slides were 
washed in PBS followed by a series of ethanol (70%, 90% and 100%) for dehydration then 
placed in xylene for 10 minutes. Sections were rehydrated through serial ethanol (100%, 
90% and 70%) then rinsed in water. Antigen retrieval was performed using 10mM citric 
buffer (PH 6.0) at 100 ºC under pressure for 10 minutes then covered with proteinase K 
working solution for 10 minutes at room temperature. Sections were rinsed in PBS and 
incubated in blocking buffer (10% normal serum, 0.5% BSA) for 1 hour at room temperature. 
Subsequently, sections were incubated in primary antibody solution (amyloid 6E10, 1:1000, 
Covance, SIG-39320, mouse monoclonal antibody; COL4, 1:400, Fitzgerald, 70R-CR013X, 
rabbit polyclonal antibody) overnight at 4 ºC. Sections were then rinsed in PBS and 
incubated in secondary antibody (anti-rabbit Alexa Fluor 546, 1:500, Invitrogen A-11010; 




Vibratome sections, generated for evaluation of glymphatic function, were rinsed in PBS and 
mounted onto superfrost plus slides (VWR international) followed by serial ethanol (70%, 
90% and 100%) and then placed in xylene for 10 minutes. Sections were rehydrated through 
serial ethanol (100%, 90% and 70%) then rinsed in running water. Antigen retrieval was 
performed using 10mM citric buffer (PH 6.0) at 100 ºC under pressure for 10 minutes. Then 
sections were incubated in primary antibody solution (GFAP, 1:1000, Life technologies, 13-
0300, Rat monoclonal antibody) overnight at 4 ºC. Sections were rinsed in PBS and 
incubated in non-fluorescent biotinylated secondary antibody (anti-rat, 1:100, Vector 
Laboratories, YO809) for 1 hour at room temperature followed by 1 hour incubation with 
Vector ABC Elite kit (Vector Laboratories). Finally, sections were visualised with the DAB 





Table 2-1 Antibodies used for immunohistochemical and immunofluorescent staining. 
Primary 
antibody 
Target Dilution Retrieval Supplier Secondary 
antibody 
Dilution Supplier 
























































 Analysis of immunohistochemistry 
Immunostained 12 µm frozen sections were analysed using a laser scanning confocal 
microscope (ZEISS LSM 710, Germany). Cortical amyloid load and blood vessel density 
were determined by the percentage of areas of positive 6E10 and COL4 staining, 
respectively. The vascular amyloid load was determined by the JACoP colocalization plugin 
by calculating the Mander’s coefficient, and data were shown as % vascular amyloid. Images 
were taken in the cortex of Tg-SwDI mice. Regions of interest were defined on DAPI channel 
covering the pial surface to approximate the depth of 250 µm. Astrogliosis was assessed 




by GFAP positive staining, images were obtained using the method described above using a 
slide scanner using auto thresholding (triangle method). All measurements were carried out 
using ImageJ (v1.46, NIH, Bethesda, MD, USA).  
 Statistical analysis  
Data were analysed using a two-way ANOVA with surgery and genotype as two between 
subject factors followed by Bonferroni’s multiple comparison test to compare ASL measured 
CBF levels, neurovascular coupling, regional glymphatic function, astrogliosis, and Barnes 
maze probe tests. Statistical comparison of cortical CBF, spatial learning, global glymphatic 
influx were carried out by repeated measures ANOVA with surgery and genotype as 
between subject factors followed by Bonferroni's multiple comparison test. One sample t-test 
was used to compare the performance of each group with the chance in the Barnes maze 
probe tests. Mann-Whitney U test was used to compare the amyloid burden and blood 
vessel density. Difference in proportions test was performed to compare vascular related 
lesions. Statistical analysis was performed using IBM SPSS Statistics 22. Unless otherwise 





Chapter 3. Effect of bilateral common carotid artery 
stenosis and amyloid on cerebral blood perfusion and 
glymphatic function and link to cognitive impairment 
 Introduction 
Cerebral vascular disease (CVD) is a significant factor contributing to cognitive impairment 
and dementia, such as Alzheimer’s disease (AD) (Gorelick et al., 2011). Extensive well-
characterised cohort studies have highlighted the co-existence of vascular disease with AD 
(Esiri et al., 1999, Snowdon et al., 1997, Hachinski and Munoz, 1997, De Jong et al., 1997, 
de la Torre, 2000b, de la Torre, 2000a, de la Torre, 2000c). Key neuroimaging features 
(white matter lesions, microbleeds, lacunes and enlarged perivascular spaces) are found in 
both AD and CVD, and they share several vascular risk factors, such as hypertension, 
diabetes and atherosclerosis (Dichgans and Leys, 2017). Vascular risk factors in midlife are 
also associated with an increased burden of Alzheimer-related pathologies, such as amyloid 
protein, in the human brain suggesting a direct relationship (Gottesman et al., 2017).  
Global reductions in cerebral blood flow are associated with increased risk of progression 
from mild cognitive impairment to dementia suggestive that perfusion plays a crucial role in 
disease progression (Alsop et al., 2010, Chao et al., 2010). Reduced cerebral perfusion has 
been linked to white matter attenuation, a key feature common to both AD and dementia 
associated with CVD (Barker et al., 2014, Schuff et al., 2009). Common artery stenosis of 
varying degrees is invariably associated with cognitive impairment (Johnston et al., 2004b, 
Cheng et al., 2012, Balestrini et al., 2013, Alosco et al., 2013) and carotid stenosis (>25%) 
has been linked to a greater burden of white matter hyperintensities (Romero et al., 2009). 
Large and small vessel disease is also linked to Alzheimer’s disease dementia (Arvanitakis 
et al., 2016). Reduced cerebral perfusion, impaired cerebrovascular reactivity and 
haemodynamic responses are increasingly recognised in the early stages of AD (Hughes et 




chronic cerebral hypoperfusion as a result of bilateral carotid stenosis leads to cognitive 
decline through mechanisms that involve hypoxia-induced white matter damage and gradual 
deterioration of the neuro-glial-vascular unit including endothelial dysfunction, microvascular 
inflammation and BBB leakage (Shibata et al., 2004, Holland et al., 2015, Fowler et al., 
2017, Kitamura et al., 2017, Roberts et al., 2018). Although there is substantive evidence 
reduced blood flow contributes to vascular disease, a causal relationship remains a matter of 
controversy; primarily due to the cross-sectional nature of clinical studies and, in the few 
longitudinal studies conducted, reduced blood flow occurs after vascular disease burden (de 
la Torre, 2012a). Emerging data have highlighted alternative mechanisms that may also 
contribute to disease progression, and in particular, the impaired glymphatic function is 
emerging as a critical player in AD and VaD. The glymphatic pathway is a brain-wide 
clearance process that relies on the movement of CSF via the perivascular network 
facilitated by aquaporin-4 water channels on the astroglial endfeet to promote the elimination 
of waste out of the brain (Iliff et al., 2012). CSF flow within the perivascular space is 
regulated by cerebrovascular pulsatility, which is now considered to be a key factor 
regulating glymphatic function (Iliff et al., 2013b, Mestre et al., 2018b). Enlarged perivascular 
space (PVS) is a common feature of CVD and dementia linked to vascular risk factors and 
inflammation (Potter et al., 2015a, Ding et al., 2017, Wardlaw et al., 2013, Doubal et al., 
2010, Aribisala et al., 2014b, Shi and Wardlaw, 2016). There is also evidence of impaired 
glymphatic function in pre-clinical models relevant to CVD. Notably advanced age, acute 
ischaemic stroke and multi-infarct stroke, diabetes and subarachnoid haemorrhage (SAH) 
have all been shown to have a significant impact on drainage function (Kress et al., 2014, 
Gaberel et al., 2014, Wang et al., 2017). Disturbances of the glymphatic function are also 
related to a build-up of amyloid, Aβ protein, in both human and rodent brain (Xu et al., 2015, 
Shokri-Kojori et al., 2018). 
The first studies in the thesis sought to examine the effect of bilateral carotid stenosis 




impairment. A well-characterised murine model of BCAS was used that has been studied 
extensively within our group and others (Medina and Avila, 2014, Shibata et al., 2004). 
Further, in light of the evidence that flow-limiting large-vessel stenosis contributes to 
vascular and AD pathophysiology (Gupta and Iadecola, 2015), and that impaired glymphatic 
function is a pivotal contributor to impaired Aβ clearance. The glymphatic function was then 
investigated in the BCAS model and Tg-SwDI mice.  
 Hypothesis 
In the present study, it was hypothesised that bilateral common carotid stenosis (BCAS) and 
microvascular amyloid lead to cognitive impairment via cerebral perfusion deficits and 
impaired glymphatic drainage function. 
 Study aims 
This study aimed to assess alterations in cerebral perfusion as primary outcome of interest 
and second to this to determine if glymphatic function was altered following BCAS. Cognitive 
impairment and interactions with microvascular amyloid were also determined by studying 
BCAS in Tg-SwDI mice.  
 Materials and Methods 
 Animals 
Male heterozygous Tg-SwDI and wild-type mice were subjected to BCAS or sham surgeries. 
Mice were group caged in standard cages with bedding, food, water and nestle under 12 h 
dark/light cycles. The Tg-SwDI mice are primarily designed to study the microvascular 
accumulation of amyloid. The Tg-SwDI expresses human neuronal amyloid precursor 
protein (APP), containing the transgenic Swedish K670N/M671L, Dutch (E693Q), and Iowa 
(D694N) mutations under the control of Thy1 promoter (Davis et al., 2004). At the outset, a 




recruited in experiments for the investigation of CBF including laser speckle contrast imaging 
and MR ASL, and behavioural tests (cohort 1). The second cohort of mice (total number=33, 
Tg-SwDI mice at 5-7 months and imported wild-type C57Bl/6J at 4-5 months old of age) 
were prepared for the investigation of glymphatic function (cohort 2). Mice were randomly 
assigned to experimental groups for all studies. In cohort 1, 1 mouse in Tg-SwDI BCAS was 
culled due to the severe bleeding during the surgery. 4 mice in Tg-SwDI and 2 mice in WT 
groups were culled due to the poor recovery following BCAS surgery. Therefore, these mice 
were excluded from the study. Final group size for cohort 1: n=8 WT sham, n=10 WT BCAS, 
n=6 Tg-SwDI sham, n=10 Tg-SwDI BCAS. In cohort 2, n=10 WT sham, n=8 WT BCAS, n=7 
Tg-SwDI sham, n=8 Tg-SwDI BCAS. A summary of mice used in experiments has been 






Figure 3-1 Summary of animals used in experiments. 
A brief summary demonstrates that mice from cohort 1 were used in experiments including laser speckle 
imaging, MRI ASL, behavioural tests and whisker stimulation, as well as cohort 2 aimed to investigate the 
glymphatic function. Both cohorts underwent a period of 3 months following BCAS or sham surgeries.  
 Bilateral common carotid stenosis (BCAS) surgery 
BCAS surgery was performed under isoflurane anaesthesia by applying microcoils (0.18mm 
internal diameter, Sawane Spring Co, Shizuoka, Japan) permanently to both common 
carotid arteries. Details of surgical methods have been described in previous studies 
(Shibata et al., 2004, Coltman et al., 2011, Reimer et al., 2011a, Holland et al., 2011b). A 30 
minute interval was given between the application of the two microcoils to minimise the 
acute CBF changes caused by the placement of microcoils. Sham-operated animals 




 In vivo laser speckle contrast imaging  
Laser speckle contrast imaging was used for measuring in vivo cortical blood flow using a 
method reported previously (McQueen et al., 2014). Mice were anaesthetised with Isoflurane 
in oxygen-enriched air, and an incision was made along the midline to expose the skull then 
properly covered with gel to keep the surface moisturised. Cortical CBF data was recorded 
at baseline (before surgery), 24h, 1 month and 3 months following BCAS and sham 
surgeries and then the surgical incision was sutured, and mice were fully recovered in an 
incubator at the end of each imaging session except the endpoint experiment at 3 months 
post-surgery. Raw images from laser speckle imaging were analysed using moorFLPI2 
Review software (v4.0). Two uniformed squares were drawn on barrel cortex on both left and 
right hemisphere and made to avoid any artefacts on the skull. Regions of interest were 
consistent over time and between each mouse. Data were presented in perfusion units (PU) 
and calculated as the percentage change to baseline blood flow. 
 CBF measured by MR arterial spin labelling (ASL)  
A 7.0T Agilen (Varian) preclinical MRI system was used to collect T1-weighted and arterial 
spin labelling (ASL) data, as described in Section Chapter 2. The T1-weighted images were 
acquired at 1.7 mm posterior to Bregma in stereotactic coordinates of Mouse Brain Atlas 
(Paxinos and Franklin, 2001). Resting CBF was measured using ASL at the level 
corresponding to T1-weighted scans with a Look-Locker FAIR single gradient echo 
(LLFAIRGE) sequence (Kober et al., 2008). Maps of CBF were constructed from ASL data in 
Matlab using in-house scripts. CBF maps were analysed in ImageJ (v1.46, NIH, Bethesda, 





 Assessment of spatial learning and memory using Barnes maze 
The Barnes Maze was used to determine the differences in spatial learning and memory at 3 
months after BCAS or sham surgery. The maze is comprised of one white circular platform 
and 20 circular holes around the outside edge of the platform, and an escape chamber was 
attached to one of the holes allocated to each experimental animal. Visual cues were 
specially designed and placed on the curtains and walls around the maze. All the tests were 
recorded using a camera connected with a tracking software ANY-maze v 4.99 (San Diego, 
California). The detailed information for the setting and testing schedule can be found in the 
general materials and methods section Chapter 2.  
 Assessment of glymphatic function by intracisternal injection of CSF 
tracers 
Mice were anaesthetised with isoflurane and maintained with 1.5% isoflurane in oxygen 
enriched airflow. The respiration was regulated using a ventilator. The posterior 
atlantooccipital membrane was surgically exposed as described in Chapter 2, D-3 (green) 
and OA-45 (red) tracers were mixed at 1:1 ratio and infused at a concentration of 5 μg/μl, at 
a rate of 0.5 μl/min over 20 minutes through a syringe pump (Harvard Apparatus). The 
needle was held in place for 10 minutes after the completion of the injection, then removed, 
and the atlantooccipital membrane was sealed to avoid any reflux of CSF. For fast 
observation of CSF glymphatic entry, 1% Evans blue dye in PBS was injected into cisterna 
magna using the same methods described above.  
 Tissue processing 
At the end of the experiments, mice from both cohort 1 and 2 were transcardially perfused 
with 30 ml PBS then whole brains were fixed in 4% paraformaldehyde in PBS for 24 hours. 
For cohort 1, brain tissues were further transferred into 30% sucrose solution in PBS for 72 




freezer, and coronal sections (12 µm) were cut using a cryostat. For cohort 2, the brains 
were sectioned into coronal planes (100 µm) on a vibratome then stored in the 
cryoprotective medium in -20 ºC freezer. 
Tracer movement from the subarachnoid space into the brain was imaged using a slide 
scanner (ZEISS Axio Scan.Z1). Multi-channel whole-slice images of each animal at 
hippocampal level (-1.82 mm to bregma) were generated at 20x magnification. This included 
separate DAPI, Alexa Fluor 488 and Alexa Fluor 594 channels. All images were scanned 
using constant exposure time for each channel by the slide scanner. For the quantification of 
tracer movement into the brain, scanned images were analysed in ImageJ software (v1.46, 
NIH, Bethesda, MD, USA) as described previously (Iliff et al., 2012). Region of interest (ROI) 
was defined using the DAPI channel to identify anatomical regions. Auto-thresholding 
(triangle method) was used to measure the % area of positive signal that is the glymphatic 
CSF influx. 
 Immunohistochemistry 
To visualise the spatial location of fluorescent CSF tracers, basement membrane (COL4) 
and astrocytic endfeet marker (AQP4) were stained following standard protocols introduced 
in the Methods section (Chapter 2). Images were obtained using a laser scanning confocal 
microscope (ZEISS LSM 710, Germany). 
 Statistical analysis 
Details of statistical analysis were summarised in Chapter 2. CBF results from ASL, regional 
CSF tracer influx, Barnes maze probe tests, were analysed by two-way ANOVA followed by 
Bonferroni’s multiple comparison test. Cortical CBF from laser speckle imaging, Barnes 
maze spatial learning and global CSF tracer influx were carried out by repeated measures 
ANOVA followed by Bonferroni's multiple comparisons. One sample t-test was used to 
compare the performance of each group with the chance. Statistical analysis was performed 





 CBF reductions at 24 hours, 1 month and 3 months after the 
establishment of carotid stenosis  
At the outset of the studies, a key aim was to define the extent of CBF reductions post-BCAS 
and determine if there were differences between WT and Tg-SwDI mice. Laser speckle 
contrast imaging was used to investigate the effect of BCAS on cortical blood flow in WT and 
Tg-SwDI mice. Cortical CBF was recorded at baseline (CBF data collected at 24 hours 
before surgeries), 24 hours, 1 month and 3 months post-surgery, respectively (Figure 3-2). 
Data was quantified as percentage changes from baseline blood flow at each point post-
surgery.  
CBF was reduced post-BCAS and there was a significant effect of time (F (2.4, 128.4) =45.9, 
p<0.001) and BCAS surgery (F (1, 53) =180.1, p<0.001). However, there was no significant 
effect of genotype (Aβ) (F (1, 53) =0.001, p>0.05) (Figure 3-3). A significant interaction 
between time and surgery (F (2.4, 128.4) =47.3, p<0.001) was observed. Post-hoc tests showed 
significant reductions of CBF in both WT and Tg-SwDI mice when compared to their sham 
counterparts following hypoperfusion surgery at 24 hours (p<0.001), 1 month (p<0.001) and 
3 months (p<0.001), respectively. Thus, the study demonstrated that BCAS results in 





Figure 3-2 Representative images of cortical CBF measured by laser speckle imaging. 
Laser speckle imaging was used to evaluate cortical CBF. Images taken at 24 hours before BCAS or sham 







Figure 3-3 CBF reductions at 24h, 1 and 3 months following surgery. 
Cortical CBF was assessed using laser speckle contrast imaging at baseline, 24 hours, 1 month and 3 months 
following BCAS surgery. BCAS surgery but not amyloid had a significant effect on CBF reduction. A significant 
interaction between time and surgery was observed. Post-hoc analysis showed significantly reduced CBF in both 
WT and Tg-SwDI mice when compared to their sham counterparts following hypoperfusion surgery at all three-
time points after surgery: 24 hours, 1 month, and 3 months (p<0.001, respectively). Data presented as mean ± 
SEM.  
 Regional cerebral arterial perfusion is reduced post-BCAS in wild-type 
and Tg-SwDI mice 
To verify the effect of BCAS surgery on the CBF and determine whether CBF was altered in 
deeper parts of the brain, the regional CBF was further assessed using MR arterial spin 
labelling (ASL). This advanced non-invasive technique was able to determine regional CBF 
changes throughout different brain regions. Previous studies have mainly used measures 
such as Laser Doppler flowmetry which only provide a measure of cortical CBF. The aim 
was to determine both the extent of reductions in regional CBF post-BCAS and whether this 


























Regional alterations in CBF were measured in the dorsolateral cortex (DL CTX), 
hippocampus and hypothalamus.  
Resting CBF (rCBF) at hippocampal level (Bregma -1.82mm) was collected at baseline and 
3 months following BCAS or sham surgeries (Figure 3-4). In DL CTX, there was a significant 
main effect of surgery (F (1, 26) =14.8, p<0.001) but not genotype (p>0.05) and interaction 
(p>0.05) on rCBF (Figure 3-5A). Post-hoc analysis indicated that rCBF was significantly 
reduced in BCAS mice in both wild-type (p=0.013) and Tg-SwDI (p=0.010) groups. 
Furthermore, in the hippocampus CA1-DG molecular region, there was a main effect of 
surgery (F (1, 26) =17.96, p<0.001) but not genotype (p>0.05) and interaction (p>0.05) (Figure 
3-5B). Post-hoc analysis showed significantly reduced CBF in BCAS mice from both wild-
type (p=0.022) and Tg-SwDI (p=0.002) groups. Interestingly, in the basal hypothalamus 
region, BCAS did not lead to significantly reduced blood perfusion (p>0.05) and similarly 
there was no significant main effect of genotype (p>0.05) (Figure 3-5C).  
 
Figure 3-4 MR ASL imaging was used to measure rCBF at baseline and 3 months post-surgery. 
MR ASL imaging was used to verify regional CBF levels. Representative images of baseline and 3 months from 
the WT or Tg-SwDI mice subjected to sham or BCAS surgeries have been collected at hippocampal level 
(Bregma -1.82mm). Three regions of interests including DL CTX, hippocampus and hypothalamus were selected 





Figure 3-5 MR ASL imaging (7.0 T) shows decreased rCBF in the cerebral cortex, hippocampus and 
hypothalamus. 
ASL measured the rCBF level in the dorsolateral cortex (DL CTX), hippocampus CA1-DG molecular region and 
hypothalamus. (A) The comparison of blood flow in the DL CTX. BCAS surgery but not genotype was found to 
have a significant effect on rCBF. Post-hoc analysis indicated that CBF was significantly reduced in BCAS mice 
in both wild-type and Tg-SwDI groups. (B) The comparison of rCBF between groups in the hippocampus. There 
was a main effect of surgery but not genotype and interaction. Post-hoc analysis showed significantly reduced 
blood flow in BCAS mice from both wild-type and Tg-SwDI groups. (C) In the hypothalamus region, there was no 
significant main effect of either BCAS surgery or genotype. Data are presented as mean ± SEM and analysed by 
two-way mixed ANOVA with post-hoc Bonferroni procedure; n=7 WT sham, n=9 WT BCAS, n=5 Tg-SwDI sham, 




 Cognitive function was significantly impaired in BCAS mice at 3 months 
following surgery 
In order to investigate whether long-term carotid stenosis has a further effect on cognitive 
function in our experimental animals, Barnes maze was performed to evaluate the visuo-
spatial learning and memory at 3 months following surgery (Figure 3-6). Motor ability across 
groups was compared as a control measurement to determine whether the motor function 
was altered due to surgery (BCAS) or genotype (Aβ) effect.  
There was a significant effect of genotype but not BCAS on the motor movement across 
groups (F (1, 30) =8.2, p<0.01) and time (Day) (F (5,150) =8.334, p<0.001) across groups (Figure 
3-7A). Therefore, the measurement relying on motor ability cannot be used to compare the 
difference between different genotype groups. Escape latency was a velocity-dependent 
measure defined as the total time that mice spent to escape into the target chamber in each 
training test. This parameter was taken to evaluate the visuo-spatial learning of experimental 
animals. In WT groups (Figure 3-7B), there was a significant main effect of time (F (5, 80) 
=19.8, p<0.001) showing decreased escape latency with increasing training days, and 
surgery (F (1, 16) =4.6, p<0.05) showing BCAS mice spent more extended time than sham 
group to enter target chamber. In Tg-SwDI mice (Figure 3-7C), there was also a significant 
effect of time (F (5, 70) =13.9, p<0.001) showing decreased time to escape with increasing 
training days and surgery (F (1, 14) =5.4, p<0.05) showing BCAS mice spent significantly 
longer time to escape the maze than sham group. These results indicated that both BCAS 
and sham mice successfully learned the task with performance improving over time. 
Moreover, BCAS mice took significantly longer time to escape the maze in both WT, and 
transgenic mice, suggesting distinct impairment of visuo-spatial learning in mice following 





Figure 3-6 Barnes maze was performed to assess visuo-spatial learning and working memory. 
Visuo-spatial learning and memory were assessed using Barnes maze consisting of training trials, 72 hours 
probe trial, reversal training and reversal 72 hours probe trials. Acquisition training sessions and probe trials were 
used to assess cognitive function. Test schedule was shown briefly to explain the 6 consecutive training days 
with 2 trials per day followed by a 72 h probe test (acquisition phase) and 3-day sessions of reversal tests 
followed by a 72 h probe test (reversal phase). Example images of escape hole and defined target quadrant are 





Figure 3-7 Visuo-spatial learning was significantly impaired at 3 months following BCAS surgery. 
The velocity was taken as a control measure to assess whether the motor function was affected by the genotype 
or surgery across different groups. (A) A significant effect of amyloid (p<0.01) but not BCAS was found to 
influence the motor function across groups. (B) Escape latency in WT animals was measured to assess the 
visuo-spatial learning ability following 3 months Sham or BCAS surgery, a significant effect of time (p<0.001) 
showing a decreased latency to escape into target chamber with increasing training days, and BCAS surgery 
showing longer time for BCAS mice to escape the chamber. (C) Escape latency in Tg-SwDI mice showed a 































































































































showing BCAS mice spent a significantly longer time to escape. *, **, *** and ns indicate p<0.05, 0.01, 0.001 and 
not significant, respectively. Data presented as mean ± SEM, n=8 WT sham, n=10 WT BCAS, n=6 Tg-SwDI 
sham, n=10 Tg-SwDI BCAS. 
To investigate the effect of chronic BCAS on long-term memory, a probe test was taken after 
72 hours of the final training trial to examine whether experimental animals remembered the 
previous training target after removing the escape chamber. Data was quantified as 
percentage time spent in the target quadrant where the allocated chamber used to be. 
Results indicated that mice from WT sham (p=0.004), Tg-SwDI sham (p=0.021) and Tg-
SwDI BCAS (p=0.025) all spent a significantly higher percentage of time than by chance 
(25%). Exclusively in WT BCAS mice, the percentage time spent in the target quadrant was 
significantly lower by 18.20 (95% CI, 2.97 to 39.37) than average by chance, t (9) =1.95, 
p=0.84 (Figure 3-8) There was no significant effect of surgery or genotype on the % time 
spent in the correct quadrant. 
 
Figure 3-8 Long-term memory was not impaired in BCAS and the presence of amyloid. 
In the acquisition 72h probe test, all mice performed above chance (WT sham p=0.004, Tg-SwDI sham p=0.021 
and Tg-SwDI BCAS p=0.025) except WT BCAS mice that did not spend significantly longer time than average by 
chance (p>0.05) (** indicates p<0.01, and * indicates p<0.05, one sample t-test compared to chance=25%). 
There was no significant effect of either genotype or surgery on the % time spent the correct quadrant (p>0.05, 




 Reversal test 
To further enhance the detection of spatial learning and memory impairment, reversal trials 
were taken to evaluate the ability of experimental animals to learn a new location and testing 
the flexibility of executive function, escape hole location was switched 180° to the opposite 
side of maze (Figure 3-9). In the WT mice, there was a significant effect of time (F (2, 32) 
=10.4, p<0.001) showing decreased time to escape with increasing training trails but no 
significant effects of surgery (p>0.05) on escape latency were detected (Figure 3-10A). In 
Tg-SwDI mice, no significant effects of time (p>0.05) and surgery (p>0.05) were detectable 
in both sham and BCAS mice indicating transgenic mice failed to learn the new task and 
unsurprisingly no significant effects of time (p>0.05), and surgery (p>0.05) were observed 
(Figure 3-10B). These suggest WT mice subjected to BCAS surgery still learnt the enhanced 
task, but Tg-SwDI mice failed to learn the reversal task due to amyloid pathology. 
 
Figure 3-9 Reversal training trials and probe tests were performed to evaluate the cognitive function after 
enhancement of tests. 
Reversal training and probe tests were performed to evaluate the cognitive function, representative images 






Figure 3-10 Tg-SwDI mice failed in spatial reversal learning. 
(A) In WT mice, a significant effect of time (p<0.001) shows decreased time to escape with increasing training 
trails but no significant effects of surgery on escape latency. (B) In Tg-SwDI mice, no significant effects of time 
and surgery were detectable in both sham and BCAS mice. *** and ns indicate p<0.001 and not significant, 
respectively. Data presented as mean ± SEM, n=8 WT sham, n=10 WT BCAS, n=6 Tg-SwDI sham, n=10 Tg-
SwDI BCAS. 
The reversal probe test was performed following 72 hours of the final training trial (Figure 
3-11). Results indicated only mice from WT sham (37.40 ± 12.63) (p<0.05) spent a 
significantly higher percentage of time by 12.40 (95%CI, 1.84 to 22.96) than by chance, 
t(7)=2.8, p=0.027 and a significantly higher percentage of time than Tg-SwDI BCAS mice 






























































































BCAS: 27.57 ± 11.12%, Tg-SwDI sham: 20.36 ± 15.50%, Tg-SwDI BCAS: 26.79 ± 16.79%) 
(Figure 3-11). There was no significant effect of surgery (p>0.05) or genotype (p>0.05) on % 
time spent in the correct quadrant (Figure 3-11).  
 
Figure 3-11 Long-term memory was impaired in both WT and Tg-SwDI BCAS as well as in the presence of 
amyloid. 
72 hours reversal probe test showed impaired long-term memory in BCAS and transgenic mice after enhanced 
detection of memory impairment. The reversal probe was performed following 72 hours of the final training trial. * 
and ns indicate p<0.05 and not significant, respectively. Data presented as mean ± SEM, n=8 WT sham, n=10 
WT BCAS, n=6 Tg-SwDI sham, n=10 Tg-SwDI BCAS. 
 Validation of CSF glymphatic influx/entry 
Previously, our group has reported that BCAS altered Aβ peptide pools leading to increased 
Aβ accumulation in the cerebral vasculature (Salvadores et al., 2017). The current 
experiment aimed to interrogate whether the glymphatic function is modified following BCAS 
and whether amyloid interacts with BCAS leading to further changes on glymphatic pathway 
since this pathway has been proposed in relation to the progression of CAA (Iliff et al., 
2012). To visualise glymphatic entry, Evans blue dye was used for in vivo injection into 
cisterna magna since this technique allows fast observation of the presence of CSF. Normal 
wild-type mice were injected then whole brain was carefully collected without perfusion to 



























































show the Evans blue dye distributed along the surface of brain vessels (e.g. Middle cerebral 
artery) (Figure 3-12A and B).  
To understand the localisation of the CSF glymphatic influx, fluorescent tracers were further 
injected into the cisterna magna when mice were anaesthetised with isoflurane. The brain 
slices were immunostained with several markers to illustrate the spatial location of CSF 
tracer and other cellular components such as basement membrane and water channel 
AQP4. In the first place, the CSF glymphatic influx was imaged in ex vivo fixed brain slices, 
and collagen IV was stained as a marker of basement membranes. As shown in the 
representative images, the D-3 tracer was located in the perivascular domains that are 
perivascular space (PVS) (Figure 3-13A and C) or colocalised with the basement membrane 





Figure 3-12 Evans blue dyes in CSF moved along perivascular domains in the middle cerebral artery (MCA) 
supplied cerebral cortex.  
Evans blue dyes in aCSF were injected into cisterna magna of a normal mouse without transcardial perfusion. At 
the surface of the brain, dyes were found distributed along blood vessels, and the middle cerebral artery (MCA) 






Figure 3-13 Representative images of CSF glymphatic influx in the cerebral cortex. 
The immunostaining of vascular basement membrane marker COL4 (collagen 4, magenta) revealed the 
localisation of CSF fluorescent tracer (D-3, green) is inside the perivascular space (A and C) or colocalised with 
the basement membrane (B and D).  
To determine the localisation between CSF tracers and astroglial compartment, I further 
investigated the CSF tracers and astrocytic endfeet marker AQP4. Representative images 
obtained after the immunostaining work of AQP4 with the CSF tracers at multiple areas of 




D-3 tracer had a higher occupancy of the signal. By contrast the OA-45 tracer had very few 
glymphatic influx near the same penetrating artery (Figure 3-14A). In the images from the 
level of a superficial cortical blood vessel, both tracers were surrounded with the tissue 
expressing AQP4 (Figure 3-14B) showing a donut-shaped tunnel surrounding vasculature. 
The images obtained near the area between hippocampal CA3 and dorsal part of the lateral 
geniculate complex showed a consistent pattern of the CSF influx is along the vessel walls 
and wrapped with the tissue expressing AQP4 (Figure 3-14C).  
In summary, the CSF glymphatic influx from our observation using the ex vivo imaging 
showed the localisation of CSF tracers, basement membrane and astroglial compartment. 
Thus, the following work aimed to address the initial questions regarding the BCAS, amyloid 






Figure 3-14 Representative images of CSF tracers in relation to astrocytic endfeet marker AQP4 and proposed 
glymphatic influx. 
Representative images showing the spatial location of tracers D-3, fluorescein labelled 3 kDa soluble lysine 
fixable dextran (green). D-3 tracer is surrounded by the glial astrocytic endfeet expressing AQP4. (A) Surface 
artery penetrates cerebral cortex surrounded by AQP4 stained brain tissue; the D-3 tracer shows filling the 
space along the blood vessel at the surface of the brain. (B) Coronal image of a superficial blood vessel and 
spatial location with astrocytic endfeet. (C) Tracers and AQP4 immunostaining in the deep brain region at the 







 The global influx of CSF tracers is different across the anatomical levels 
but unaltered post-BCAS in wild-type and Tg-SwDI mice  
After verifying the cerebral blood perfusion changes after BCAS and localisation of the CSF 
glymphatic influx, the next aim was to examine whether BCAS affected the global glymphatic 
function. At the outset, global glymphatic tracer influx was evaluated in wild-type and Tg-
SwDI mice and determined whether glymphatic influx was altered after BCAS. The global 
intensity of including Dextran-3 kDa (D-3) and Alexa Fluor Ovalbumin-45 kDa (OA-45) was 
measured in coronal sections sampled throughout the brain using a method previously 
described (Iliff et al., 2012) (Figure 3-15). In the first place, the total intensity of each group 
was measured. There was no significant effect of BCAS or amyloid when measuring D-3 and 
OA-45 occupancy at the whole brain level (surgery p>0.05, genotype p>0.05, respectively) 
(Figure 3-16A and B). Eight sequential levels of ex vivo brain sections from each animal 
were collected to evaluate the CSF tracer influx at 1.18, 0.74, 0.14, -0.34, -1.06, -1.82, -2.46 
and -2.70 mm to bregma (Figure 3-15A). A significant effect of the anatomical level (F (3.36, 
90.71) =23.2, p<0.001), and a trend of interaction between the anatomical level and BCAS (F 
(3.36, 90.71) =2.4, p=0.068) on the influx of the D-3 tracer were observed (Figure 3-16C). At the 
most rostral and caudal side of the brain, tracer influx was higher than other levels (Figure 
3-16C). At the level of -1.06 mm to bregma, mean global tracer intensity (47.4 AU) was the 
lowest compared to other levels. However, there was no significant effect of genotype and 
surgery or interaction between these two factors (p>0.05). For the evaluation of OA-45 tracer 
influx, there was a significant effect of anatomical level (F (4.21, 113.71) =20.3, p<0.001) (Figure 
3-16D). The highest intensity was observed at the most rostral and caudal levels similar to 
the D-3 tracer. There was no significant effect of surgery, genotype and interactions between 
these factors (p>0.05).  
Overall, the brain-wide measurement of tracer influx indicated that glymphatic drainage was 





Figure 3-15 Representative images of global tracer influx in wild-type and Tg-SwDI mice and in response to 
BCAS. 
(A) Schematic diagrams for 8 sequential levels (1.18, 0.74, 0.14, -0.34, -1.06, -1.82, -2.46 and -2.70 mm to 
bregma) of chosen. Representative images for whole-brain scanned fluorescent images: (B) fluorescein labelled 






Figure 3-16 Global tracer influx in wild-type and Tg-SwDI mice and in response to chronic cerebral 
hypoperfusion. 
(A and B) Total fluorescent intensity measures of whole-brain sections measuring D-3 (A) and OA-45 (B), 
respectively. (C and D) Fluorescent intensity measures of global brain sections at each level. Data are presented 
as mean ± SEM, n=10 WT sham, n=8 WT BCAS, n=7 Tg-SwDI sham, n=7 Tg-SwDI BCAS. 
 Regional CSF tracer influx is altered post-BCAS in wild-type and Tg-SwDI 
mice  
To further investigate whether BCAS influences CSF glymphatic influx, ex vivo images of the 
CSF tracer influx in the dorsolateral cortex (DL CTX) and hippocampus (CA1-DG molecular 
layer) on the D-3 tracer were measured.  
CSF glymphatic influx was first measured in the region of the dorsolateral cortex, which 
shows tracer distributed along the middle cerebral artery (MCA) and its branches (Figure 




glymphatic influx that was reduced in the dorsolateral area of D-3 (F (1, 27) =4.8, p=0.037) 
(Figure 3-17B). There was no statistically significant interaction between genotype and 
BCAS surgery (p>0.05) or main effect of genotype (p=0.064). Post-hoc analysis showed a 







Figure 3-17 Assessment of glymphatic function in the cerebral cortex (dorsolateral cortex) showing altered CSF 
influx in the BCAS and Tg-SwDI mice.  
(A) Representative images of tracer influx in the dorsolateral cortex (DL CTX). (B) Ex vivo imaging of fluorescent 
density of the Dextran-3 kDa (D-3) tracer was measured at the hippocampal level. Data are presented as mean ± 
SEM, n=10 WT sham, n=8 WT BCAS, n=7 Tg-SwDI sham, n=7 Tg-SwDI BCAS, * indicates p<0.05. Scale 
bar=500 µm. 
The CSF tracer influx in the hippocampal subregion was further measured: CA1-DG 





















interaction (p>0.05) or main effect of genotype (p>0.05) were found. Post-hoc tests showed 
a significant reduction between wild-type sham and BCAS mice (p=0.005) (Figure 3-18).  
 
 
Figure 3-18 Assessment of glymphatic function in the cerebral cortex (dorsolateral cortex) showing altered CSF 
influx in the BCAS and Tg-SwDI mice.  
(A) Representative images of the glymphatic influx in the hippocampal CA1 dentate gyrus molecular layer (CA1-
DG) and schematic image of the selected region of interests (ROIs) for the CA1-DG molecular regions. (B) Ex 
vivo imaging of fluorescent density of the Dextran-3 kDa (D-3) tracer was measured at the hippocampal level. 
Data are presented as mean ± SEM and n=10 WT sham, n=8 WT BCAS, n=7 Tg-SwDI sham, n=7 Tg-SwDI 








































































These first studies support the original hypothesis that BCAS causes cognitive impairment 
via reduced cerebral perfusion and impaired glymphatic function. However, contrary to the 
hypothesis, there was no exacerbation of these effects in Tg-SwDI mice. To begin with, the 
CBF was measured using laser speckle imaging and supported by MR ASL, to provide 
comprehensive information at multiple timescales and brain regions. In contrast to the 
hypothesis, the resting CBF (rCBF) in the cortex and hippocampus were found to be 
significantly reduced after BCAS, but there was no evidence that suggested amyloid alone 
could exacerbate this or interact with carotid stenosis. This finding is consistent within the 
cortical region measured by both laser speckle imaging and MR ASL. In the hypothalamus, 
there was no significant reduction in CBF either caused by BCAS or amyloid, which is 
contrary to my hypothesis. A slight increase of CBF after BCAS in the wild-type mice was 
observed suggesting that vascular remodelling might occur due to the long-term exposure to 
the insufficient blood supply. Barnes maze revealed significantly impaired visual-spatial 
learning and memory in mice following 3 months of BCAS. Amyloid did not exacerbate 
impaired learning and memory until in reversal tests that showed Tg-SwDI mice failed to 
learn the tests in the reversal trials and poorly performed in the reversal 72 hours probe 
suggesting impaired long-term memory by amyloid.  
 Bilateral common carotid artery stenosis (BCAS) showed sustained 
effects on cerebral perfusion with potential vascular remodelling 
At the outset of the study, sustained reductions in cortical CBF was confirmed by laser 
speckle imaging at 24h, 1 and 3 months post-BCAS. This set of data added new information 
demonstrating the blood flow changes over a longer term of carotid stenosis. It is consistent 
with previous reports from our group and others that BCAS induced a reduction of CBF at 
approximate 30% at 1 month post-BCAS (Shibata et al., 2004, McQueen et al., 2014). 




amyloid did not worsen the hypoperfusion effect at the 3 month time point (10-12 months 
old). This is not in agreement with another study using laser speckle imaging assessing 
younger wild-type and Tg-SwDI mice that indicated Aβ deposition was able to accelerate 
compromised blood perfusion following 3 months of BCAS (Okamoto et al., 2012).  
In BCAS models and other models relevant to VCI, CBF has been predominantly assessed 
using Laser Doppler probes or Laser Doppler Flowmetry. Although this is useful to measure 
cortical CBF over extended periods, it lacks the spatial resolution of other imaging 
approaches. CBF can also be evaluated using MR arterial spin labelling (ASL), positron 
emission tomography (PET) and single photon emission computed tomography (SPECT). 
Among these methods, ASL is advantageous in assessing CBF due to its non-invasive 
feature that can be easily transferred to clinical applications. Also, the ability to measure 
regional alterations in CBF is relevant to VCI in which pathological alterations occur 
predominantly subcortically.  
In the present study following 3 months of BCAS surgery, CBF assessed by MR ASL was 
found to be reduced to approximately 60% of baseline in wild-type mice and slightly lower in 
Tg-SwDI mice (50% of baseline) post-BCAS in both cortical and hippocampal regions post-
BCAS. To date, there have been no studies that have assessed the longer-term effect of 
BCAS on rCBF using MR ASL imaging. Instead, a previous study by Hattori et al. (Hattori et 
al., 2016), using ASL in the BCAS model, demonstrated a substantial decrease of CBF at 
approximate 50% of the baseline between day 1 to 14 following BCAS, with gradual 
recovery to 70% of the baseline until 28 days of surgery. In the current study, the 
progression of CBF changes was not measured, and thus it is not clear if there was a similar 
recovery in CBF in the first few weeks. Instead I was only able to show CBF at 3 month post-
BCAS. The studies above using laser speckle imaging to measure cortical CBF would 
suggest that CBF is partially restored up to 28 days post-BCAS, but then in the subsequent 
period this is further reduced. In contrast to the original hypothesis, rCBF was not further 




In addition, in the present study using ASL, it was also determined that in the hypothalamus, 
rCBF was not reduced post-BCAS in WT mice that showed similar values to sham mice 
although there was a modest reduction of CBF in Tg-SwDI mice post-BCAS. The 
hypothalamus receives CBF supplied via multiple arteries originating from internal carotid 
artery (e.g. middle cerebral artery and anterior cerebral artery), which contrasts to the 
hippocampus and cortex, which receive CBF via the middle cerebral artery or posterior 
cerebral artery, respectively (Xiong et al., 2017). Post-BCAS there may be compensation of 
blood flow to the hypothalamus from other parts of the circulation, e.g. collaterals, supporting 
the possibility of a vascular remodelling mechanism after the long-term exposure to 
insufficient blood supply from the narrowed carotid arteries. Notably this ability to 
compensate may be impaired in Tg-SwDI mice. 
 BCAS caused an impaired cognitive function 
In the behavioural trials, evaluation of cognitive function revealed impaired visuo-spatial 
learning induced by BCAS surgery in both WT and Tg-SwDI mice. However, this was not 
further exacerbated in the presence of amyloid pathology. BCAS and amyloid did not result 
in impaired long-term spatial memory in acquisition phase. In the reversal test, increased 
challenge revealed no significant effect of BCAS on spatial learning, but Tg-SwDI mice failed 
to learn the task irrespective of BCAS potentially due to the presence of amyloid pathology.  
Chronic cerebral hypoperfusion has been suggested to cause cognitive decline, such as 
impaired learning and memory and advance the risk of Alzheimer’s disease and vascular 
dementia. In a recent study, (Holland et al., 2015) showed the following 6 months of 
hypoperfusion impaired spatial working memory in BCAS mice measured using radial arm 
maze. Moreover, impaired spatial reference learning and memory were identified in the 
water maze. Here a significant effect of hypoperfusion on escape latency between sham and 
BCAS mice was seen. In the probe trials, the sham group spent more time than by chance 




similar behavioural test to water maze and radial arm maze but does not include a strong 
aversive stimulus or food deprivation as reinforcement. Therefore, the Barnes maze applied 
in the present study provided weak aversive stimulation, only aiming to increase the 
motivation of experimental mice and eliminate the stress-induced confounds. The present 
data coincide with the findings from (Holland et al., 2015) that BCAS results in impaired 
spatial learning and memory and also extend our knowledge of the effect induced by amyloid 
pathology. Also, my data documented behavioural deficits at 3 months post-BCAS, which 
occurs earlier than 6 months that is reported by (Holland et al., 2015), although amyloid 
pathology did not exacerbate cognitive decline induced by hypoperfusion. In another study, 
comprehensive behavioural tests were performed to evaluate cognitive function in mice after 
5~6 months of BCAS and significantly impaired reference, and working memory was 
detected using Barnes maze and radial arm maze respectively (Nishio et al., 2010). Another 
earlier study demonstrated impaired working memory at 30 days following BCAS surgery 
which was attributable to damaged frontal-subcortical circuits (Shibata et al., 2007). In this 
shorter-term (30 days) study, there was no marked cortical or hippocampal alterations that 
might explain preferential damage to the working memory but not the reference memory. By 
contrast, in a longer-term study (5-6 months for the behavioural test; 8 months for 
histological assessment), pathological changes including hippocampal atrophy and cell 
deaths were documented in addition to white matter damage at 8 months after BCAS. These 
are correlated with both impaired working and reference memory (Nishio et al., 2010). My 
present behavioural and pathological results showed impaired spatial learning and long-term 
spatial memory following 3 months of BCAS, with vascular lesions documented mainly in the 
regions of the cortex, hippocampus, white matter, and thalamus. This present study fits in 
the intermediate time course of previous investigations, suggesting that the brain regions 




 Compromised glymphatic function after BCAS 
The mechanistic link between BCAS and VCI has primarily been attributed to the post-BCAS 
cerebral perfusion deficits initiating hypoxia-induced white matter pathology and 
degenerative changes to the glial-vascular unit (Holland et al., 2015). My new data indicates 
that BCAS can also lead to impaired CSF influx along the glymphatic pathway. In the first 
instance, tracers were injected into the cisterna magna and were able to be observed 
surrounding cerebral arteries e.g. middle cerebral artery (MCA) within the perivascular space 
(Figure 3-12 and Figure 3-13) consistent with previous observations showing that CSF influx 
moves along the periarterial components into deeper brain regions (Iliff et al., 2012). It has 
been shown by in vivo two-photon imaging that intracisternal CSF tracer travels along with 
the perivascular component surrounding pial surface (Iliff et al., 2012, Xie et al., 2013). Using 
this approach, we were able to measure the regional distribution of tracers post-BCAS. 
Following 3 months of carotid stenosis, the impaired glymphatic function was determined in 
cortical and deep hippocampal regions suggesting that prolonged disruption to the vascular 
system may lead to enduring suppression of CSF influx to the brain.  
CSF glymphatic influx has also shown to be impaired in other models relevant to cerebral 
vascular disease. In a rodent model of multiple infarcts, caused by intra-arterial injection of 
cholesterol crystals via the internal carotid artery, transient suppression of CSF influx was 
determined (Wang et al., 2017). However, in this study, the glymphatic function was restored 
within 2 weeks. In other models, a sustained or progressive impairment of glymphatic 
function has been shown, such as with ageing and in models relevant to AD. For example, in 
APP/PS1 mice, a model relevant to AD, both glymphatic periarterial influx and amyloid β 
(Aβ) clearance have been found impaired, with glymphatic failure occurring before significant 
Aβ accumulation (Peng et al., 2016). Malfunction of the glymphatic pathway has also been 
shown to be related to a build-up of amyloid, Aβ protein, in the vasculature (Kress et al., 
2014). Consistent with this, in the present study, microvascular amyloid as studied in the Tg-




further altered with stenosis. The reason for this is not clear but maybe in part due to the 
already prominent impairment of glymphatic function caused by the microvascular amyloid 
load.  
Cerebrovascular pulsatility is a critical driving force facilitating CSF flow into and through 
brain parenchyma (Iliff et al., 2013b, Mestre et al., 2018b). In work using two-photon imaging 
assessing vessel pulsation after carotid stenosis, there was evidence showing an impaired 
pulsation is a potential mechanism. In a parallel study, conducted with other researchers in 
the group (see Appendix) using intravital imaging, we found that arterial pulsation was 
specifically impaired and pulsation of other vessels within the vascular network unaltered 
post-BCAS. Previously, it has been reported that 30 minutes unilateral ligation of the internal 
carotid artery leads to significantly reduced pulsatility in the penetrating artery with impaired 
paravascular influx (Iliff et al., 2013b). Collectively, the data suggest altered arterial pulsatility 
is associated with a reduction in CSF influx post-BCAS (Iliff et al., 2013b).  
 Conclusion 
In summary, the findings in this chapter provide evidence linking carotid stenosis with 
cognitive impairment and demonstrate that whilst cerebral perfusion is reduced and 
sustained over several months, there may additionally be an impairment to glymphatic 
function that is emerging as having a significant role in the pathogenesis of VCI. This new 
data adds credence to a growing body of human studies that have challenged the view that 
cerebral hypoperfusion post-carotid stenosis is the predominant contributor to VCI. It 
strongly suggests alternate or additional mechanisms need to be considered (Shi et al., 
2018, Aribisala et al., 2014a, Wardlaw et al., 2017, Alhusaini et al., 2018). Furthermore, the 
efficient cellular communications within the brain cells, in particular the neurovascular unit is 
essential for maintaining tissue health and normal functioning. What happens to the efficient 
communication within NVU is extremely important to elucidate the underlying mechanism by 




next studies sought to explore neurovascular coupling and degenerative changes in both WT 






Chapter 4. Long-term effects of bilateral common carotid 
artery stenosis and amyloid-β (Aβ) on neurovascular function 
and degenerative changes 
 Introduction 
The studies outlined in Chapter 3 provide evidence that BCAS causes cognitive impairment 
via mechanisms involving reduced cerebral perfusion and impaired glymphatic function. 
Emerging evidence from epidemiology, imaging, clinical, and animal models suggest chronic 
cerebral hypoperfusion is associated with impaired haemodynamic abnormalities (Liu and 
Zhang, 2012, Ihara et al., 2014, Sarti et al., 2002). In the brain, the neurovascular unit 
facilitates dynamic changes in blood flow in response to changes in the neural activity, which 
is known as the process called neurovascular coupling.  
Neurovascular coupling ensures that the brain receives a proportionally matched blood 
perfusion in response to local neural activity. However, mounting evidence has suggested 
that neurovascular coupling may be impaired either in ageing or neurological disorders such 
as Vascular dementia and Alzheimer’s disease (Kisler et al., 2017, Shin et al., 2007). It is 
postulated that impaired blood flow responses to neural activity, as a result of mis-
coordinated activity of the neurovascular unit, may cause a mismatch between neural activity 
and delivery of energy substrates to meet sufficiently adequate metabolic demands (Kisler et 
al., 2017). Whether neurovascular coupling is altered following chronic cerebral 
hypoperfusion and whether these effects interact with microvascular Aβ accumulation are 
still unclear. In addition to the functional changes of cerebral blood vessels, 
neurodegenerative changes following BCAS is also suggested to be associated with 
cognitive dysfunction (Iadecola, 2013).  
VCI is commonly attributed to brain ischaemic or haemorrhagic injuries such as microinfarcts 




direct consequence of vascular pathology with profound alterations to the neurovascular unit 
and the normal physiology of neurovascular coupling. Evidence from our group has 
demonstrated the gliovascular alterations, including microinfarcts, fibrinoid necrosis, white 
matter disruption and widespread reactive gliosis induced by BCAS (Holland et al., 2015). 
Also, previous studies such as the NUN study has highlighted that the presence of amyloid 
lowers the threshold for precipitation of dementia in vascular disease (Snowdon et al., 1997). 
Thus, whether the presence of microvascular amyloid could affect the degenerative process 
in response to BCAS requires urgent investigation. The BCAS model in Tg-SwDI mice 
affords a unique opportunity to study mechanisms related to VCI and the development of 
dementia. Furthermore, the perivascular or glymphatic clearance of soluble Aβ has been 
gaining interest since the failure of Aβ clearance is recognised as a critical mechanism 
related to CVD and AD, leading to cognitive decline. It was shown in the previous chapter 
that glymphatic function was altered in the cerebral cortex and hippocampus in response to 
bilateral common carotid stenosis, whether the failure of clearance via glymphatic pathway 
could result in Aβ accumulation in the microvasculature remains to be determined. The 
neurodegenerative changes, including vascular related lesions, astrogliosis and the 
microvascular amyloid post-BCAS will be assessed in this chapter.  
 Hypothesis 
BCAS leads to cognitive impairment by impairing vascular function leading to degenerative 
changes and that these effects will be exacerbated in the presence of microvascular 
amyloid.  
 Study aims 
The present study aimed to assess neurovascular coupling, vascular related lesions, and 
astrogliosis following 3 months of BCAS, and to determine whether these are exacerbated in 
the presence of vascular Aβ. Second to this, the study also aimed to determine if BCAS 




 Materials and methods  
 Animals 
Male heterozygous Tg-SwDI mice and wild-type C57Bl/6J littermates were subjected to 
BCAS or sham surgeries. A group of mice from cohort 1 (n=42) (Tg-SwDI and wild-type 
littermates at 7-9 months old of age) were used in experiments for the investigation of 
neurovascular coupling, vascular related lesions and amyloid. The second cohort of mice 
(total number=33, Tg-SwDI mice at 5-7 months and wild-type C57Bl/6J at 4-5 months old of 
age) were prepared to determine the astrogliosis following surgery (cohort 2). Mice were 
randomly assigned to all the studies. All data were collected and analysed by experimenters 
that were blind to surgery types, genotype and treatments. In cohort 1, 1 mouse in Tg-SwDI 
BCAS was culled due to the severe bleeding during the surgery. 4 mice in Tg-SwDI and 2 
mice WT groups were culled due to the poor recovery following BCAS surgery. Therefore, 
these mice were excluded from the study. Final group size for cohort 1: n=8 WT sham, n=10 
WT BCAS, n=6 Tg-SwDI sham, n=10 Tg-SwDI BCAS. In cohort 2, n=10 WT sham, n=8 WT 
BCAS, n=7 Tg-SwDI sham, n=8 Tg-SwDI BCAS. 
 BCAS surgery 
Mice were anaesthetised under isoflurane in oxygen-enriched airflow. BCAS surgery was 
performed using microcoils (0.18mm internal diameter) to both common carotid arteries that 
modestly reduces cerebral blood flow (<30%) to induce luminal narrowing, and methods 
have been described in previous studies (Shibata et al., 2004, Coltman et al., 2011, Holland 
et al., 2011a, Reimer et al., 2011b). An interval of 30 minutes was given between the 
placement of coils to minimise the acute CBF changes caused by the placement of 
microcoils. Sham-operated animals underwent the identical procedure except for the 




 In vivo whisker stimulation and neurovascular coupling 
In vivo whisker stimulation was performed on mice anaesthetised by intraperitoneal injection 
with α-chloralose (50 mg/kg) and urethane (750 mg/kg) to preserve physiological vascular 
responses. Repeated whisker stimulation was used to evoke neurovascular coupling in the 
barrel cortex. Whiskers on the right side were trimmed at approximate 1 cm for stimulation 
and were cut on the left to avoid any unwanted disturbances. Mice were positioned on the 
stereotaxic frame with their head fixed into position. Oxygen airflow was supplied, and the 
rectal temperature was monitored and maintained at around 37 ºC. Laser speckle imager 
(moorFLPI-2, Moor Instruments, UK) was set up according to the methods described in the 
previous section. Stable cortical blood flow in the barrel cortex was recorded for 2 minutes 
as the baseline recording. During stimulation, the whiskers were deflected by rapid back-
and-forth movements using an electric stimulator for 30 seconds to evoke the neuronal 
activity in the contralateral barrel cortex. CBF was set to return to baseline before the next 
stimulation. Three successful recordings were recorded for data processing. Raw images 
from laser speckle imaging were analysed using moorFLPI2 Review software (v4.0). The 
mean response amplitude was collected and calculated as the result of the percentage 
increase from baseline.  
 Perfusion fixation  
Mice were perfused with 30 ml PBS then whole brains were fixed in 4% paraformaldehyde 
(PFA) in PBS for 24 hours and either transferred into 30% sucrose solution for 72 hours 
followed by snap freezing in dry ice-cooled isopentane then stored in -80 ºC freezer, or cut 
by vibratome and stored in -20 ºC freezer.  
 Haematoxylin and eosin (H&E) and Perl’s Prussian blue staining  
Brain slices at 12 µm thickness were obtained at the stereotactic level of (0.86 mm, 0.14 




related lesions, such as microinfarcts and microbleeds, sections were stained with H&E and 
Perl’s Prussian blue using methods described in the previous chapter (Chapter 2) to 
visualise the presence of ischaemic and haemorrhagic tissue damage. Ischaemic lesions 
were confirmed under a light microscope using H&E staining, and haemorrhagic lesions 
were confirmed using Perl’s staining.  
 Quantification of amyloid burden 
Immunohistochemistry was performed to determine the burden of amyloid in the cerebral 
cortex. 12 µm thick cryostat sections at the level of -1.82 mm to Bregma were stained 
following the immunostaining protocol introduced in Chapter 2. Tissues were double labelled 
with antibodies of amyloid (6E10) and collagen 4 (COL4) and labelled with secondary 
antibodies Alexa Fluor 546 and Alexa Fluor 488 for 6E10 and COL4, respectively. Raw 
images were obtained using a laser scanning confocal microscope (ZEISS LSM 710, 
Germany) then analysed using ImageJ JACoP plugin.  
 Analysis of astrogliosis 
Immunostained 100 µm vibratome sections were analysed using a slide scanner (ZEISS 
Axio Scan.Z1). Astrogliosis was assessed by measuring the percentage of stained area 
occupied by GFAP staining, using auto thresholding (triangle method). All measurements 
were carried out using ImageJ (v1.46, NIH, Bethesda, MD, USA). 
 Statistical analysis  
Neurovascular coupling and astrogliosis were analysed using two-way ANOVA with 
Bonferroni’s multiple comparisons. Mann-Whitney U test was used to compare the amyloid 
burden and blood vessel density. Difference in proportions test was performed to compare 







 Neurovascular coupling is significantly impaired in both WT and Tg-
SwDI mice at 3 months following BCAS surgery 
In the previous studies, CBF was measured post-BCAS and determined to be reduced in the 
long-term in both WT and Tg-SwDI mice with no difference between these groups. Although 
CBF may not be different, neurovascular coupling, (i.e. the CBF response to neural 
stimulation) as has been shown in studies of other VCI models may be differentially altered. 
To investigate whether long-term BCAS (3 months) causes alterations in neurovascular 
coupling, CBF was measured in the barrel cortex at baseline and then changes in CBF in 
response to whisker stimulation was measured. Responses of cortical blood vessels to 
whisker stimulation were recorded and quantified as the mean percentage increase from the 
baseline (Figure 4-1). There was a significant effect of BCAS surgery (F (3, 34) =16.61, 
p<0.001), whereby impaired neurovascular coupling was observed in the BCAS mice from 
both WT and Tg-SwDI mice. However, there was no significant effect of genotype in these 
mice (p>0.05). Post-hoc tests showed significantly impaired neurovascular coupling in WT 
(p<0.05) and Tg-SwDI groups (p<0.01) compared to their sham counterparts, respectively 






Figure 4-1 BCAS results in impaired neurovascular coupling at 3 months after BCAS surgery. 
Neurovascular coupling was assessed using laser speckle contrast imaging with whisker stimulation at 3 months 
of BCAS surgery. Significant effect of the surgery was found in both WT and Tg-SwDI mice. No effect of 
genotype was observed. Post-hoc analysis showed significantly impaired neurovascular coupling in WT and Tg-
SwDI group compared to the sham animals, respectively. Data presented as mean ± SEM, n=8 WT sham, n= 10 
WT BCAS, n= 6 Tg-SwDI sham, n=10 Tg-SwDI BCAS, * indicates p<0.05 and ** indicates p<0.01. 
 Degenerative changes: vascular related lesions were found in the WT 
and Tg-SwDI mice after BCAS surgery 
Building on the findings that neurovascular coupling was impaired in both WT and Tg-SwDI 
mice, the impact of BCAS on degenerative changes in the brain was assessed. Chronic 
cerebral hypoperfusion produced by BCAS has been previously shown to increase the 
microinfarct area in the Tg-SwDI mice. The present study aimed to use H&E staining to 
determine the presence of ischaemic lesions (microinfarcts) and Perl’s Prussian blue 
staining to determine the burden of haemorrhagic stroke lesions (microbleeds).  
In none of the sham-operated mice were vascular related lesions detected (0 out of 8 in WT 
sham and 0 out of 6 in Tg-SwDI sham). Further investigation at stereotactic levels (0.86 mm, 
0.14 mm, -0.46 mm, -1.34 mm, -1.70 mm and -2.30 mm to Bregma) revealed that 4 out of 10 





























































lesions. Difference in proportion test showed that mice in the Tg-SwDI BCAS group did not 
demonstrate a significantly higher proportion of mice with vascular related lesions compared 
to WT BCAS mice (p=0.371) (Table 4-1). Representative images of ischaemic lesions in the 
cortex (Figure 4-2A), white matter lesions (Figure 4-2B and D), neuronal damage in the 
hippocampus CA1 (Figure 4-2C and E) and subcortical lesion (Figure 4-2F) are shown. 
Subcortical haemorrhagic lesions were predominantly found in the thalamus (Figure 4-2G, I 
and H). 
Table 4-1 Vascular related lesions are found in both WT and Tg-SwDI mice post-BCAS.  
 Normal Vascular related lesions 
WT BCAS 6 4 








Figure 4-2 Representative images of vascular related lesions in multiple brain regions. 
Images of ischaemic lesions were taken from regions of the cortex (A), corpus callosum (B and D), hippocampus 
(C and E), subcortex (F). Perl’s positive staining for haemorrhagic lesion is surrounding a big vessel (H) and 










 Increased astrogliosis following bilateral common carotid stenosis 
(BCAS) 
To discern the mechanisms by which BCAS and microvascular amyloid may impact on the 
glymphatic function, the extent of astrogliosis was further studied since astrocytes and their 
end-feet have been shown to alter glymphatic function (Iliff et al., 2012). GFAP 
immunostaining was undertaken to investigate the extent of reactive gliosis post-BCAS and 
in Tg-SwDI mice (Figure 4-3A and B). There was a significant effect of BCAS surgery (F (1, 27) 
=0.3, p=0.01) but no effect of genotype (p>0.05) and interaction (p>0.05) on the extent of 
astrogliosis in the dorsolateral cortex. Post-hoc tests showed a significant increase of 





Figure 4-3 GFAP staining was used to assess the degree of astrogliosis in the dorsal lateral cortex.  
(A) Representative images of GFAP staining in the dorsal lateral (DL CTX). (B) BCAS caused increased 
astrogliosis, and there was no effect on amyloid or interaction. Data are presented as mean ± SEM and analysed 
by two-way ANOVA with post-hoc Bonferroni procedure, n=10 WT sham, n= 7 WT BCAS, n= 7 Tg-SwDI sham, 




The hippocampal CA1-DG molecular layer was further analysed (Figure 4-4A and B). There 
was a significant effect of genotype (F (1, 28) =0.457, p=0.002) but no effect of BCAS (p>0.05) 
and interactions (p>0.05) on astrogliosis. Post-hoc tests showed a significant increase 
between WT BCAS and Tg-SwDI BCAS mice (p=0.009) and a slightly increased astrogliosis 






Figure 4-4 GFAP staining was used to assess the degree of astrogliosis in hippocampal CA1-DG molecular layer. 
(A) Representative images of GFAP staining in the hippocampus CA1-DG molecular layer. (B) In the 
hippocampus, amyloid showed main effect but not BCAS, with increased astrogliosis in the Tg-SwDI mice after 
carotid stenosis. Data are presented as mean ± SEM, n=10 WT sham, n= 8 WT BCAS, n= 7 Tg-SwDI sham, n=7 
Tg-SwDI BCAS, ** indicates p<0.01. Scale bar=100 µm. 
WT Sham WT BCAS














































 BCAS leads to increased amyloid burden in the cortical cerebral 
vasculature 
To date, all data suggests that Tg-SwDI mice respond similarly to BCAS than WT mice with 
comparable rCBF reductions, cognitive alterations and neurovascular alterations. This was 
contrary to the original hypothesis particularly given that Tg-SwDI mice are reported to have 
increased microvascular amyloid (Davis et al., 2004). Thus, given that previous studies have 
shown BCAS can alter amyloid accumulation the next study also sought to determine 
amyloid levels post-BCAS and compare to sham.  
There is no evidence of amyloid accumulation in WT sham or BCAS mice. To investigate the 
potential changes of amyloid burden following 3 months of BCAS, Aβ (6E10) load was 
evaluated in the cortex and co-labelled with collagen 4 (COL4) (a marker of the basement 
membrane of blood vessels) to enable the assessment of microvascular amyloid in our Tg-
SwDI mouse model (Figure 4-5A). A significant increase in the total amount of amyloid in the 
cortex was determined post-stenosis (Figure 4-5B) (p<0.05). Additionally, a significant 
increase in vascular amyloid was determined post-stenosis (p<0.05) (Figure 4-5C). Since 
basement membrane has been shown as pathways for the clearance of Aβ, we further 
evaluated the collagen 4 levels and did not find significant changes in the mice with 3 







Figure 4-5 Increased amyloid load in the superficial cortex. 
Representative images of amyloid (green) colocalised to the vasculature (red) in the Tg-SwDI sham and BCAS 
mice (A). Total amyloid was analysed using % area of positive 6E10 staining. Increased total amyloid was found 
in the superficial cortical area (~250 µm from the pial surface) (B). The percentage of vascular amyloid in total 
amyloid was analysed using JACoP plugin (ImageJ). Amyloid that was colocalised with COL4 positive staining 
was considered as vascular amyloid. A increased vascular amyloid load (percentage of vascular amyloid in total 
amyloid) was found in the same area (C). No alterations of the density of vascular basement membranes (as 
measured by COL4 immunostaining) were found (D). n=6 Tg-SwDI sham and n=9 Tg-SwDI BCAS, * indicates 





The present study demonstrated that BCAS impaired neurovascular coupling and promoted 
degenerative changes and second to this provided evidence that BCAS could promote 
amyloid accumulation in the cerebral microvasculature. In contrast to the hypothesis, 
neurovascular coupling was found to be impaired solely by the BCAS effect with no further 
exacerbation by the presence of microvascular amyloid. Neurodegenerative changes 
including white matter lesions, microinfarcts and microbleeds were observed following 
BCAS, and found to be promoted in the Tg-SwDI mice.  
Widespread reactive astrocytes are a key feature observed in BCAS models and associated 
with hypoxia-induced neurodegenerative changes contributing to cognitive impairment. To 
further elucidate the potential mechanisms underlying the structural and functional changes 
in the neurovascular unit and observed glymphatic dysfunction in response to BCAS, the 
extent of astrogliosis was assessed. However, the extent of astrogliosis did not always 
reflect the impaired glymphatic function in different regions: in the cortex following post-
BCAS, there was pronounced astrogliosis whereas in the hippocampus astrogliosis was 
unaltered post-BCAS and instead increased in Tg-SwDI mice. Lastly, the investigation of 
amyloid load demonstrated that both total amyloid deposition and microvascular amyloid 
accumulation were increased in the cerebral cortex in response to the BCAS. 
 Bilateral common carotid artery stenosis (BCAS) impairs neurovascular 
coupling 
The bilateral common carotid artery stenosis (BCAS) model in mouse has been described as 
the optimal model to replicate chronic cerebral hypoperfusion. Previous studies as outlined 
in this thesis (Chapter 3) using laser speckle contrast imaging and ASL indicates that 
cerebral perfusion is markedly reduced and sustained throughout the three months. 
However, this level of reduced perfusion may still be sufficient to meet the metabolic 




coupling was investigated since sustained reduced perfusion may be insufficient to meet the 
metabolic demands of tissue. In the present study, BCAS caused a marked impairment in 
neurovascular coupling in both WT and Tg-SwDI mice to levels of approximately 18% that of 
baseline. Although no previous studies have specifically measured the neurovascular 
coupling in response to BCAS using whisker stimulation method. In another relevant model, 
resting CBF and neurovascular coupling were measured in mice subjected to unilateral 
common carotid artery occlusion (UCCAO) (Nishino et al., 2016). The percentage changes 
of CBF response after whisker stimulation in the ipsilateral hemisphere to UCCAO side were 
significantly decreased at 7 (6.9 ± 2.8%), 14 (6.8 ± 2.3%) and 28 days (4.9 ± 2.4%) following 
surgery.  
In contrast to initial predictions, neurovascular coupling was not further impaired in Tg-SwDI 
mice post-BCAS compared to WT BCAS mice. To date, there have been no other studies 
that have measured neurovascular coupling in vivo in the Tg-SwDI mice post-BCAS. 
However neurovascular coupling, independent of BCAS has been reported in Tg-SwDI mice 
exhibiting impaired responses to whisker stimulation at 3 months, prior to the onset of 
cerebrovascular amyloid deposition (Park et al., 2014). A recent study from our group 
investigated the effect of ageing on neurovascular coupling, cellular components within the 
neurovascular unit and whether these effects would be exacerbated in the presence of 
amyloid in Tg-SwDI mice (Duncombe et al., 2017b). Impaired neurovascular coupling was 
detected with advancing age starting at 12 months and notably, similar to the present study, 
amyloid did not exacerbate these effects. The impaired NVU coupling correlated closely with 
a loss of astrocytic end feet contacts with vessels and a prominent microglial response.  
Although cellular components of the NVU were not measured in the current study, loss of 
NVU integrity likely underpins this. Previous work by our group has shown a gradual 
disintegration of the glial-vascular unit post-BCAS with loss of astrocytic end feet contacts 
and a prominent microglial response (Holland et al., 2015). The reasons for the differences 




coupling in such an early stage to the presence of soluble amyloid. Different imaging 
techniques (e.g. laser doppler vs laser speckle imaging, and cranial window vs intact skull) 
may also influence the detection of CBF changes produced by whisker stimulation. Future 
investigations on the direct effect of variable amyloid species on the neurovascular coupling 
remain required.  
Indirect evidence of neurovascular unit changes and remodelling have been shown. 
Evidence from another group investigating the impact of BCAS in another Alzheimer’s 
disease transgenic mouse model (APP23) demonstrated a major impact of BCAS on the 
neurovascular unit (Shang et al., 2016). In this study, post-BCAS APP23 mice showed 
significantly enhanced AD pathology, including cerebrovascular remodelling and restored 
neuropathological abnormalities by galantamine treatment (Shang et al., 2016). BCAS was 
induced by surgically placed ameroid constrictors (a device similar to microcoils but 
gradually narrowing the vessel) on bilateral common carotid arteries rather than using micro 
coils (as used in this thesis) and in relatively younger mice (4 months old at the time of 
surgery) and at 2 and 8 months following surgery respectively. Instead of using in vivo 
imaging technique, they used in vitro BDNF/TrkB double staining method to examine the 
neurovascular coupling and found no significant changes at 2 months but significant 
reductions in the neurovascular unit at 8 months in the subcortical regions including CA1, 
thalamus and polymorph layer of the dentate gyrus. By contrast, the present study provides 
the novel evidence of the neurovascular coupling changes following BCAS in a mouse 
model exhibiting microvascular amyloid.  
 Chronic cerebral hypoperfusion induced neurodegenerative pathology 
BCAS models usually exhibit a well-described white matter pathology (Coltman et al., 2011). 
However, our group has reported an increase in subcortical vascular lesions in the longer-
term post BCAS in WT mice (Holland et al. 2015). Similarly, in the present study, vascular 




surgery and none were found in sham groups. There was no significant difference between 
the proportions of WT and Tg-SwDI mice subjected to BCAS (p>0.05) suggesting amyloid 
pathology did not exacerbate vascular related neurodegeneration after BCAS induced 
cerebral hypoperfusion.  
Our group first identified gliovascular alterations after 6 months of BCAS including a marked 
increase in haemorrhage, fibrinoid necrosis and blood-brain barrier (BBB) breakdown with 
minimal vascular lesions after 1 month of hypoperfusion and these ischaemic and 
haemorrhagic lesions were confirmed using T2-weighted MRI scans (Holland et al., 2015). 
After 6 months of hypoperfusion, 60% of BCAS mice demonstrated ischaemic lesions 
including cortical infarcts, or areas of hyperintensity, which were located in the region 
supplied by the middle cerebral artery. 35% of BCAS mice were detected with small focal 
subcortical infarcts in the thalamus with fewer lesions in hypothalamus and striatum. The 
haemorrhagic lesions were most intense after 6 months of hypoperfusion which 75% of 
BCAS mice showed lesions in subcortical regions, particularly thalamic nuclei. In 
comparison, in the present study, after 3 months hypoperfusion, vascular lesions were 
mostly identified in the cortex and subcortical regions such as corpus callosum, 
hippocampus and thalamus, with remarkable vascular pathology including fibrinoid necrosis, 
microinfarcts and microbleeds. The present study also showed less ischaemic and 
haemorrhagic lesions compared with 6 months of BCAS surgery, but a higher proportion of 
ischaemic lesions and a marked increase of haemorrhagic lesions were found compared 
with 1-month hypoperfusion that has minimal lesion load. The co-occurrence of ischaemic 
and haemorrhagic lesions at 3 months of hypoperfusion, which is absent in 1 month, 
indicates the progressive vascular pathology that coincides with previous data and provides 
additional evidence between the time course of 6 months. The underlying mechanism for the 
increased pathological burden in Tg-SwDI mice may indicate the potential interactions 
between vascular and amyloid load leading to neurodegenerative changes, which have been 




 BCAS increases the accumulation of microvascular amyloid 
The increased amyloid load, including both total amyloid and in the cerebral vasculature in 
the Tg-SwDI mice with BCAS, suggested an impaired balance between the production and 
clearance of the Aβ might occur. Although it was not assessed in the current study, Tg-SwDI 
hypoperfused mice have demonstrated altered amyloid peptide pools with accelerated 
microinfarcts compared to the hypoperfused WT mice (Salvadores et al., 2017). Following 1 
month of BCAS, increased soluble Aβ (Aβ40/42) was determined with elevated APP and 
APP proteolytic products. At the stage of 3 months, an increase in insoluble Aβ40/42 was 
detected in both parenchyma and vasculature. Microinfarct load was significantly increased 
in the Tg-SwDI as compared with wild-type mice and further exacerbated by hypoperfusion 
at 1 and 3 months. Also, the number of Tg-SwDI hypoperfused mice with haemorrhages was 
increased compared with hypoperfused wild-type mice. These findings suggest increased 
Aβ production occurred following hypoperfusion contributing neurodegenerative process.  
In the current study, increased Aβ accumulation was evident and impairment in the 
glymphatic function was determined in the previous chapter. This provides additional 
evidence that following long-term cerebral hypoperfusion, alterations in both Aβ production 
and glymphatic clearance have been produced contributing to the accumulation of Aβ. In 
accordance with the present results, previous studies have demonstrated that cerebral 
hypoperfusion accelerates cerebral amyloid angiopathy and promotes cortical microinfarcts 
(Okamoto et al., 2012). In the first set of post-mortem analysis, CAA severity was detected 
as the only predictor among all the investigated factors including age, disease, senile 
plaques, neurofibrillary tangles, CAA, atherosclerosis as well as white matter damage that is 
associated with the cortical microinfarcts. This finding was further supported by a parallel 
study in Tg-SwDI mice following BCAS, showing exacerbated deposition of leptomeningeal 
Aβ with developing microinfarcts in the cerebral cortex. By contrast, without the effect of 
hypoperfusion, Tg-SwDI mice did not exhibit microinfarcts with fewer Aβ detected in the 




was impaired due to the perivascular accumulation of Aβ following hypoperfusion, which was 
not measured in the study. Okamoto et al. also suggested an implication of this is the 
possibility that the perivascular drainage pathway was impaired, forming a vicious cycle of 
vascular Aβ deposition. Overall, the findings reported here shed new light on the 
accumulation of microvascular Aβ post-hypoperfusion, which was due to impaired 
microvascular function as a result of BCAS rather Aβ alone. These results also add to the 
rapidly expanding field of impairment in the glymphatic function following damaged 
neurovascular integrity is a potential mechanism responsible for the increased Aβ 
accumulation in the cortical microvasculature. 
 Conclusions 
The studies within this chapter provide further support that BCAS has damaging effects on 
the brain, causing not only impaired neurovascular function, degenerative changes but can 
also lead to a build-up of amyloid. These findings have provided a more in-depth insight into 
the role of cerebral hypoperfusion and microvascular amyloid in the progression of VCI. It 
may also help to highlight that cerebral hypoperfusion is the major contributor impacting 
neurovascular function; however, the amyloid in the microvasculature promotes the 
degenerative changes. Unfortunately, the study was not able to include data from human 
studies with perfusion deficits, and Aβ detected in the early stage of VCI. Further 
investigation to understand the underlying mechanisms leading to the relevant 
pathophysiological changes following cerebral hypoperfusion is required. Functional 
magnetic resonance imaging (fMRI), the blood oxygenation level-dependent (BOLD) 
contrast has become more frequently used in clinical settings, as well as animal studies, to 
map brain activation and may be a useful tool to detect the longitudinal changes of amyloid 
deposition in the human brain. The following studies will focus on NADPH oxidase, which 
has been associated with vascular damage and CAA formation, which may contribute to the 




Chapter 5. The effect of an NADPH oxidase inhibitor in Tg-
SwDI mice following carotid stenosis 
 Introduction 
The previous studies outlined in this thesis have shown that BCAS caused reduced cerebral 
hypoperfusion, impaired NVU coupling and cognitive deficits. In Tg-SwDI mice, BCAS was 
found to promote the accumulation of amyloid as well as promote degenerative lesions. 
Although the mechanisms remain ill-defined previous work has shown that excessive 
production of reactive oxygen species (ROS), which causes increased oxidative stress in the 
central nervous system may contribute to degenerative processes and amyloid accumulation 
(Kanamaru et al., 2015, Salvadores et al., 2017).  
Oxidative stress is the result of imbalance in levels of antioxidants and ROS production, 
contributing to the damage to endothelial, glial and neuronal cells in the brain and 
neurovascular dysregulation (Freeman and Keller, 2012, von Bernhardi et al., 2015, Ma et 
al., 2017a, Park et al., 2007). There are several enzymes and metabolic processes that can 
produce ROS, a family of enzymes called the NADPH oxidase (NOX), which is expressed in 
multiple cell types in the CNS, including endothelial cells. NOX has recently emerged as a 
primary source of ROS in neurodegenerative diseases (Ma et al., 2017a). Recent evidence 
suggests NOX-derived ROS mediating vascular amyloidosis is associated with impaired 
cerebral vascular dysfunction. Importantly, data from our group has demonstrated that BCAS 
causes increased levels of soluble amyloid, which is associated with increased NOX2 levels 
(Figure 5-1) (Salvadores et al., 2017). Furthermore, apocynin, a natural source NOX 
inhibitor, has been shown to ameliorate cerebral vascular reactivity in aged mice developing 
vascular amyloid (Han et al., 2015). Supported by the close link between NOX activity and 
cerebral vascular function in the Tg2576 transgenic lines expressing vascular amyloidosis, 
the present study focuses on the effect of NOX inhibitor on the previously described 





Figure 5-1 Increased NOX2 level in Tg-SwDI mice, which was exacerbated by BCAS induced chronic cerebral 
hypoperfusion. 
Using a setting similar to studies in this thesis, WT and Tg-SwDI mice were subjected to sham or BCAS surgery 
at the outset of the study, NOX2 levels were quantified in protein extracts from brain homogenates using ELISA 
following after 1 (a) and 3 (b) months of hypoperfusion. (c) There was a positive correlation between NOX2 levels 
and soluble parenchymal Aβ40 levels. * indicates p<0.05 and *** indicates p<0.001. Data presented from a 
previous study in our group (Salvadores et al., 2017). 
 Hypothesis  
This current study tests the hypothesis that increased NOX levels post-BCAS mediates 
impaired vascular function and pathological alterations leading to impaired cognitive 
function.  
 Aims 
This study sought to assess whether a NOX inhibitor apocynin would improve cortical blood 
flow, neurovascular coupling, development of vascular lesions and cognitive performance in 
Tg-SwDI mice subjected to BCAS.  
 Materials and methods  
 Animals 
Male heterozygous Tg-SwDI mice (n=41) at approximate 9 months of age were used at the 




behavioural tests and histology assessments. Mice were group held in standard cages with 
access to bedding, diet, drinking water, and nestles under 12 h dark/light cycles. The Tg-
SwDI mice are expressing human amyloid precursor protein (APP) in the microvasculature 
(Davis et al., 2004). At the outset, mice were randomly assigned to all the studies. All data 
were collected and analysed by experimenters that were blind to surgery types and 
treatment methods. Final group numbers included for analysis are n=6 sham vehicle, n=6 
sham apocynin, n=10 BCAS vehicle and n=9 BCAS apocynin (Figure 5-2).  
 
Figure 5-2 Summary for the use of animals in the experiments. 
A summary to demonstrate the use of animals in the experiments of this chapter. Tg-SwDI mice were given 
apocynin/vehicle treatment immediately after BCAS/sham surgeries. These mice were used for in vivo 
experiments to measure CBF changes over a period of 3 months. Barnes maze was performed to evaluate 
cognitive function at about 3 months. CBF and vascular function were measured at 3 months following treatment 
then tissue was collected for histological examination.  
 BCAS surgery 
Tg-SwDI mice received surgery at 9 months of their age. Details of surgical methods were 
described in the Chapter 2. In brief, Tg-SwDI mice were anaesthetised under isoflurane in 
oxygen-enriched airflow then subjected to BCAS or sham surgery. 5 mice were culled from 
BCAS vehicle group (1 mouse was culled without recovery due to serious bleeding during 




group. 1 mouse was found seizure and dead in sham apocynin group. Therefore, these mice 
were excluded from in vivo study.  
 Administration of NOX inhibitor apocynin  
Following BCAS surgery, mice were immediately fed with either apocynin or vehicle in their 
drinking water for 12 weeks at a dose of 30 mg/kg/day. Apocynin stock was freshly made 
using commercially obtained compound (Sigma, UK). A working solution was defrosted with 
light protection before the administration. Apocynin and vehicle were changed three times 
per week with a maximal duration less than three days to keep the freshness. The 
consumption of apocynin and water were monitored throughout the study.  
 In vivo laser speckle contrast imaging  
In vivo laser speckle imaging was performed to measure the cortical CBF level. Repeated 
cortical CBF data were collected at baseline before the surgery, 24h, 1 month and 3 months 
post-surgery. After each measurement, the surgical incision was sutured, and mice were 
recovered at the end of each imaging session except the endpoint experiment. Details see 
Methods section (Chapter 2). 
 Assessment of spatial learning and memory using Barnes maze 
Barnes Maze was used to assess the spatial learning and memory ability at about 3 months 
following BCAS or sham surgery. At the outset, the velocity was taken as a control 
measurement to decide whether the motor function was altered by drug treatment and 
surgery. Several parameters were included in the final analysis of behavioural tests, 
including escape latency and % time spent in quadrants. Barnes maze was recorded using a 
camera connected with a tracking software ANY-maze v 4.99 (San Diego, California). 




 Perfusion fixation  
Mice were perfused with 30 ml PBS then whole brains were fixed in 4% paraformaldehyde 
(PFA) in PBS for 24 hours and transferred into 30% sucrose solution for 72 hours followed 
by snap freezing in dry ice-cooled isopentane then stored in a -80 ºC freezer.  
 Haematoxylin and eosin (H&E) and Perl’s Prussian blue staining  
Brain tissue slices at 12 μm thickness were obtained at the stereotactic level of 0.86 mm, 
0.14 mm, -0.46 mm, -1.34 mm, -1.70 mm and -2.30 mm to Bregma. To determine the 
vascular related lesions, such as microinfarcts and microbleeds, sections were stained with 
H&E and Perl’s Prussian blue using methods described in the previous Chapter 2 to 
visualise the presence of ischaemic and haemorrhagic tissue damage. Ischaemic lesions 
were confirmed under the microscope using H&E staining and haemorrhagic lesions were 
confirmed using Perl’s staining.  
 Quantification of amyloid burden 
Immunohistochemistry was performed to determine the burden of amyloid in the cerebral 
cortex. 12 μm thick cryostat sections at the level -1.82 mm to Bregma were stained following 
the immunostaining protocol introduced in Chapter 2. Subsequently, tissues were double 
labelled with antibodies of amyloid (6E10) and collagen 4 (COL4). Sections were labelled 
with secondary antibody Alexa Fluor 546 and Alexa Fluor 488 for 6E10 and COL4, 
respectively. Raw images were obtained using a laser scanning confocal microscope (ZEISS 
LSM 710, Germany) then analysed using ImageJ JACoP plugin.  
 Statistical analysis  
Details of statistical analysis were summarised in Chapter 2. Cortical CBF from laser speckle 
imaging and Barnes maze spatial learning were carried out by repeated measures ANOVA 




two-way ANOVA followed by Bonferroni’s multiple comparison test. Difference in proportions 
test was performed to compare the proportions of vascular related lesions. Amyloid burden 
and vessel density were compared using Mann-Whitney U test. One sample t-test was used 
to compare the performance of each group with the chance. Statistical analysis was 
performed using IBM SPSS Statistics 22.  
 Results:  
 NADPH oxidase inhibitor improved CBF following 3 months of carotid 
stenosis 
To investigate the effect of apocynin on cortical CBF, laser speckle contrast imaging was 
applied to a subset of Tg-SwDI mice at approximate 9 months old to determine cortical blood 
perfusion levels at baseline, 24 hours, 1 month and 3 months post-BCAS surgery. The data 
were quantified as percentage changes from baseline blood flow at each point following 
surgery. Significant effects of time (F (2.0, 65.2) =13.9, p<0.001) and surgery (F (1, 32) =41.8, 
p<0.001) were observed. However, no overall effect of apocynin treatment (F (1, 32) =0.1, 
p>0.05) was detected (Figure 5-3). A significant interaction between time and surgery (F (2.0, 
65.2) =9.4, p<0.001) was detected. Further post-hoc tests revealed significantly reduced CBF 
between sham and BCAS mice at 24 hours (p<0.001), 1 month (p<0.001), and 3 months 
(p<0.001) by giving vehicle treatment following surgery. Meanwhile, in apocynin treated 
mice, there was a significant difference in cortical blood flow at 24 hours (p<0.05) and 1 
month (p<0.05) between sham and BCAS mice. However, no significant difference was 
detected at 3 months (p=0.67). This data indicates that apocynin restored reduced blood 





Figure 5-3 Representative images of cortical CBF measured by laser speckle imaging.  
Tg-SwDI mice were given treatment for a period of 3 months after BCAS or sham surgeries. The cortical CBF 
levels were measured by laser speckle imaging. Representative images were taken at 24 hours before BCAS or 
sham surgeries (baseline), each animal was then imaged at 24 hours, 1 month and 3 months after surgeries. 













Figure 5-4 Improved cortical blood flow following 3 months of apocynin treatment in Tg-SwDI mice.  
BCAS showed a significant effect on CBF over 3 months. Further post-hoc analysis revealed significantly 
reduced CBF between sham and BCAS mice at 24 hours, 1 month and 3 months compared to mice given vehicle 
treatment following surgery, respectively. Meanwhile, in apocynin treated mice, there were significant differences 
in cortical blood flow at both 24 hours and 1 month following surgery between the sham and BCAS animals. 
Notably, at the end of 3 months, recovery of CBF from the BCAS apocynin group after 3 months of treatment can 
be found; n=4 sham vehicle, n=3 sham apocynin, n=4 BCAS vehicle, n= 5 BCAS apocynin. *** and ### indicate 
p<0.001, respectively. Data presented as Mean ± SEM. 
 Apocynin restored neurovascular uncoupling following 3 months of 
cerebral hypoperfusion 
In order to determine whether apocynin affects neurovascular coupling, the cortical vascular 
function was assessed using whisker stimulation at 3 months following BCAS (Figure 5-5). A 
significant interaction between BCAS surgery and apocynin treatment (F (1, 26) =1.9, p<0.05) 
was found after 3 months of BCAS/treatment. In vehicle treated mice, there was a significant 
difference between sham and BCAS mice (p<0.05) confirming the impaired neurovascular 
coupling following BCAS surgery. However, there was no significant difference between 
sham and BCAS Tg-SwDI mice in the apocynin treated group (p>0.05), which indicates 
improved neurovascular coupling in the BCAS mice after 3 months of apocynin treatment. 
Besides, in the mice that received BCAS surgery, apocynin treated mice demonstrated 















































supporting the finding that apocynin restored impaired neurovascular coupling after 3 
months treatment (Figure 5-6). 
 
Figure 5-5 Representative images of CBF changes in the barrel cortex during whisker stimulation.  
Vascular function was assessed by whisker stimulation in Tg-SwDI mice at about 12 months old. Representative 







Figure 5-6 Apocynin restored vascular function following carotid stenosis. 
BCAS vehicle group showed an inadequate response, but the mice received 3 months of apocynin treatment 
showed robust response during the stimulation. There was a significant interaction between BCAS surgery and 
treatment in the mice treated with apocynin following surgery. In the vehicle treated mice, there was a significant 
difference between sham and BCAS mice, confirming the impaired neurovascular coupling following BCAS 
surgery. However, there was no significant difference between sham and BCAS mice treated with apocynin, 
suggesting restored vascular function in the BCAS mice after apocynin treatment. BCAS mice with apocynin 
treatment demonstrated significantly higher vascular responses compared to vehicle treated group, supporting 
the finding that apocynin restored impaired neurovascular coupling after 3 months of treatment; n=6 sham 
vehicle, n=6 sham apocynin, n=10 BCAS vehicle, n=8 BCAS apocynin. * indicates p<0.05. Data presented as 
Mean ± SEM. 
 Vascular related pathology was not ameliorated by apocynin treatment 
In the previous studies (Chapter 4), it was shown that BCAS promoted the development of 
vascular lesions in Tg-SwDI mice. In order to determine whether inhibiting NOX activity 
could provide any beneficial effect on the development of vascular pathology, the number of 
animals that presented evident microinfarcts and microbleeds was counted through 6 































































and haemorrhagic lesions, respectively (Figure 5-7). 6 out of 10 mice from the vehicle 
treated group (60%) and 3 out of 9 mice (33%) from the apocynin treated group showed 
vascular related lesions (Table 5-1). However, there was no significant difference between 
the proportions of these groups (p>0.05). Thus, apocynin treatment did not influence the 
development of neurodegenerative pathology of mice with vascular related lesions.  
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Figure 5-7 Apocynin treatment did not ameliorate vascular related lesions induced by carotid stenosis. 
The effect of apocynin on the development of vascular related pathology has been examined by counting the 
frequency of mice with vascular lesions. H&E (A-F) staining shows hypoxia-induced microinfarcts in the cerebral 
cortex (A) and microbleeds in deep cortical region (B). Comprehensive neuronal damage in the hippocampal 
brain regions (C). Ischaemic lesions in the fimbria (below the lateral ventricle) (D). Perl’s Prussian blue staining 
shows haemorrhagic lesions in the medial amygdala region (E and F). Scale bar in B=100 μm, C-F= 200 μm. 
 The amyloid burden in the cerebral cortex was not reduced after 
apocynin treatment 
In previous studies described in this thesis (Chapter 4), it was shown that BCAS promoted 
the accumulation of Aβ. Other work from our lab indicated increased soluble Aβ was 
associated with increased NOX2 levels (Salvadores et al., 2017). The effect of NOX 







measured after 3 months of apocynin treatment in the BCAS groups. The amyloid burden 
was investigated in the cerebral cortex in which it was shown apocynin partially restored 
CBF and vascular function (Figure 5-8A). When comparing the total amyloid load, there was 
no significant difference between vehicle treated, and apocynin treated mice after BCAS 
surgery (p>0.05) (Figure 5-8B). There was no significant difference when comparing the 
burden of cortical vascular amyloid (percentage of total amyloid that is vascular type) in the 
vehicle, and apocynin treated mice (p>0.05) (Figure 5-8C). When further comparing the 
amyloid load distributed in the parenchyma, there was no significant difference of the 
parenchymal amyloid load in the cerebral cortex (p>0.05) (Figure 5-8D). Because COL4 has 
been reported to play a pivotal role in the clearance of amyloid, the percentage area of 
COL4 distribution in the cerebral cortex was measured, but there was no significant 


























































































































































































The cortical amyloid load was assessed by double labelling of COL4 and 6E10 in Tg-SwDI mice. (A) 
Representative images for BCAS Vehicle (top panel) and apocynin treated group (bottom panel). The COL4 and 
6E10 markers showed the localisation of Aβ with microvasculature in the cerebral cortex. (B) Total amyloid was 
analysed using % area of positive 6E10 staining. The comparison of total amyloid level in vehicle and apocynin 
treated mice following carotid stenosis. There were no significant changes in total amyloid load after apocynin 
treatment. (C) Amyloid that was colocalised with COL4 positive staining was considered as vascular amyloid. The 
percentage of vascular amyloid in total amyloid was analysed using JACoP plugin (ImageJ). There was no 
alteration of vascular amyloid load (percentage of total amyloid that is vascular type) between the two groups. (D) 
The parenchymal amyloid load was calculated by the subtraction of the vascular amyloid by total amyloid. No 
significant difference in parenchymal amyloid load was observed when comparing vehicle, and apocynin treated 
mice following BCAS surgery. (E) As COL4 is involved in the build-up of amyloid in the vessel walls, the COL4 
density was compared between two groups showing no significant difference. n=9 per group, ns indicates not 
significant. Mann-Whitney U test was performed to compare the difference between two groups. Scale bar=50 
µm. 
 Apocynin did not rescue cognitive dysfunction caused by 3-month of 
BCAS  
Previously, BCAS has been shown to lead to cognitive deficits. To determine whether 
apocynin treatment has any beneficial effects on the impaired cognitive function, a Barnes 
maze task was used to assess visuo-spatial learning and memory. At the outset of analysis, 
velocity was compared between groups to investigate whether the motor function was 
altered by drug treatment and surgery. Both drug treatment and surgery did not have a 
significant effect on the velocity suggesting that there were no changes in motor ability due 
to these two factors (p>0.05, respectively) (Figure 5-9). Escape latency was used to 
evaluate learning ability of experimental animals. There was a significant effect of time (F 
(5,135) =26.0, p<0.001) showing decreased escape latency with increasing training days, and 
surgery (F (1, 27) =11.2, p<0.05) showing that BCAS Vehicle mice took longer to complete the 
task than their sham-operated counterparts. However, no significant effect of apocynin 
treatment could be detected (p>0.05) (Figure 5-9). To investigate the effect of apocynin on 




longer time than by chance (Sham vehicle 58.2 ± 24.4%, BCAS vehicle 50.7 ± 30.3%, Sham 
apocynin 60.5 ± 33.5%) except BCAS apocynin treated mice (39.5 ± 36.4, p>0.05). There 
were no significant effects of apocynin and surgery on the duration spent on the target 





Figure 5-9 Apocynin did not protect spatial learning and memory in the acquisition training and probe trial. 
Mice were assessed using Barnes maze to evaluate the visuo-spatial learning and memory function. Motor ability 



















































































































































No effect of surgery and drug treatment on the motor ability between groups were detected. (B) Spatial learning 
ability was assessed by comparing escape latency. There was a significant effect of time showing decreased 
escape latency over time, and surgery showing BCAS mice spent more prolonged time to complete the task 
escape the maze than their sham-operated counterparts. However, there was no significant effect of apocynin 
treatment can be detected. (C) Long-term memory was determined using a 72 hours probe test. All groups spent 
significantly longer time than by chance except BCAS apocynin treated mice (39.53 ± 36.42, p>0.05); * indicates 
p<0.05 and ns indicates not significant (p>0.05). n=6 sham vehicle, n=6 sham apocynin, n=10 BCAS vehicle, n=8 
BCAS apocynin. There were no significant effects of treatment and BCAS on time spent on the target quadrant. 
 Reversal test 
The Barnes maze task can also be used to probe cognitive flexibility. In the reversal task, 
there were no significant effects of time, surgery, and apocynin treatment on the escape 
latency when comparing between groups, which suggests mice from all groups failed to 
learn the new location and apocynin did not help to improve the visuo-spatial learning when 
the task was enhanced (Figure 5-10). In the 72 hours reversal probe test, mice from all four 
groups spent time lower than chance (Sham vehicle 20.36 ± 15.50, BCAS vehicle 26.79 ± 
16.79, Sham apocynin 20.46 ± 26.14, BCAS apocynin: 15.79 ± 117.46) (Figure 5-10). In 
summary, apocynin did not restore the impaired visuo-spatial learning and memory at 3 





Figure 5-10 Apocynin did not improve spatial learning and memory in the reversal acquisition and probe trial. 
In the reversal task, there were no significant effects of time, surgery, and apocynin treatment on the escape 
latency when comparing between groups, which suggested mice from all groups failed to learn the new 
location and apocynin did not help to improve the visuo-spatial learning when the task was enhanced. In the 72 
hours reversal probe test, mice from all four groups spent time lower than by chance; ns indicates not 
significant (p>0.05). n=6 sham vehicle, n=6 sham apocynin, n=10 BCAS vehicle, n=7 BCAS apocynin. In 

















































































































Several reports have shown that NADPH oxidase is a potential target contributing to the 
pathogenesis of cognitive impairment (Park et al., 2008, Choi et al., 2014, Toyama et al., 
2014, Han et al., 2015). However, these studies demonstrated that whilst apocynin treatment 
had a beneficial effect on the neurovascular function, it was unable to restore the BCAS-
induced degenerative changes and impaired cognitive function.  
 NADPH oxidase inhibitor impacts on the CBF and vascular function 
Prior evidence has suggested NOX2 is the primary source of reactive oxygen species (ROS) 
in several conditions including hypertension, hypercholesterolaemia, diabetes and ageing, 
and so they are significant producers of oxidative stress leading to endothelial dysfunction 
and vascular inflammation (Drummond et al., 2011). Among the NOX isoforms, NOX2 has 
been the most widely studied in cerebral vascular diseases such as focal ischaemia and 
stroke. The use of pharmacological inhibitors of NADPH oxidase (NOX) to defeat oxidative 
stress and its cerebral perfusion deficits has been supported by the previous evidence (Yao 
et al., 2017, Han et al., 2015). When apocynin (1.5 mM) was fed in drinking water for 10-12 
weeks, the responses of a live pial vessel to vascular smooth muscle cell-dependent 
vasodilators and constrictor and endothelial cell-dependent vasodilator were restored in 
aged Tg2576 mice through the mechanism of reducing oxidative stress (Han et al., 2015). 
Since cerebral hypoperfusion has been reported as the earliest alteration before the onset of 
dementia symptoms and shown to have a vital role in the progression of Alzheimer’s 
disease, including the accumulation of amyloid pathology in the cerebral vasculature 
(Salvadores et al., 2017). In the present study, to elucidate the effect of NADPH oxidase 
inhibitor on the vascular function following chronic cerebral hypoperfusion and its 
interactions with amyloid pathology, Tg-SwDI mice subjected to BCAS were given apocynin 
in drinking water for 3 months. The dose of apocynin (1.5 mM) was selected from previous 




Notably, it was shown that there were significantly higher perfusion responses after whisker 
stimulation in apocynin treated BCAS mice compared to vehicle treated group, indicating a 
restored vascular function by apocynin. Our finding is in line with Han and colleagues who 
reported a protective effect of apocynin on cerebral vascular dysfunction in aged Tg2576 
mice (Han et al., 2015). 
In another study on NOX2-null mice, angiotensin II (Ang II) was shown to have a detrimental 
effect on neurovascular coupling, evoking an impaired CBF response to the neural activity 
via a mechanism involving NOX mediated reactive oxygen species (Kazama et al., 2004). 
These effects were blocked after the administration of ROS scavenger Mn(III)tetrakis (4-
benzoic acid) porphyrin and by the NOX inhibitor apocynin. Furthermore, Ang II significantly 
increased mean arterial pressure in the neocortex and the immediate superfusion of ROS 
scavenger restored the neurovascular coupling that was impaired by increased arterial 
pressure.  
Hypertension has been suggested as a major vascular risk factor contributing to the vascular 
dysfunction leading to the development of vascular cognitive impairment. It has also been 
suggested that ROS, the main product of NADPH oxidase, is a crucial factor influencing 
vascular function during hypertension. Our present study has provided additional evidence 
that following BCAS induced cerebral vascular dysfunction, blocking the NADPH oxidase 
can be a potential strategy to restore damaged cerebral vascular responses. These studies 
provide important evidence that oxidative stress may play a common role in vascular 
disease. Notably, targeting the NOX-derived ROS using the pharmacological NOX inhibitor 
apocynin can restore vascular function after damage to the cerebral vascular system. The 
deletion of NOX2 in aged Tg2576 mice has also been linked to rescue cerebrovascular 
dysfunction, which was in line with the effect of NADPH oxidase inhibitor MnTBAP that 
counteracted the neurovascular dysfunction in aged Tg2576 mice (Park et al., 2008).  
However, ROS are potent signalling molecules that are involved in both physiological and 




dependent vasodilators (Niwa et al., 2001a, Rosenblum, 1987) and to disrupt the 
cerebrovascular regulation in conditions including ageing and Alzheimer’s disease (Iadecola, 
2004). In the previous study, CBF was shown to be increased by the exogenous NADPH 
through NADPH oxidase-dependent and independent mechanisms (Park et al., 2004b). 
When CBF was measured using laser Doppler imaging, the CBF increase was attenuated by 
a free radical scavenger MnTBAP but not by the H2O2 scavenger catalase. The CBF 
increase was also attenuated by NOX inhibitor (gp91ds-tat) and by the nitric oxide synthase 
inhibitor Nω-nitro-L-arginine. There was also an attenuated increase in CBF by NADPH in the 
gp91-null mice supporting the involvement of NOX. In the present study, an increase of 
cortical blood flow after feeding 3 months of apocynin was observed, suggesting a long-term 
beneficial effect that inhibition of NADPH oxidase ameliorates CBF following BCAS. Our 
result does not support the data that the NOX inhibitor attenuated CBF after cerebral 
vascular insults.  
 NADPH oxidase inhibitor did not improve cerebrovascular pathology 
Several studies have described NOX isoforms in the cerebral vasculature, suggestive that 
inhibition of the ROS-producing NADPH oxidases activity may benefit cerebrovascular 
disease (Chrissobolis and Faraci, 2008, De Silva and Miller, 2016). Moreover, evidence 
revealed that the expression of NOX in multiple cell types in the brain as the primary sources 
of ROS involved in ischaemic brain injury. It has been reported by Walder et al. that the 
infarct volume was significantly reduced in mice lacking functional type 2 NADPH oxidase 
(NOX2), suggesting NOX2 is a key mediator in the pathogenesis of ischaemia-reperfusion 
injury in the CNS (Walder et al., 1997). NOX2 has been shown accounting for the oxidative 
stress that contributes to the vascular related stroke lesions in focal and global stroke 
models (De Silva et al., 2011, Brait et al., 2010). More importantly, targeting NOX2-derived 
superoxide by apocynin was shown to be neuroprotective that led to reduced infarct volume, 
indicating its promising effect on ischaemic brain injury (Chen et al., 2009, Tang et al., 2008, 




protective role on experimental stroke models. In a study using transient middle cerebral 
artery occlusion (tMCAO) model, apocynin was given intravenously at different doses and 
shown to reduce the volume of infarcts, cerebral haemorrhage and neurological function 
(Tang et al., 2008). Moreover, in another study looking at the effect of apocynin in BCAS 
model after a short-term of surgery, they reported improved outcomes of white matter 
lesions, reduced haemorrhagic lesions as well as astrocytes activation after apocynin 
treatment (Toyama et al., 2014). In the present study, apocynin did not rescue vascular 
related lesions such as microinfarcts and haemorrhages following 3 months of treatment. 
Current data supports the finding that apocynin has a protective effect on the vascular 
function but not the coexisting pathological changes in the microvasculature.  
In previous literature, a dose-dependent effect of apocynin has been indicated. A wide range 
of doses might be associated with different treatment outcomes. Various results suggest that 
the daily administration of apocynin in drinking water at different doses (30, 150 and 300 
mg/kg) in a mouse model of amyotrophic lateral sclerosis (ALS) led to an improved survival 
rate with increasing doses of apocynin (Harraz et al., 2008). By contrast, an apocynin dose 
below 5 mg/kg was considered ineffective to provide a protective effect against 
neurodegenerative changes (Ferreira et al., 2013). It is worth noting that in my study 5 mice 
from the vehicle treated group were culled due to the severe damage or poor recovery after 
the BCAS surgery compared to the apocynin treated group. A higher dose of apocynin at 
3.75 or 5 mg/kg was shown to increase the brain haemorrhage compared to 2.5 mg/kg that 
reduced infarct volume. A narrow dose range has therefore been suggested when acutely 
applying the selective NOX inhibitor apocynin in experimental stroke models (Tang et al., 
2008).  
Apocynin has also been shown to reduce the cerebral infarct volume in pre-treatment and 
absent in post-treatment. In another study, apocynin was applied 0.5 h prior to the ischaemia 
induced by MCAO. As a result, infarct volume, neurological impairment and mortality were 




protective effect. My data provide evidence that long-term administration of apocynin could 
not protect the brain against cerebral infarcts caused by lasting hypoperfusion. Although 
most of the studies support the protective role of apocynin on the brain post-ischaemic 
injuries, it is suspected that in aged animals after MCAO, there is an increased mortality rate 
and failure to restore functional outcome, infarct size, BBB integrity have been observed 
(Jackman et al., 2009). In the current study, there was also an unexpected vascular lesion in 
the sham apocynin treated group suggesting a risk of worsened vascular related 
pathological outcome may happen when treating against ischaemic injuries especially in 
aged animals involving vascular amyloidosis. In summary, apocynin is so far the most 
selective inhibitor for NOX and is thought to effectively block the activation of the enzyme by 
preventing translocation of p47phox. However, the data from the current study suggest 
apocynin was not able to ameliorate vascular related lesions following chronic cerebral 
hypoperfusion in the model expressing microvascular amyloid.  
 NADPH oxidase inhibitor and amyloid accumulation 
Vascular oxidative stress has been shown to play a causal role in vascular amyloid-induced 
cerebrovascular dysfunction, accumulation of microvascular amyloid and related brain 
haemorrhagic injuries (Han et al., 2015). Amyloid accumulation in the cerebral vasculature is 
one of the pathological hallmarks of AD and is recognised as a strong risk factor for cerebral 
ischaemic lesion, intracerebral haemorrhage and cognitive impairment. Recently, Han and 
colleagues provided evidence that NADPH oxidase-derived ROS is the key mediator of 
vascular amyloid-induced cerebral vascular deficits. In their study, apocynin was applied to 
reduce oxidative stress leading to a reduction in vascular amyloid accumulation and related 
vasomotor impairment (Han et al., 2015). Besides, apocynin also reduced ApoE levels, with 
no significant effect on the levels of Aβ40 and Aβ42 nor the Aβ40/Aβ42 ratios in the cerebral 




The exact role of oxidative stress in the development of Aβ accumulation in the parenchyma 
and cerebral vasculature is not fully understood. In my study, the combination of BCAS with 
Tg-SwDI mice allowed me to investigate the effect of a NOX inhibitor on the microvascular 
amyloid load in response to chronic cerebral hypoperfusion. The data suggests no significant 
effect of apocynin on the amyloid load in the microvasculature, parenchyma and total 
amyloid in the cerebral cortex. This is in line with past literature that apocynin treatment was 
not sufficient to alter the amyloid load in aged Tg2576 mice (Park et al., 2008). Mice 
overexpressing the Swedish mutation of the APP (Tg2576) crossed with mice deficient in the 
NOX2 subtype of NADPH oxidase have been studied to determine the role of NOX2 in the 
formation of vascular amyloid (Park et al., 2008). Park et al. showed the deletion of NOX2 in 
aged Tg2576 mice did not develop oxidative stress, neurovascular dysfunction and cognitive 
deficits, which were independent of brain plaque load and Aβ levels. Given the fact that 
amyloid levels are determined by the production and clearance of Aβ in the brain, although 
the apocynin improved vascular function and reduced perfusion, the effect of apocynin 
treatment might not be enough to reverse the damage caused by a combined effect of BCAS 
and amyloid toxicity. In the current study, the level amyloid species was not investigated to 
test the effect of apocynin on the Aβ peptide pools that have been reported to be affected in 
Tg-SwDI model following BCAS (Salvadores et al., 2017).  
Another consideration regarding the ineffectiveness of apocynin against amyloid 
accumulation is its role in the glymphatic pathway. In the previous study (Chapter 3 and 4), 
an impairment in glymphatic function was observed following BCAS, and this was postulated 
to accelerate the Aβ accumulation in the cerebral microvasculature. It is still unclear whether 
NOX playing a role in the glymphatic pathway, since it is a common target associated with 




 NADPH oxidase inhibitor impacts on the cognitive function 
Oxidative stress is one of the factors contributing to the pathogenesis of dementia, such as 
AD and VaD. Moreover, administration of antioxidants has been reported to ameliorate 
cognitive impairment in animal models of vascular cognitive impairment (VCI). Histidine, a 
precursor of histamine with properties in antioxidant, anti-apoptosis, and against 
excitotoxicity, shows neuroprotective effects that alleviate cognitive impairment caused by 
chronic cerebral hypoperfusion (Song et al., 2018). Similarly, polyphenol antioxidants have 
been reported to reduce cognitive decline and superoxide levels following chronic cerebral 
hypoperfusion (Xu et al., 2010). A recent study focused more specifically on the inhibition of 
NOX2 in animal models of VCI has shown neuroprotective effects of apocynin against motor 
and spatial memory deficits following transient global cerebral ischaemia (Shen et al., 2011). 
Other pharmaceutical methods targeting the NOX2’s subunit Rac1-GTPase also reduces 
oxidative stress and reference memory deficit following global cerebral ischaemia (Zhang et 
al., 2009) (Raz et al., 2010). Furthermore, in another investigation on the CCH induced by 
bilateral occlusion of the common carotid arteries (2VO), apocynin, as well as adeno-
associated virus (AAV) mediated NOX1 knockdown, reduced memory impairment, 
superoxide generation and hippocampal neuronal death (Choi et al., 2014). In the present 
study, apocynin did not show a beneficial effect in reducing the cognitive impairment induced 
by BCAS. In the acquisition training tests, regardless of apocynin treatment, BCAS mice took 
relatively longer time to escape compared to the sham groups, indicating a more powerful 
effect of BCAS over the apocynin on the spatial learning ability in the Tg-SwDI mice. This is 
further evident even after the difficulty is increased in the reversal training tests. In the 72 h 
probe tests that evaluate the long-term memory function, the apocynin treated BCAS group 
shows a lower chance staying in the target quadrant compared to the vehicle treated group 
with both sham groups performed nicely above the chance. Furthermore, the BCAS mice 




in the target quadrant (3/8 in 72 h and 2/8 in reversal 72 h probe test) suggesting no 
beneficial effect of apocynin on the long-term memory after a period of hypoperfusion effect.  
 Conclusions 
Vascular cognitive impairment (VCI) refers to the full spectrum of disorders associated with 
cerebrovascular disease (CVD). Vascular dementia is a severe form of VCI and is the 
second most prevalent cause of age-related cognitive impairment and dementia after 
Alzheimer’s disease (AD). There is mounting evidence that management of vascular risk 
factors may assist in preventing dementia including AD (Dichgans and Leys, 2017). Recent 
advances have suggested the role of oxidative stress in the pathogenesis of CVD and AD 
that shows a promising effect by targeting NADPH oxidase to reduce the pathological 
changes leading to cognitive deficits. Therefore, in the present study, we focused on an AD 
model that expresses an average level of amyloid in the cerebral vasculature and combine 
the long-term cerebral hypoperfusion with building a more clinically relevant model and 
tested a range of effects following antioxidant treatment. This set of data suggested that the 
NOX inhibitor apocynin provided powerful effects to restore cortical perfusion as well as 
vascular function. However, apocynin was not able to affect the amyloid load and reduce 
ultimately improve cognitive performance. These data have provided novel evidence in a 
well-established preclinical VCI model and challenging the view that targeting NADPH 
oxidases is an effective therapeutic strategy to treat VCI.  
Despite the fact that the amyloid accumulation was investigated in the current study, the 
exact changes in the soluble and insoluble species of Aβ is still unclear. Since Tg-SwDI mice 
do not express high-level oligomeric amyloid, a further study looking at the biochemical 
changes following the treatment of apocynin in this model will provide useful information. 
Furthermore, due to the lack of available inhibitor that targets the specific NOX isoforms. The 
current study was unable to selectively block the NOX2 enzyme among others. Future work 




overexpressing model) or developing more selective pharmacological compounds may be 





Chapter 6. General discussion  
The findings in this thesis present novel evidence of how carotid stenosis damages the 
cerebral microcirculation and structure, contributing to the pathogenesis of cognitive 
impairment. Specifically, long-term bilateral common carotid stenosis causes chronic 
cerebral hypoperfusion as a primary outcome and impaired glymphatic function, which is 
likely to contribute to the accumulation of Aβ in the microvasculature. Additionally, carotid 
stenosis causes sustained cerebral hypoperfusion and leads to secondary outcomes 
including impaired neurovascular coupling, neurodegenerative changes and cognitive 
deficits. However, despite evidence supporting a basis for targeting NADPH oxidase, there 
was an only modest beneficial effect of the NOX inhibitor on neurovascular function.  
Collectively, this thesis provides evidence that following the carotid stenosis, while reducing 
cerebral perfusion, it may also affect the glymphatic drainage pathway, leading to cognitive 
impairment. These new data add credence to a growing body of human studies that have 
challenged the theory that hypoperfusion is the major contributor leading to VCI, and instead 
alternate or additional mechanisms need to be considered (Shi et al., 2018, Aribisala et al., 
2014a, Wardlaw et al., 2017, Alhusaini et al., 2018). The treatment with non-selective NOX 
inhibitor successfully restored blood perfusion and vascular function with no ultimate 
improvement in cognitive function, suggesting a limited role in targeting NOX to restore the 
full pathological processes in VCI. Thus, further studies using more specific method targeting 
post-carotid stenosis events will help to understand the proposed mechanisms and provide a 
therapeutic strategy.  
 Limitations 
The studies are limited by the lack of CAA models that is ethically available for studying a 
long-term effect of carotid stenosis on Aβ deposition. In my thesis, I have used a 
heterozygous Tg-SwDI mouse model that predominantly expresses microvascular Aβ. The 




cognitive impairment. This is not in agreement with the previous study that conducted 
behavioural tests on homozygous Tg-SwDI mice (Xu et al., 2007). A consideration of using 
heterozygous Tg-SwDI model was due to a high mortality risk of performing BCAS surgery 
on homozygous Tg-SwDI mice and it was not practical to observe combined BCAS and Aβ 
effects over a period of three months. Further, accumulation of the peptide Aβ and tau 
protein in brains are thought to both initiates the pathological process of AD. Being limited to 
AD model in this thesis, it was not possible to assess the impact of BCAS on the 
accumulation of tau protein in the brains. Further studies using different AD models need to 
be carried out in order to validate how carotid stenosis influences other forms of Aβ and tau 
protein and whether there would be interactions in the pathophysiological processes leading 
to cognitive impairment. 
Another limitation of my thesis is that the glymphatic drainage pathway was primarily 
investigated as it was hypothesized to accelerate the Aβ accumulation in the cerebral 
microvasculature. However, other clearance mechanisms might be also involved in the 
accumulation of Aβ and affected by BCAS. The role of BBB transport is important for 
maintaining the homeostasis of Aβ in the brain. Evidence also suggests that vascular-
mediated pathophysiology can lead to BBB dysfunction that is associated with the 
accumulation of molecules such as Aβ within the brain parenchyma (Zlokovic, 2011). 
Whether BCAS has any impact on receptors mediating Aβ across BBB, such as the receptor 
for advanced glycation end products (RAGE) and low-density lipoprotein receptor-related 
protein 1 (LRP1), is largely unknown. This would be a fruitful area for further work studying 
BBB changes following BCAS and its contribution to the formation of CAA. More information 
on these vascular-mediated clearance pathways (i.g. BBB and glymphatic pathway) would 




 Future directions 
Future investigations on the role of the glymphatic system in the pathogenesis of vascular 
cognitive impairment and dementia is an encouraging field. As described previously, the 
glymphatic system is a drainage pathway depending on the cerebral vascular network and 
its cellular components in the brain. In cerebral vascular diseases, it is reasonable to 
postulate that the homeostasis and the integrity of the cerebral vascular system are 
disrupted, and therefore impaired glymphatic system fails to remove the waste out of the 
brain, which may lead to a vicious circle. Given the fact that the accumulation of Aβ in the 
brain is a common finding in elderly people with VaD and AD, the present studies highlighted 
the link between vascular disturbances and the Aβ accumulation in the vasculature. 
Specifically, carotid stenosis is the initiator that influences brain haemodynamics in the blood 
vessels as well as the glymphatic pathway in the perivascular regions. Therefore, 
longitudinal studies of the population with carotid stenosis would help to detect the 
development or changes in the patients exposed to such risk factors across the life span. 
The glymphatic system has been proposed to have three functional stages: the CSF 
glymphatic influx, CSF and interstitial fluid (ISF) exchange and the final efflux stage. The 
current studies are focused on the CSF glymphatic influx, which is the process most relevant 
to the cerebral vascular system and the CAA model. Future work is needed to confirm 
whether altered glymphatic function in response to carotid stenosis/cerebral hypoperfusion 
also applies in the patients diagnosed with AD or VaD. The glymphatic system has been 
visualised in animal studies using a variety of approaches including ex vivo microscopy and 
in vivo imaging such as two-photon microscopy and MRI. However, visualising glymphatic 
system in human is an emerging field, and progress has been made to achieve a non-
invasive or minimally invasive method. Novel techniques such as contrast-enhanced MR 
imaging may provide in vivo information of access to all brain subregions. By injecting 




dimension and real-time manner. It also enables the quantification of glymphatic function in 
both experiments and clinical settings (Iliff et al., 2013a, Ringstad et al., 2018).  
The outflow routes of CSF in neurological disorders are still poorly documented. However, 
recent studies have reported a variety of efflux pathways in rodents. These outflow sites 
include perineural sheaths surrounding cranial and spinal nerves (Ma et al., 2017b, Johnston 
et al., 2004a), dura lymphatic vessels (Louveau et al., 2015), skull (Cai et al., 2019, Ahn et 
al., 2019) and arachnoid granulations (Pollay, 2010). Whether carotid stenosis affects these 
post-glymphatic outflow pathway is unclear, and its interrelation with cerebral hypoperfusion 
and soluble Aβ require further investigation. 
Besides, in response to cerebral hypoperfusion, Aβ accumulation is associated with 
increased NOX2 that contributes to cerebral vascular dysfunction and the development of 
vascular related lesions (Salvadores et al., 2017). In the current studies, apocynin treatment 
did not improve the vascular pathology and the cognitive function but demonstrated strong 
effect ameliorating vascular function. Therefore, future studies using NOX2 specific inhibitors 
that can block the individual isoforms within the NOX2 complex is urgently demanded. Novel 
NOX2 specific inhibitors CPP11G and CPP11H demonstrated beneficial effects ameliorating 
TNFα-induced ROS and neuroinflammation and shown to improve vascular function and 
hind-limb blood flow (Li et al., 2019). These studies support the therapeutic value of NOX2 
inhibition in periphery inflammatory disease. However, more evidence is still needed to 
confirm whether these compounds are suitable for the use in the scenario of neurological 
disorders (e.g. BBB permeability) and safety-related issues. The observed improvement in 
blood perfusion and neurovascular coupling indicates apocynin still has beneficial effects on 
the neuro-glial-vascular network. Further studies regarding its role on CSF movement and 
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Pial artery pulsatility is reduced post-BCAS. 
(A) Two-photon microscopy was used to assess vessel pulsation in sham and post-BCAS WT mice. Four 
categories of blood vessels were investigated: 1. Pial arteries; 2. Penetrating arteries; 3. Ascending veins; 
4. Pial veins. (B) Significantly decreased pulsatility was found in pial arteries but not in other vessels in the 




not in other vessels in the mice post-BCAS. Data are presented as mean ± SEM, n=6-7 per group. Data 
provided by Dr Juraj Koudelka and Joshua Beverley. 
